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ABSTRACT 
(iv) 
The transcellular route that bile acids follow during 
the hepatic phase of the enterohepatic circulation has 
been a matter of controversy for some time. Among the 
modes of intracellular transport proposed have been free 
diffusion and partitioning within cellular organelles, 
vesicular transport, and association with cytosolic 
binding proteins. 
It is known that several groups of bile acid -binding 
proteins exist in rat hepatic cytosol; these include Z 
protein(s) and the glutathione S- transferases (Y 
proteins). A new group, the Y proteins, has been disco- 
vered recently and a purification scheme reported for two 
bile acid -binding proteins, which have been partially 
characterised. 
The aims of this study have been to investigate bile 
acid -binding proteins from rat hepatic cytosol, with par- 
ticular reference to the Y proteins. The technique of 
photoaffinity labelling has been employed as a method of 
assessing the bile acid -binding potential of these pro- 
teins. The photoaffinity label used in these experiments 
has been [125I]- 3ßazidocholylhistamine, a photolabile 
derivative of cholic acid, radioiodinated to a specific 
radioactivity of 1900 Ci /mmol. This labelled molecule 
was shown to retain the properties of the parent bile acid 
with regard to hepatic transport. 
(y) 
In photoaffinity labelling studies with cytosolic pro- 
teins from rat liver, previously undescribed bile acid - 
binding proteins have been identified in the Y' fraction. 
These proteins were purified using gel filtration, ion - 
exchange, chromatofocusing and hydroxyapatite chroma- 
tography. The resulting homogeneous proteins fell into 
two categories: - 
1) Proteins (designated binders 5B, 6E and 7F) consisting 
of two identical subunits each having an approximate mole- 
cular mass of 15 000 - 19 000 Da. These showed a high 
specific incorporation of radioactivity after photoaf- 
finity labelling, and were present at low concentrations. 
2) Proteins (designated binders 5C, 5D and 8c) of molecu- 
lar mass approximately 33 000 - 36 000 Da. These showed 
a lower specific incorporation of radioactivity after pho- 
toaffinity labelling than those in group 1, but had a 
higher total incorporation of [1251] owing to their higher 
concentration in the liver. 
These proteins were analysed by peptide "mapping" on 
reverse -phase high performance liquid chromatography to 
determine their genetic relationships. In addition, 
along with several glutathione S- transferases, they were 
photoaffinity labelled and peptide "mapped" to determine 
the position of the radioactive label, and thus the bile 
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STRUCTURE AND PHYSIOLOGY OF BILE ACIDS 
Bile acid structure 
The molecular structure of bile acids is based on 
perhydrocyclopentanophenanthrene, a nucleus of four rings, 
labelled A to D. Figure 1.1 shows the prototype bile 
acid, cholanic acid. The number and arrangement of 
hydroxyl groups around this basic molecule varies with 
individual bile acids - for example, cholic acid has 
hydroxyl groups at positions 3, 7 and 12, chenodeoxycholic 
acid at 3 and 7, deoxycholic acid at 3 and 12, and 
lithocholic acid a single hydroxyl at position 3. The 
molecule is not flat; rather it is L- shaped, bent at the 
A -B ring junction, with the hydroxyl groups and carboxyl 
sidechain oriented to one side of the molecule (0c-orient- 
ation) and the methyl groups to the other side (j3- orient- 
ation). This arrangement has the effect of dividing the 
molecule - one side is polar (hydroxyl groups and carboxyl 
sidechain), while the other is non -polar or hydrophobic 
(ring nucleus and methyl groups). A perspective formula 
of deoxycholic acid is also shown in Figure 1.1. 
HO' 
(a) 
TRI - HYDROXY 
Cho lic acid 







DI - HYDRCXY 
Chenocceoxycholic acid 
(3a, 7oc - dihydroxy 
cholaniC acid ) 










cholaniC acid ) 
FIGURE 1.1 Bile acid structure 
(a) cholanic acid, with C atoms numbered; 
(b) primary and secondary bile acids; 
(c) perspective formula of deoxycholic acid; 
4. 
Bile acid function 
Bile acids have three physiological roles: - 
1) Emulsification of fat 
2) Stimulation of bile flow 
3) Excretion of excess cholesterol 
1) Bile acids emulsify dietary lipid in the intestine, 
thereby aiding digestion and subsequent absorption 
(Hofmann & Borgstrom, 1962; Hofmann, 1963, 1976). That 
they are able to do this is due to their amphipathic pro- 
perties - that is, in common with other detergents, one 
part of the molecule is non -polar and water insoluble, and 
the other is polar and soluble. When the concentration 
of bile acids reaches a certain level, the critical 
micellár concentration (0.75 - 2 mM), micelles are formed; 
these are polymolecular aggregates of bile acids about 
10 nm in diameter, discoid in shape and comprising 4 -20 
bile acid molecules (Holt, 1972). Each molecule is 
oriented with the hydrophobic areas towards the centre of 
the aggregrate and the polar groups on the outside 
directed towards the aqueous phase (Hofmann & Small, 1967; 
Carey & Small, 1972). 
Most dietary lipid is in the form of triglyceride, the 
digestion of which is catalysed by pancreatic lipase, 
acting on the fat droplets in the intestine. Bile acids 
assist by emulsifying these droplets, thereby increasing 
the effective surface area available on which the enzyme 
acts. The triglycerides are broken down into mono- 
5. 
glycerides and fatty acids, which are then solubilized by 
bile acids in the form of mixed micelles (Small, 1970). 
In such micelles, where the digestion products are inter- 
mingled with the bile acid molecules, the monoglycerides 
and fatty acids are delivered to the intestinal mucosal 
surface where they are absorbed, at a rate apparently 
directly related to their concentration in micellar solu- 
tion (Simmonds, 1974). The fat- soluble vitamins, which 
are very poorly soluble in water, are also handled in the 
same manner, and biliary cholesterol, too, is solubilized 
in this way (Admirand & Small, 1968; Neiderhiser & Roth, 
1968; Dam & Hegardt, 1971; Ockner & Isselbacher, 1974). 
2) Bile acids are also believed to have choleretic acti- 
vity. This idea is based on observations that the active 
transport of any compound, including bile salts, into 
bile, would result in water and other solutes following 
due to osmotic effects; thus bile flow would be stimulated 
(Sperber, 1963, 1965). The portion of canalicular bile 
flow that results from bile acid excretion is termed bile 
acid -dependent flow (Boyer & Klatskin, 1970; Wheeler, 
1972; Boyer & Bloomer, 1974). The relationship between 
these two processes was believed to be linear, but recent 
work has shown a curvilinear variation; this is thought to 
be due to bile acids forming micelles at higher con- 
centrations and thus being less osmotically potent 
(Balabaud et al., 1977; Baker et al., 1979; Blitzer & 
Boyer, 1982). 
6. 
3) Bile acids also provide a means whereby the body may 
excrete excess cholesterol; elevated serum cholesterol 
levels are associated with arterial disease (Elliot & 
Hyde, 1971). Indeed, bile acid synthesis is believed to 
play an important role in cholesterol homeostasis 
(Danielsson & Sjovall, 1975). Cholesterol is both pre- 
sent in the diet and synthesized endogenously. Bile 
acids are synthesized from cholesterol in the liver (for 
details see p.8 -9) and secreted into bile with cholesterol, 
where they form mixed micelles. Ultimately, the cho- 
lesterol is excreted in the faeces whilst the majority of 
the bile acids are recycled to the liver to further 
mediate cholesterol excretion. Thus, bile acids are not 
only quantitatively the major products of cholesterol 
catabolism, but also function in solubilizing and helping 
to eliminate their own precursor from the body (Myant & 
Mitropoulis, 1977). 
Bile acids may also regulate their own synthesis, and 
that of cholesterol, through negative feedback inhibition 
(Myant & Mitropoulis, 1977). The rate of bile acid 
synthesis is apparently controlled by the size, com- 
position and circulation rate of the bile acid pool 
returning to the liver (Shefer, 1969, 1970; Danielsson, 
1973). In experiments where the enterohepatic cir- 
culation (for details, see p.15) is interrupted either 
by ileal resection, or by oral administration of the bile 
acid -binding resin cholestyramine, or by external 
7 
diversion of the bile, the rate of bile acid synthesis is 
increased, as indeed is the rate of cholesterol synthesis 
(Shefer et al., 1968, 1972; Boyd et al., 1969; Back et 
al., 1969; Grundy, 1977). Conversely, the oral admi- 
nistration of bile acid leads to a decrease in the rate of 
synthesis (Einarsson et al., 1973; Schoenfield et al., 
1973; Shefer et al., 1973a,b; Danielsson & Johanssen, 
1974). Although the site of action of bile acids in the 
regulation of both their own synthesis and of cholesterol 
is unclear, there is evidence to suggest that the hepatic 
bile acid concentration may control the activities of two 
enzymes, cholesterol lot hydroxylase and 3- hydroxy -3- methyl 
glutaryl CoA (HMG CoA) reductase (Mosbach & Salen, 1974). 
The former catalyses the first step in bile acid synthe- 
sis, and is rate -limiting in both man and the rat, while 
the latter is known to be rate -limiting for cholesterol 
synthesis (Einarsson et al., 1973; Botham et al., 1979). 
However, more recent work with cultured rat hepatocytes 
has shown that bile acids have no direct effect on bile 
acid synthesis by a feedback mechanism (Botham et al., 
1980, 1981). In addition, Davis et al. (1983) speculate 
that a factor derived from the intestine, which would be 
absent in culture, may initiate negative feedback control. 
The observation that there appears to be a concerted regu- 
lation of 70C- hydroxylase and HMG CoA reductase may be 
explained by cholesterol availability as a function of HMG 
CoA reductase regulating bile acid synthesis (Cronholm & 
8. 
Sjovall, 1967; Danielsson, 1972; Myant & Mitropoulis, 
1977; Davis et al., 1983b). Alternatively, a common fac- 
tor may regulate the synthesis of both bile acids and cho- 
lesterol (Davis et al., 1983a). 
Bile acid synthesis 
The primary bile acids, cholic acid and chenodeoxycho- 
lic acid, are synthesized only in the liver from cho- 
lesterol (Elliot & Hyde, 1971; Boyd & Percy -Robb, 1971; 
Danielsson, 1973; Bjorkham & Danielsson, 1974). Studies 
in vivo and in vitro have indicated that the synthetic 
pathways involved are the same or similar in man and the 
rat (Daniellson & Sjovall, 1975). For both bile acids, 
the first step is the introduction of a hydroxyl group 
into the 70c.position by the microsomal enzyme 7oC. 
-hydroxylase, requiring NADPH, molecular oxygen and 
cytochrome P450 for activity (Danielsson & Sjovall, 1973; 
Shefer et al., 1975). It is currently believed that this 
step is rate -limiting for bile acid synthesis (Myant & 
Mitropoulis, 1977). The 3p- hydroxy group of 70:.- hydroxy- 
cholesterol is oxidized to a 3 -keto group, and the A 5 
double bond is isomerised to the L\ 4 position by other 
microsomal enzymes to give 70C- hydroxy -4- cholesten -3 -one 
(Mendelsohn et al., 1966; Bjorkhem & Daniellson, 1967). 
This compound represents a branch point in the synthesis 
of the two principal primary bile acids. Within the 
endoplasmic reticulum, a hydroxyl group is inserted at the 
120(position by microsomal 120- hydroxylase and the 
9. 
synthesis is committed to cholic acid (Danielsson & 
Einarsson, 1966; Bjorkhem & Danielsson, 1967; Percy -Robb, 
1975). Alternatively 70C hydroxy- 4- cholesten -3 -one is 
passed into the cytosol where it is converted ultimately 
into chenodeoxycholic acid (Percy -Robb, 1975). With both 
reactions, modifications to the ring structure occur 
first, followed by alterations to the sidechain. Final 
conversion occurs within the mitochondria, involving 
hydroxylation at C -26 (Matern & Gerok, 1979). 
An alternative pathway apparently exists in 
mitochondria, which is initiated by hydroxylation of C -26 
in the cholesterol sidechain (Danielsson, 1973; Taniguchi, 
1973; Danielsson & Sjovall, 1975). Both cholic acid and 
chenodeoxycholic acid can be synthesized in this manner 
(Anderson et al., 1972). However, difficulty with sub- 
sequent insertion of the 12QC- hydroxyl group after 
sidechain hydroxylation means that the predominant product 
is chenodeoxycholic acid (Hansen, 1971). Small amounts 
of cholesterol may also be converted through this pathway 
into lithocholic acid, which may have toxic properties 
(Javitt, 1975), (see p.14). 
Bile acid metabolism 
Following their synthesis from cholesterol, bile acids 
are metabolized, both in the liver before being excreted 
into bile, and also in the intestine following excretion. 
The following mechanisms are involved in the metabolism of 
bile acids:- 
10. 
1) Conjugation - with either glycine or taurine; 
2) Glucuronidation; 
3) Sulphation; 
4) Dehydroxylation and deconjugation. 
1) Conjugation 
Glycine and taurine are the two major amino acids 
which are linked to the carboxyl group of the bile acid 
sidechain, both in humans, where the ratio of glycine to 
taurine conjugates is 3:1 under normal conditions, and 
also in the rat where the ratio is 20 :1 (Sjovall, 1960). 
In both cases the ratios can be altered by nutritional 
factors or disease states (Garbutt & Kennedy, 1972). The 
conjugation reaction takes place in two steps (Elliot, 
1955; Bremner, 1956). The first is the ATP -dependent 
formation of a CoA -bile acid derivative (Polokoff & Bell, 
1977; Killenberg, 1978; Vessey & Zakim, 1977). This 
derivative is then reacted with glycine or taurine (Vessey 
et al., 1977). Whereas the rat possesses a single enzyme 
for the latter reaction, in humans there may be more than 
one bile acid -CoA:amino acid N -acyl transferase involved 
in the conjugation (Abberger et al., 1978; Killenberg & 
Jordan, 1978). Conjugation results in the pKa of bile 
acids being lowered; with glycine, the reduction is from 
6 to 4 whilst with taurine, the pKa is reduced from 
6 to 2 (Scharschmidt, 1q83). As a result, 
at the pH of the intestinal lumen (approximately 6.5), the 
11. 
conjugated bile acids are largely ionised and are more 
easily absorbed from the intestine (Schiff et al., 1972). 
In addition, the conjugated bile acids, being more polar, 
are excreted into bile more rapidly than their uncon- 
jugated counterparts (0'Maille et al., 1965). Moreover, 
conjugated bile acids are apparently less toxic to the 
intestinal mucosa (Pope et al., 1966; Teem & Phillips, 
1972). 
2) Sulphation 
The 3c(- hydroxyl group of the bile acid molecule can 
react with sulphuric acid and form a sulphate ester 
(Palmer, 1967). An enzyme which catalyses bile acid - 
sulphate formation has been found in human and rat liver, 
and also in rat kidney (Loof & Wengle, 1978; Chen et al., 
1977). This enzyme utilizes 3'phosphoadenosine 
5'- phosphosulphate (PAPS) as a cofactor and sulphate donor 
in the sulphation reaction (Chen et al., 1977). 
The sulphate esters are of particular importance in 
the metabolism of the monohydroxy bile acids such as 
lithocholic acid. In man, this bile acid is preferen- 
tially sulphated, and it appears that this reaction redu- 
ces the intestinal absorption of such derivatives of 
glyco- and taurolithocholic acids, thus protecting the 




A liver microsomal enzyme, UDP- glucuronyl trans - 
ferase, will catalyse the transfer of a glucuronyl moiety 
from glucuronic acid to the 3ß- position of the bile acid 
molecule. Such bile acid -glucuronides have recently been 
found in patients with cholestasis; 7 -16% of the bile 
acids in the urine were glucuronidated (Back et al., 1974; 
Back, 1975; Frohling & Stiehl, 1976; Frohling et al., 
1977). It is speculated that although glucuronidation of 
bile acids occurs quantitatively to a lesser extent than 
suiphation, the former may also be involved in the elimi- 
nation of toxic monohydroxy bile acids by forming highly 
polar metabolites which are more water -soluble (Javitt & 
Emerman, 1968; Back, 1976; Alme et al., 1977). 
4) Dehydroxylation and deconjugation 
Breakdown of bile salts by bacterial action occurs 
mainly in the large intestine, but also to a smaller 
extent in the small intestine (Gustafssen & Norman, 1962; 
Aries & Hill, 1970; Tabaqchali, 1970). Bile salts are 
broken down by obligate anaerobes; a total bacterial count 
of over 104/mm3 is apparently required for bile salt 
breakdown to be significant (Drasar & Shiner, 1969; 
Gorbach & Tabaqchali, 1969). The low amount of bacteria 
present in the small intestine under normal physiological 
circumstances means that little bile salt breakdown 
occurs, except in the terminal part of the ileum, proximal 
to the ileocaecal sphincter, where anaerobes are found in 
13. 
large numbers (Gorbach et al., 1967). In normal human 
subjects, only this area of the small intestine is found 
to have bacterially altered bile acids. However, as the 
rat eats its own faeces, it normally possesses a more 
extensive bacterial colonisation of the small gut. 
The major changes brought about by intestinal bac- 
terial action on bile salts are deconjugation and 70.- 
-dehydroxylation (Lewis & Gorbach, 1972). However, oxi- 
dation, reduction and epimerisation can also occur (Matern 
& Gerok, 1979). Liberation of the free bile acid from 
the parent bile salt by deconjugation is effected by a 
cholanyl glycine hydrolase, produced by several strains of 
bacteria including Streptococcus faecalis and Clostridium 
perfringens (Aries & Hill, 1970; Lewis & Gorbach, 1972). 
This enzyme will also deconjugate other bile salts (Drasar 
et al., 1966; Dickenson et al., 1971). 
The two primary bile acids, cholic acid and cheno- 
deoxycholic acid, can be dehydroxylated at the 7 position 
to form the secondary bile acids, deoxycholic acid and 
lithocholic acid respectively (Lewis & Gorbach, 1972). 
Although deconjugation normally occurs first, 70c- 
-dehydroxylation can take place without preceding decon- 
jugation (Norman, 1970; Hepner et al., 1972a,ó). It is 
believed that deconjugation takes place in the terminal 
ileum, and both deconjugation and dehydroxylation in the 
large intestine (Matern & Gerok, 1979). 
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The toxic effects of lithocholic acid include altera- 
tion of liver structure in a number of mammalian species 
following oral administration of the acid itself or the 
glycine or taurine conjugates of lithocholic acid. 
Intra- muscular injection of lithocholic acid in man will 
produce pyrogenic reactions (Percy -Robb, 1975). The 
lysis of human erythrocytes in vivo has been demonstrated 
(Palmer, 1964). 
In man, the major bile acids are cholic, cheno- 
deoxycholic and deoxycholic with very little of the other 
secondary bile acid, lithocholic, owing to its insolubi- 
lity even when conjugated. In the rat, the principal 
bile acid is cholic acid, with chenodeoxycholic and urso- 
deoxycholic (30c,713- dihydroxy -5/3- cholanic) acid also 
occurring. 
Bile acid or bile salt 
These terms are commonly used 
interchangeably. Although the state of ionisation of the 
molecule is the strict criterion, such that a bile acid is 
unionised and a bile salt ionised, further confusion ari- 
ses from reference in the literature to free, unconjugated 
molecules as bile acids, and bile salts as conjugated 
molecules. It is the latter definition which will be 
on most occasions 
usedb,in this thesis. It should be remembered that at 
physiological pH, most conjugated and unconjugated bile 
acids exist as sodium salts. 
15. 
bfLE ACID- BINDING PROTEINS 
The hri enterohepatic circulation of bile acids 
The enterohepatic circulation (Figure 1.2) is respon- 
sible for the recycling of bile acids between the liver 
and intestine. In man, after synthesis and conjugation 
in the liver, bile salts are secreted into bile and pass 
down the bile duct to the gall bladder, where the bile is 
concentrated by a factor of 5 -10 with respect to organic 
components (Davenport, 1966). This concentration is 
achieved by removal of water and electrolytes, mainly by a 
coupled active absorption of sodium and chloride ions 
(Dietschy, 1966). In a cholecystokinin -mediated 
response to eating, the gallbladder contracts and 
discharges its contents into the third part of the duode- 
num (Meyer & Grossman, 1972). The rat does not possess a 
gall bladder. 
Intestinal events 
In the small intestine, bile salts aid the digestion 
and subsequent absorption of fat and its digestive pro- 
ducts (see p.4-5). Some of the bile salts will be decon- 
jugated and /or dehydroxylated by bacterial action; 
together bile salts and bile acids are reabsorbed from the 
intestine, mainly at the terminal ileum, and also from the 










FIGURE 1.2 The enterohepatic circulation 
17. 
Active intestinal transport 
Some 70 -85 per cent of bile acids are reabsorbed at 
the terminal ileum (Tyor, 1971; Hepner et al., 1972b). 
The mechanism involved is concentrative and can be blocked 
by metabolic inhibitors and hypoxia (Lack & Weiner, 1961; 
Holt, 1964; Glasser, 1965; Gallagher et al., 1976). In 
addition, the uptake exhibits saturation, is sodium - 
dependent and competition between bile acids can be 
demonstrated (Holt, 1964; Schiff et al., 1972; Krag & 
Phillips, 1974; Gallagher et al., 1976). It is believed 
that the active site of the ileal transport system con- 
tains a positive charge for electrostatic interaction with 
anionic bile salts and a negative charge associated with 
sodium ions (Gallagher et al., 1976; Bundy et al., 1977). 
The arrangement of these charges is such that both the 
bile salt and sodium ion occupy the membrane transport 
site simultaneously in a co- operative manner. 
Photoaffinity labelling experiments (see p.77) with 
brush -border membrane vesicles from the jejunum and ileum 
of the rat have revealed several bile salt- binding poly- 
peptides, which are listed in Table 1.1 (Kramer et al., 
1983). These polypeptides, speculated to be involved in 
the transport of bile salts out of the intestine, are 
distinct from those found in the hepatocyte using the same 
technique (see Table 1.2). 
18. 
Area of small Molecular masses of bile salt -bindin 
intestine polypeptides Da) 
Ileum 125 000; 99 000; 83 000; 67 000; 
43 000 
Jejunum 125 000; 94 000; 83 000; 67 000; 
43 000 
Table 1.1 Bile salt- binding polypeptides from rat 
small intestine revealed by photoaffinity 
labelling. 
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Together, these results are consistent with the 
existence, in the terminal ileal brush -border mucosa of 
the rat, of a carrier -mediated, energy -linked sodium -bile 
acid co- transport system. 
Passive intestinal absorption 
Passive absorption may occur at any point in the small 
or large intestine, relying on ionic or non -ionic dif- 
fusion (Dietschy et al., 1966; Schiff, 1972; Wilson & 
Dietschy, 1972). Intraluminal pH, the dissociation 
constants (pKa) of individual bile acids, and lipid solu- 
bilities of ionic and non -ionic species are all factors 
that determine which of the two diffusion processes pre- 
vail. At physiological pH (5.0 -7.0), more unconjugated 
bile acids will be non -ionized (pKa 5.5 -6.5) than glycine - 
conjugated bile acids (pKa 3.8 -4.8), whereas taurine - 
conjugated bile acids (pKa 1.85 -1.95) will be almost 
entirely in the ionized form (Small, 1971). Thus, free 
bile acids are absorbed more rapidly from extra -ileal 
sites than glycine conjugates, and taurine conjugates are 
almost totally dependent on the active transport system in 
the ileum (Hislop et al., 1967; Dowling et al., 1972). 
Almost total reabsorption of bile acids from the intestine 
is achieved by the active and passive transport systems 
together. However, small amounts of bile acids are not 
reabsorbed, being finally excreted in the faeces after 
bacterial transformation and yielding as many as 30 dif- 
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ferent bile acids (Eneroth et al., 1966a,ó). Bile acids, 
particularly dihydroxy forms, inhibit water reabsorption 
by the colon, and thus under conditions of bile acid malab- 
sorption, severe diarrhoea can occur (Hofmann & Poley, 
1972). 
Hepatic events 
Bile acids and salts are returned to the liver, after 
absorption, in the portal blood bound mainly to albumin 
(Rudman & Kendal, 1957; Kakis et al., 1979). They are 
extracted from the blood by hepatic parenchymal cells and 
transported across the hepatocyte. During their passage 
back through the liver, free bile acids are reconjugated 
very efficiently, both cholic acid and chenodeoxycholic 
acid being completely conjugated in a single pass (von 
Bergmann et al., 1975). Mice and rats also possess a 
large capacity for the rehydroxylation of conjugated 
deoxycholic acid at the 70C- position, the reaction being 
catalyzed by the microsomal fraction and requiring NADPH, 
molecular oxygen and cytochrome P -450 (Prager et al., 
1973). Human liver, in contrast, appears unable to 
rehydroxylate reabsorbed bile acids to any great degree 
(Einarsson & Hellstrom, 1974). 
After crossing the liver, the bile salts are 
resecreted against a concentration gradient into the bile 
canaliculi (0'Maille et al., 1965, 1967). In this 
manner, the enterohepatic circulation conserves the body's 
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pool of bile acids and bile salts, estimated to be between 
2g and 5 g, which circulates between liver and intestine 
two to three times per meal (Bergstrom et al., 1957; Small 
et al., 1972). The bile acid pool is kept in a steady 
state. In man, the liver synthesises approximately 500- 
800 mg of bile acids per day; faecal losses amount to 200- 
800 mg per day (Bergstrom et al., 1962; Grundy et al., 
1965). In the rat, the bile acid pool is 20 mg, and 
about 200 mg of bile salt and bile acid are transported 
daily across the liver (Cronholm & Sjovall, 1967). 
Hepatic bile acid transport 
The transport of bile acids across the liver can be 
divided into three phases as follows - transport across 
the hepatocyte sinusoidal membrane, transport across the 
hepatocyte itself and transport across the canalicular 
membrane. This thesis is primarily concerned with the 
intracellular transport of bile acids. 
1) Uptake across sinusoidal membrane and 
secretion across canalicular membrane 
Owing to technical difficulties with hepatic membrane 
preparations, it has so far proved impossible for workers 
to obtain "pure" preparation of sinusoidal or canalicular 
membranes. Preparations enriched in one or the other of 
these two membranes is the best that has so far been 
achieved. As a result of this, and owing to apparent 
similarities between the two processes, transport of bile 
acids across the sinusoidal and canalicular membranes will 
be covered together, in one section. 
22. 
The arrangement of hepatocyte parenchymal cells along 
the sinusoidal lumen is shown in Figure 1.3. The 
fenestrations of the lining cells allow free access for 
even large molecules to the space of Disse and facilitate 
uptake of substances, such as bile acids, which circulate 
in plasma tightly bound to albumin. The sinusoidal 
transport system has been proposed to be carrier -mediated 
following various studies in the dog, in isolated perfused 
rat liver and in isolated rat liver cells (Glasinovic et 
al., 1975; Reichen & Paumgartner, 1975, 1976; Schwarz et 
al., 1975; Reichen et al., 1977). In these cases, the 
bile acid transport system has exhibited Michaelis -Menten 
kinetics, bile acid specificity, competition between the 
bile acids and sodium dependence. 
Although the molecular components of this transport 
system are not known, bile acid receptors in isolated rat 
liver sinusoidal (and canalicular) membranes have been 
reported (Accantino & Simon, 1976). Also, a high affi- 
nity site for cholic acid has been described in isolated 
rat liver plasma membranes (Anwer et al., 1977). 
Competitive inhibition has been demonstrated between dif- 
ferent bile acids, suggesting a common pathway which is 
distinct from that by which organic anions enter the hepa- 
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FIGURE 1.3 Liver cell plate 
Schematic illustration of the arrangement of 
hepatocytes in single cell -thick sheets within 
the liver. 
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Anwer and Hegner (1978a) suggest that bile acid 
uptake consists of three components - (a) non -saturable, 
Na +- independent (probably diffusion); (b) Na +- independent, 
saturable and (c) Na +- dependent saturable - and that as a 
result of inhibition and competition studies, cholate and 
taurocholate share a Na +- independent transport system, 
while taurocholate has at least two Na +- dependent systems, 
one of which is shared by cholate. These authors also 
speculate that the Na +- independent uptake of bile acids is 
a common carrier for organic anions, e.g. bromosulphtha- 
lein and bilirubin, whilst the Na +- dependent system is 
specific for bile acids (Anwer & Hegner, 1978b). 
The uptake capacity (Vmax) of the rat liver for bile 
acids greatly exceeds the excretory transport maximum (Tm) 
in the steady state (Glasinovic et al., 1975; Paumgartner, 
1975; Reichen & Paumgartner, 1975, 1976; Poupon et al., 
1976). This step, then, is not rate- limiting in bile acid 
transport from blood to bile. Recent studies have pro- 
vided evidence for a lobular gradient of bile acid uptake 
by hepatocytes, transport across the sinusoidal membrane 
being greater at the periportal than the pericentral 
region of the liver lobule (Jones et al., 1980b). 
into 
Transport of bile acids the canaliculus is also 
believed to be carrier -mediated as it is saturable and a 
transport maximum has been measured (Paumgartner et al., 
1974, 1975; Poupon et al., 1976; Schwarz et al., 1976). 
25. 
This step is rate -limiting in the overall transport of 
bile acids from blood to bile (Paumgartner et al., 1975; 
Poupon et al., 1976). 
Experiments with photoaffinity probes (see p.39) and 
hepatocyte plasma membrane fractions enriched either with 
sinusoidal surfaces or canalicular membranes, have 
demonstrated the presence of bile salt- binding polypep- 
tides in these membranes. These are listed in Table 1.2 
(Kramer et al., 1980; Abberger et al., 1981; Frisker et 
al., 1982; Kramer et al., 1982). Of these, the 20 000 
Da polypeptide contributes little to the total bile salt - 
binding capacity and the 67 000 Da polypeptide has been 
shown to be albumin. Other workers have used the same 
technique with both intact hepatocytes and membrane pre- 
parations enriched with sinusoidal surfaces to reveal a 
polypeptide of approximate molecular mass 54 000 Da 
(Wolkoff & Chung, 1980; von Dippe et al., 1983; von Dippe 
& Levy, 1983), which is believed to be a component of the 
rat hepatocyte bile acid transport system. Photoaffinity 
labelling of intact hepatocytes from tissue cultures of 
hepatoma cells known to lack bile acid transport activity 
have failed to reveal this protein (von Dippe & Levy, 
1983). A bile salt- binding polypeptide of molecular mass 
43 000 has also been demonstrated in intact rat hepatocyte 
plasma membranes by other workers (Cheng & Levy, 1979). 
26. 




67 000; 54 000; 48 000; 43 000; 20 000 
Table 1.2 Bile salt -binding polypeptides from rat 
hepatocyte plasma membranes (sinusoidal 
and canalicular) revealed by photoaffinity 
labelling. 
27. 
A working model of canalicular bile formation has 
been proposed and is shown in Figure 1.4 (Boyer, 1980). 
The model proposes that a Na + -K +- adenosine triphosphatase 
(ATPase) on the sinusoidal and lateral hepatocyte membra- 
nes extrudes sodium from the cell, thereby creating an 
electrochemical gradient. A carrier in the sinusoidal 
membrane couples the transport of sodium and bile acids 
into the cell, thus concentrating bile acids within the 
hepatocyte. Subsequent entry of bile acids into the 
canaliculus, whether carrier -mediated or as a result of 
vesicular transport (see p.29) is against a concentration 
gradient and is thus energy- requiring (Erlinger et al., 
1970). Sodium, and also other inorganic electrolytes, 
organic solutes and water, may enter the canaliculus by 
crossing the tight junctions. 
2) Intra- cellular transport of bile acids 
The pathway which bile acids take once inside the 
hepatocyte, i.e. from sinusoidal to canalicular membrane, 
is unknown. There are several alternatives (a) bile acids 
might cross the cell partitioned between organelle membra- 
nes and the cytosol; (b) vesicular transport; (c) asso- 
ciation with cytosolic carrier proteins (Strange et al., 
1979a,b,c). 
(a) Partitioning 
By studying the different degrees to which various 
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FIGURE 1.14 Model of canalicular bile formation 
BA = bile acids; A = Na +- K +- ATPase; 
B,C = anion- sodium coupled transport systems; 
D = hydroxyl- anion, E = protein- sodium ion 
exchangers; F = vesicular transport. 
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bound to cytosolic protein(s), it has been possible to 
calculate a diffusion coefficient, D (Smallwood et al., 
F974; Strange et al., 1979a,b,c). The magnitude of D, 
when compared to observed transit times for bile acids 
crossing the liver, is compatible with bile acids tra- 
versing the hepatocyte in free solution, the rate of 
passage being proportional to the concentration of bile 
acid in free solution (Strange et al., 1979b). This, 
however, is a mathematical concept which has not been pro- 
ven. 
(b) Vesicular transport 
Recent studies have shown that the protein components 
of bile may cross the hepatocyte in membrane -bound 
vesicles (Renston et al., 1980a,ó). This concept has 
been extended to bile acids themselves, supported by the 
observed increase in pericanalicular vesicles during bile 
salt- induced choleresis (Boyer et al., 1979; Jones et al., 
1979). The Golgi complex has also been implicated in the 
intra- hepatic transport of bile acids (Jones et al., 
}976a,b; Jones & Spring -Mills, 1977). A model linking 
these ideas has been proposed in which the bile acids are 
taken to the endoplasmic reticulum and Golgi, possibly by 
a carrier protein, and after processing are taken to the 
canaliculus in vesicles and excreted into bile (Goldmsith 
et al., 1983). The Golgi complex and bile secreting pro- 
cess have previously been linked (Jones et al., 
1980a). 
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(c) Cytosolic binding proteins 
A large number of compounds, including organic anions 
such as bilirubin, bromosulphthalein and indocyanine 
green, as well as bile acids, are transported across the 
hepatocyte, and may be bound to cytosolic protein. Gel 
filtration of rat hepatic cytosol mixed with bilirubin 
results in three peaks of binding - X (eluted in the void 
volume, - Y (Mr approximately 45 000 Da) and Z (Mr 
approximately 12 000 Da) - the majority of the binding 
being associated with the Y and Z peaks (Levi et al., 
1969). Bile salt binding to the latter has been 
recognised for a number of years - Z protein is also 
known under several other names (Ockner et al., 1972; 
Ketterer et al., 1976; Dempsey et al., 1981). Table 1.3 
lists the organic anion binding polypeptides found in rat 
hepatic cytosol. 
The Y peak was found to contain a group of detoxifi- 
cation enzymes, the glutathione S- transferases 
(EC.2.5.1.18), which collectively represent 3 -8% of the 
total cytosolic protein (Kaplowitz et al., 1973; Habig et 
al., 1974; Jakoby et al., 1978). These enzymes catalyse 
the conjugation of glutathione with a large number of 
electrophiles, and also bind hydrophobic compounds that 
are not substrates, such as bile acids (Strange et 
al., 
1977; Hayes et al., 1979, 1980; Pattinson, 1981; 
Vessey & 
Zakim, 1981). The rat hepatic transferases, which 
are 
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dimeric proteins, each comprise two of five subunits - Ya 
(Mr 25 500), Yn (26 500), Ybi and Yb2 (27 000) and Ye 
(28 500) (Bass et al., 1977; Hayes et al., 1980; Scully & 
Mantle. 1981; Hayes, 1984; Pickett et al., 1984). These 
enzymes have been shown to be inhibited to differing 
extents by bile salts, namely cholate, chenodeoxycholate 
and lithocholate -3- sulphate (Hayes & Chalmers, 1983). 
The physiological significance of bile salt- binding by the 
glutathione S- transferases is not clear; they may par- 
ticipate in the intrahepatic transport of both newly 
synthesized and recycled bile acids or they may act to 
restrict the amount of bile acid available for par- 
titioning into subcellular organelles and protect the 
hepatocyte from the potentially damaging effects of bile 
acids (Strange, 1981). Alternatively, they may minimise 
the back diffusion of bile acids in the hepatocyte 
(Wolkoff et al., 1979). 
High resolution gel filtration of rat hepatic cytosol 
incubated with radioactive bile acids has revealed a 
further bile salt- binding fraction within the Y peak, 
which has been termed Y' (see Table 1.3) containing poly - 
peptides in the molecular mass range 30 000 - 40 000 Da 
(Sugiyama et al., 1982, 1983). Further purification has 
apparently resolved a total of six binding proteins, four 
of which bind organic anions, Dv, Dl, D2 and D3, and also 
two distinct bile acid -binding proteins, I and II. These 
32. 
Fraction Alternative Names Molecular Mass (Da) 
X No further study; 
possibly membrane 
fragment 
> 100 000 
Y Ligandin; 45 000 - 56 000 
Glutathione S-transferase 
Y; Dv, Di, D2 and D3; 30 000 - 40 000 
Bile acid binders I and II 
Z Fatty acid -binding protein; 12 000 - 14 000 
Amino azo dye -binding 
protein A; squalene and 
sterol carrier protein 
Table 1.3 Organic anion -binding polypeptides in 
rat hepatic cytosol. 
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latter proteins are monomeric, with a molecular mass of 
approximately 33 000 Da and isoelectric points of 5.6 and 
5.5 respectively. Although they have very similar amino 
acid compositions, the genetic relationship between these 
two bile acid -binding proteins is unknown. The two bin- 
ders have been shown to possess different binding charac- 
teristics, II generally having a higher affinity for con- 
jugated bile acids as measured by amino -naphthalene 
sulphonate (ANS) fluorescence inhibition (Sugiyama et al., 
1983). 
Experiments with isolated hepatocytes and bile acid - 
derivatives used as photoaffinity probes have shown no 
interaction between glutathione S- transferases and bile 
acids under physiological conditions (Abberger et al., 
1983). However, using rat hepatic cytosol, the same tech- 
nique has labelled, with conjugated or unconjugated deri- 
vatives, five or six polypeptides, as listed in Table 1.4 
(Abberger et al., 1981). Of these polypeptides, the 
67 000 Da polypeptide is thought to be albumin, the 23 000 
Da polypeptide a glutathione S- transferase subunit, and 
the 43 000 Da polypeptide has been identified as a subunit 
of hydroxycholanoyl transferase (EC.2.3.1. ?) an enzyme 
which catalyses the final step in the synthesis of con- 
jugated bile salts (Abberger et al., 1981). The 
remaining proteins have still to be identified. 
3)4. 
Bile acid -derivative Molecular masses of bile salt - 
used for labelling binding polypeptides (Da) 
Conjugated 67 000; 43 000; 39 000; 32 000. 
23 000 
Unconjugated 67 000; 43 000; 39 000; 32 000; 
23 000; 15 000 
Table 1.4 Bile salt -binding polypeptides from rat 
hepatic cytosol revealed by photoaffinity 
labelling. 
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INVESTIGATION OF BILE ACID- BINDING 
There are a variety of techniques available for the 
study of ligand- binding to proteins generally which can be 
applied specifically to bile acid -protein binding. These 
include (a) equilibrium dialysis; (b) equilibrium gel 
filtration chromatography; (c) affinity chromatography; 
(d) enzyme inhibition; (e) photoaffinity labelling. The 
last of these methods has played an important role in this 
project. 
Equilibrium dialysis 
This method involves the use of a semi- permeable 
membrane to separate two solutions, one of which contains 
the putative binding protein, the other a ligand which may 
bind to the protein. Provided the ligand involved is 
small enough to cross the semi -permeable membrane during 
dialysis, and that an assay exists to measure the ligand 
concentration, this technique allows the investigation of 
ligand- protein binding and the calculation of a disso- 
ciation constant, K, for the ligand to the protein. Both 
solutions, separated by the semi -permeable membrane, are 
arranged within a dialysis cell, which is rotated in a 
water bath at, for example, 37 °C for several hours until 
equilibrium within the system has been achieved. At this 
point, the concentration of free ligand on both sides of 
the membrane will be equal. However, if the protein 
binds the ligand, then the total concentration of ligand 
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on the protein side will be greater. Thus, the disso- 
ciation constant for ligand can be expressed in measurable 
quantities as follows: 
K = [free li.gand][protein] 
total ligand - free ligandT 
This method has been used to investigate bile acid - 
binding to proteins (Strange et al., 1976; 1979a). 
However, the sensitivity is not great and relatively large 
amounts of protein are required. 
Equilibrium gel filtration chromatography 
The use of this technique to investigate protein - 
ligand binding was first described by Hummel & Dreyer 
(1962). A gel filtration column (commonly Sephadex G -25, 
chosen so as the protein is excluded from the matrix) is 
equilibrated with a buffer containing a ligand which will 
bind to the protein. The protein under test is dissolved 
in the same buffer, containing the ligand, and applied to 
the column. As the protein moves down the column, it 
will bind the ligand. As the zone of protein and protein - 
ligand complex continues down the column, it will move 
into a fresh solution of ligand, forming more of the 
complex. This process continues until an'equilibrium 
is 
reached, at which point the concentration of free ligand 
in the protein- ligand complex zone is the same as in the 
buffer. However, as the protein has bound the ligand, 
the 
total concentration of ligand in the zone is higher 
than 
*NOTE: This equation applies only to a molecule with 
a single binding site. A more complex equation 
is required for those molecules with multiple 
sites. 
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its initial concentration in the buffer. A corresponding 
zone of decreased concentration of ligand moves down the 
column at the rate of which the free ligand moves; the 
extent of ligand binding to the protein can be assessed by 
the excess in the total ligand concentration in the 
protein- ligand complex zone or the deficit of ligand in 
the zone of decreased concentration of ligand. 
This technique has been used to study bile acid - 
binding proteins, although problems exist in obtaining a 
stable baseline (Hayes et al., 1980). 
Affinity chromatography 
Affinity chromatography utilizes the inherent biologi- 
cal specificity of a ligand -protein interaction to effect 
the separation of ligand- binding proteins from a complex 
mixture. A ligand is immobilised on an insoluble support, 
such as the gel matrix Sepharose, by covalent attachment. 
The gel, coupled with ligand, is then packed into a 
column. Once the mixture of proteins has been passed down 
the column, those which are bound via protein- ligand 
interaction are eluted by passing a solution of free 
ligand down the column. The free ligand competes for 
binding sites on the protein with the immobilised ligand, 
and the protein(s) is thus eluted from the column. 
Rat hepatic glutathione S- transferases have been 
investigated on an affinity column where cholic acid has 
been covalently attached via a carbodiimide reaction 
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(Pattinson et al., 1980; Pattinson, 1981a,b,c). Another 
immobilised ligand which has been employed is glutathione, 
in the study of glutathione S- transferases from both rat 
and human liver and human placenta (Simons & Vander Jagt 
1977; Vander Jagt et al., 1981, 1982). 
Enzyme inhibition 
With purified bile acid -binding proteins such as the 
glutathione S- transferases, which also possess enzyme 
activity, it is possible to study the extent to which dif- 
ferent types and different concentrations of bile acids 
will inhibit the enzyme activity. This may yield infor- 
mation, for example, regarding the relative affinity of 
the binding protein for various bile acids, and also the 
type of inhibition involved in each case (Vessey & Zakim, 
1981; Hayes & Chalmers, 1983). A disadvantage with this 
method is that the substrate- binding site and ligand- 
binding site of the enzyme must either be one site, or if 
not, be close enough together for ligand- binding to per- 
turb enzyme activity. 
Binding proteins do not, however, always possess 
enzyme activity; in such cases the technique of inhibition 
of fluorescence, either intrinsic or extrinsic, may be 
applicable. For proteins, there are only three intrinsic 
fluors - tryptophan, tyrosine and phenylalanine, in order 
of decreasing strength of fluorescence. If, for example, 
it is known that one of these amino acids is present at 
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the ligand- binding site of the protein, then the change in 
fluorescence of that particular fluor which occurs on the 
addition of ligand to the protein solution, may provide 
data on the structure of the ligand- binding site and 
events which occur there. 
Not all binding proteins under investigation possess a 
conveniently placed fluorescent group. However, it is 
possible to introduce an extrinsic fluor into the binding 
protein, such as 1- anilino -8- naphthalene sulphonate 
(ANS), which will bind to the ligand- binding site of the 
protein. The inhibition of fluorescence of the ANS by the 
ligand can then be studied in the same manner as with 
intrinsic fluors. This has been done with marine 
elasmobranch hepatic Z- protein and also with the newly 
discovered class of rat hepatic bile acid- and organic 
anion -binding proteins, Y' (see p.31) (Sugiyama et al., 
1982, 1983) . 
Photoaffinity labelling 
Affinity probes offer another approach in the study of 
ligand- binding sites of proteins. Using this technique, 
the active site of the binding species is covalently 
linked to the ligand. The principle of the method is the 
alteration of the ligand so as to incorporate a chemically 
labile group, which will then irreversibly react with the 
protein after binding, without disturbing the ligand- 
receptor recognition process. The ligand then becomes an 
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affinity label, theoretically able to selectively modify 
the binding site of the protein via the inserted chemi- 
cally labile group (Bayley & Knowles, 1977). This 
approach, however, has two limitations. The first is 
that the chemical reactivity of the ligand must be 
designed so as not to react rapidly with water and thus be 
destroyed by hydrolysis. Secondly, such affinity labels 
do not permit the investigation of the internal components 
of a cell, vesicle or organelle, as they will react ini- 
tially with external components. 
The solution to these problems lies in being able to 
activate the label once it is in the desired position, and 
this has been achieved through the use of photoactivatable 
reagents. Two types of such reagents have so far been 
employed. The first involves covalent attachment of the 
photoactivatable group to the protein, followed by irra- 
diation with light (photolysis) to activate the group. 
This approach was developed in the first studies performed 
with photoactivatable ligands, using a diazoacetyl deriva- 
tive of chymotrypsin (Singh et al., 1962). 
The second group of photoactivatable reagents used, 
which are more generally applicable, have been termed pho- 
toaffinity labels (Kiefer et al., 1970). This method 
employs a reversibly bound ligand which has been chemi- 
cally altered to introduce a group capable of photoac- 
tivation. Incubation of such a molecule with a putative 
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binding protein, followed by photolysis, will generate a 
highly reactive intermediate that covalently attaches to 
the binding site of the protein. The ligand can be 
radiolabelled, thus allowing subsequent analysis of the 
binding, and investigation of the biochemical structure of 
the binding site. As this technique is based on protein - 
ligand affinity, its specificity will be high (Bayley & 
Knowles, 1977). 
Over the last two decades, photoaffinity labelling has 
become increasingly valuable as a technique for the 
investigation of biochemical systems at the molecular 
level. Such work has included the study of receptors and 
transport proteins, membrane structure and function, 
protein- and drug- nucleic acid interactions, antibodies and 
enzymes (Chowdhry et al., 1976; Cantrell & Yielding, 1977; 
Guillory et al., 1977; Jakoby & Wilchek, 1977; Rosenblit 
et al., 1977; Bisson et al., 1978). There have also been 
several comprehensive reviews of the photoaffinity 
labelling of proteins (Joni, 1973; Creed, 1974; Cooperman, 
1978; Glazer et al., 1976). 
Types of photoactivatable groups 
A photoactivatable group is that part of the 
chemically- stable precursor of a photoaffinity label, 
which, on photolysis, forms a highly reactive inter- 
mediate. This can occur by homolytic cleavage, either at 
a single bond to yield two free radicals or a diradical, 
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or at a double bond to carbon and nitrogen, resulting in 
the formation of a carbene or nitrene respectively (Bayley 
& Knowles, 1977). The chemistry of the former mechanism 
is currently ill- defined. The most easily synthesized 
and best understood intermediates are nitrenes and car - 
benes, the photogenerated products of diazo compounds and 
azides respectively. These highly reactive intermediates 
can attack a variety of amino acid side -chains, including 
the hydrocarbon type. 
Azides (R- N= N - =N +) and diazo compounds (R- C= N -=N +) 
are organic nitrogen compounds with a system of cumulative 
multiple bonds. They both possess weak absorption bands 
at wavelengths above 400 nm, and stronger absorption bands 
at approximately 270 nm, tailing off toward 350 nm. 
Figure 1.5a,b shows the photo -elimination of nitrogen due 
to homolytic bond cleavage, which occurs after visible or 
near ultraviolet irradiation of such compounds. 
Carbenes 
Carbenes react very rapidly in several different ways 
and have been widely used (Singh et al., 1962; Shafer et 
al., 1966; Vaughn & Westheimer, 1969; Browne et al., 1971; 
Hexter & Westheimer, 1971; Jones & Moss, 1973; 1975). 
They may attack nucleophilic centres, add to multiple 
bonds, insert into single bonds, and by hydrogen abstrac- 
tion, form free radicals which may then couple (Figure 
1.5b) (Bayley & Knowles, 1977). 
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a) Ry N=N=N + hv --- Ri fV: + N2 
b) R2 CH=NN + hv --> Ri CH + N2 
c) R-CHZ CH --> R-CH=CH2 















FIGURE 1.5 Photoactivatable groups 
(a) Azide to nitrene; 
(b) Diazo compound to carbene; 
(c) Hydrogen migration in carbene; 
(d) Wolff rearrangement in carbene; 
(e) Carbene precursors. 
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Potential problems with the use of carbenes as pho- 
toaffinity probes include the presence of a hydrogen atom 
on the carbon atom adjacent to the carbon centre (Figure 
1.5c). Hydrogen migration may occur, leading to an 
unreactive olefin. Also, the intramolecular Wolff 
rearrangement may occur - the example given is an OC- 
-ketocarbene, yielding an unreactive ketone (Figure 1.5d). 
Several chemically -stable, easily -synthesized precursor 
species which form carbenes on photolysis are shown in 
Figure 1.5e. These include -OC-diazoketones,oC- diazo- 
acetyl- and oC- diazomalonyl- compounds, and aryldiazimines 
(Hexter & Westheimer, 1971; Hixson & Hixson, 1972; Jones & 
Moss, 1973, 1975; Smith & Knowles, 1975a,b). In the 
latter, the degree of intramolecular rearrangement is 
substantially lower than in other diazo compounds (Bayley 
& Knowles, 1977). 
Nitrenes 
Nitrenes are the nitrogen analogues of carbenes and 
were first used in the photoaffinity labelling of antibo- 
dies (Fleet et al., 1969). The range of reactions that 
nitrenes may undergo is broadly similar to that of car - 
benes, although they are more selective in the reactions 
and their reactivity is considerably lower than carbenes 
(Bayley & Knowles, 1977). Figure 1.6a illustrates 
the 
types of reactions nitrenes will participate 
in - inser- 
tions into C -H bonds to give secondary amines, 
cycload- 
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ditions to double bonds to form cyclic 3- member imines, 
addition to nucleophiles and hydrogen atom abstraction 
followed by coupling of the free radicals. Nitrenes also 
tend to be more electrophilic and prefer an O -H to a C -H 
bond. 
Several types of precursors - acyl, alkyl and aryl 
azides - yield nitrenes upon photolysis (Bayley & Knowles, 
1977). However, by far the most frequently used nitrene 
source is an aryl azide (Figure 1.6b). Acyl azides are 
powerful acylating agents and the photogenerated nitrenes 
tend to rearrange. Alkyl azides are chemically unstable 
and short -wavelength ultraviolet light, which may be 
biologically damaging, is needed for photolysis. Aryl 
azides, however, are stable in the dark, can 
at longer wavelengths and the resulting nitrenes are not 
susceptible to intramolecular rearrangement. These 
factors, together with their greater stability to changes 
of pH and temperature, make aryl azides an attractive 
alternative to diazo compounds for photoaffinity labelling 
(Fleet et al., 1969; Knowles, 1972). 
Photolysis 
Irradiation of the photoaffinity label presents two 
problems - (a) production of ultraviolet, near ultraviolet 
or visible light, and (b) selection of appropriate 
wave- 
length for smooth, fast, efficient photolysis. 
a) 
R -N --)/(. addition 
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R-ÑH. + 'C -., 
abst 
R- 









alkyl azides eg methyl azide 
n -butyl azide 
acyl azides eg acetyl azide 
ethyl azidoformate 
aryl azides eg p.methoxyphenyl azide 
2- azido -3 -nitro biphenyl 
FIGURE 1.6 Nitrenes 
(a) Reactions of nitrenes; 
(b) Nitrene precursors. 
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Several different irradiation procedures have been 
reported. Photolysis of diazocetyl chymotrypsin was 
achieved using three sunlamps, with all radiation below 
315 nm filtered out with a solution of copper sulphate 
pentahydrate (Singh et al., 1962). Fleet et al. (1969) 
used two Mazda 125 W pearl glass lamps for their studies. 
More recently, a variety of commercial photolysis reactors 
have become available, which generally employ mercury arc 
lamps as a light source (Hexter & Westheimer, 1971; 
Cooperman & Brunswick, 1973). Other sources, such as 
cadmium arc, zinc arc and helium neon laser, emit at one 
or more specific wavelengths (see Table 1.5). The most 
commonly used sources are the mercury arc lamps, of which 
there are three types - low, medium and high pressure. 
The low pressure mercury arc operates at low power 
(approximately 25 watts) and emits most of its light at 
254 nm - these lamps are commonly known as germicidal. 
The medium pressure mercury arc requires more power (100 
-500 watts), operates at a higher temperature, 
and there- 
fore needs to be cooled. In this lamp, the 
254 nm line 
is suppressed, although several other characteristic 
lines, especially 313 nm and 316 nm, 
are emitted. 
Generally, these lines are broad, and 
superimposed on a 
background emission. Figure 1.7 shows 
spectral outputs 
of a low and medium pressure mercury 
arc lamp. High 
pressure mercury arcs work at power 
up to several 
kilowatts, giving strong output at 
most wavelengths. 
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SOURCE EFFECTIVE WAVELENCT. 
(nm) 
(a) Weak 
Tungsten lamp 450 to visible 
Hydrogen lamp 165 to visible 
Carbon arc 400 to visible 
(b) Intermediate 
Mercury arc (low pressure) 185, 254 





Sunlight 340 to visible 
Mercury arc (med. pressure) 200 to visible 
Mercury arc (high pressure) 240 to visible 
Xenon arc 200 to visible 
Helium neon continuous laser 633 
Table 1.5 Light sources for photolysis. 
RANGE 
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The choice of wavelength suitable for photolysis of a 
particular label is obviously restricted by the absorption 
spectrum of the molecule. For example, diazoketone and 
diazoacetyl derivatives have two absorption bands - at 254 
nm (E 7000) and 350 nm (E 10). The intermediate formed 
at 254 nm is more reactive than the one generated at the 
longer wavelength, thus increasing the chance of covalent 
attachment to the protein. However, proteins are subject 
to photodecomposition at lower wavelengths; as a result, 
irradiation at 350 nm would probably be more suitable. 
Proteins with a low cystine or tryptophan content, 
however, are apparently not extremely sensitive to 254 nm 
radiation (Cooperman & Brunswick, 1973). Thus, each par- 
ticular protein should be studied for sensitivity to pho- 
todecomposition prior to photoaffinity labelling. 
To select a particular wavelength or range of wave- 
lengths, filters can be employed. These can take the 
form of either chemical solutions or glass window 
materials. The former tend to isolate single emission 
lines, whereas the latter tend to have "cut- offs ", 
blocking out radiation below a particular wavelength 
(Nielsen et al., 1983) (Table 1.6). 
The photolysis system used in this study is an annular 
photoreactor, shown in schematic form in Figure 2.3, and 
described more fully in the Methods section (p. 75). 
V 
















FIGURE 1.7 Spectral outputs of (a) medium pressure and 
(b) low pressure mercury are lamps. 
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Photoaffinity label design 
There are several criteria that a molecule should 
fulfil in order to be successful as a photoaffinity label: - 
(1) the precursor should be easily synthesized and chemi- 
cally stable; 
(2) such a molecule should photolyse smoothly at wave- 
lengths which are not damaging to other components of 
the reaction system; 
(3) the intermediate species generated by photolysis 
should be highly reactive, have a very short half -life 
and not be liable to intramolecular rearrangement to a 
less reactive compound (Bayley & Knowles, 1977; Jori & 
Spikes 1977). 
Consideration of structural requirements for ligand- 
binding should precede design and synthesis of the pho- 
toaffinity label (Bayley & Knowles, 1977). More 
successful labelling will be achieved if the binding of 
the photolabile ligand to the protein is tight. 
Obviously if the lifetime of the photogenerated inter- 
mediate is long and its exchange rate between protein and 
solution high, then the extent and specificity of 
labelling will be affected. In such cases, photola- 
belling may be performed in the presence of scavengers, 
which are materials intended to destroy all photogenerated 
intermediates other than those at the ligand- binding site. 
Some examples of scavengers are p- aminobenzoic acid, hydro- 
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Wavelengths (nm) Thickness 
254 +3 cm 
+1 cm 
5 cm 





Solution /Window Material 
Chlorine gas at 100 kPa 
pressure 
Iodine -potassium iodide 
0.01% I2, 0.014% kI 
Nickel and cobalt sulphate 
35 %, 1% respectively 
Potassium hydrogen 
phthalate 0.5% 
Nickel and cobalt sulphate 
35 %, 10% respectively 
Copper sulphate, 12.5% 
Chance -Pilkington OX -7 or 
Kodak Wratten 18B 
>450 nm Corning 3 -72 filter 
>370 nm WG -375 filter 
>330 nm Acetone 
>300 nm Pyrex filter 
Table 1.6 Filter solutions and window materials 
for photolysis. 
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quinone, soluble proteins, p- aminophenylalanine 
dithiothreitol, 2- mercaptoethanol and [2- amino- 2- (hydroxy- 
methyl) propane- 1,3 -diol] (Tris) ( Rucho et al., 1973; 
Maasen & Muller, 1974; Beppo et al., 1975; Escher & 
Schwyser, 1975; Rudnick et al., 1975). 
In order not to disturb the binding properties of a 
natural ligand, it may be necessary to modify a part(s) of 
the molecule which is not normally involved in recognition 
and binding. Ideally, a range of ligands, each modified 
in a different way or place, might be synthesized. 
As previously mentioned (p.49) a label with an absorp- 
tion maximum at wavelengths long enough to be clear of 
biologically- damaging regions is an advantage. In mole- 
cules which are radiolabelled, the labelled atom should be 
as close to the photolabile group as possible, and not 
liable to be separated from the rest of the molecule 
during subsequent manipulations (Bayley & Knowles, 1977). 
Bile acid photoaffinity labels 
Several different types of bile acid -derived photoaf- 
finity probes have recently been synthesized and used to 
investigate bile acid -binding proteins (Kramer & Kurz, 
1983; von Dippe et al., 1983). These molecules have been 
employed to study bile salt binding in rat hepatocyte 
plasma membranes, in rat ileal brush border membrane 
vesicles, in normal and transformed human and rat hepato- 
cytes, in human serum, and in rat hepatic cytosol (Kramer 
5)4. 
et al., 1979; Abberger et al., 1982; Kramer et al., 1982; 
Burckhardt et al., 1983; Kramer et al., 1983; von Dippe & 
Levy, 1983). These results have already been discussed. 
Among the bile acid -derivatives so far synthesized for 
use as photoaffinity labels have been both conjugated and 
unconjugated molecules, with different photolabile groups 
inserted at a variety of locations within the molecule. 
These are shown in Figure 1.8, together with specific 
radioactivities for each molecule, labelled with 14C in 
the steroid ring structure or 3H in either the steroid 








Specific radioactivity Ci /mmol 
Nucleus Sidechain 
3H -12e; 2.3 3H -2; 23 
14C -24; 50 3H -2; 23 
3H -33, 123; 3.6 3H -2; 23 
3H -33; 2.2 
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FIGURE 1.8 Photolabile bile acid derivatives 
(a) 3ß- azido- 70c,1244- dihydroxy 5ß- cholan -24 -oic acid 
(R =H) 
(3ß- azido -7a., 12)(- dihydroxy 5)6- cholan- 24 -oy1 -2 
aminoethanesulphonate (OR= NH.CH2.CH2S03H) 
(b) 114- azido -12- oxo- 3oC,77C- dihydroxy -5ß- cholan -24 -oic 
acid (R =H) 
114- azido -12- oxo- 30C,7o(- dihydroxy -5ß- cholan- 24 -oyl) 
aminoethanesulphonate (OR= NH.CH2CH2S03H) 
(c) 7,7azo- 304,12áC- dihydroxy -513- cholan -24 -oic acid 
(R =H) 
(7,7-azo-30C,120C- dihydroxy -513- cholan- 24- oyl) -2- 
aminoethanesulphonate (OR= NH.CH2.CH2S03H) 
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OBJECTIVES OF THE THESIS AND SUMMARY OF INVESTIGATIONS 
The aims of this study were to synthesize a novel bile 
acid derivative, 3f3- azidocholylhistamine, radioiodinated 
to a specific radioactivity of approximately 1900 
Ci /mmole, and to use this molecule as a photoaffinity 
probe in the investigation of bile acid -binding proteins 
in rat hepatic cytosol. 
In particular, the newly discovered Y` group of bile 
acid -binding proteins were studied; along with several 
glutathione S- transferases, these proteins were analysed 
for bile acid- binding using the photoaffinity label 
described above. 
As a result of an improved purification scheme, 
several previously undeseribed bile acid -binding proteins 
I 
were found in the Y fraction. These fell into two 
categories: - 
(1) Proteins, which were dimers of 15 000 Da - 19 000 Da 
molecular mass, and which showed a highly specific 
binding of the photoaffinity label, and were present 
in small amounts. 
(2) Proteins, which were of molecular mass 33 000 Da - 
36 000 Da, and which showed a lower specific binding 
of [125I]_3Aazidocholylhistamine. However, as 
these 
proteins were present in larger amounts, they contri- 
buted as much, if not more, to the total bile acid - 
binding capacity of the Y' fraction than those 
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proteins in Group 1. 
The binding sites of these proteins, and of the glu - 
tathione S- transferases, were investigated by photoaf- 
finity labelling and peptide "mapping" on reverse -phase 
high pressure liquid chromatography. 
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Chemicals, radiochemicals and solvents were obtained 
from a variety of commercial sources and were of analyti- 
cal grade or better. A full list of chemicals and 
suppliers is given in Appendix I, along with any further 
purification of chemicals which was undertaken. 
Buffers 
The composition of the buffers used in this study and 
the temperature at which they were prepared are listed in 
Table 2.1. 
Animals 
Wistar rats (250 -300 g), fed ad libitum, from the 
Animal Breeding Research Organisation, Bush Estate, Milton 
Bridge, Midlothian, U.K., were used in the preparation of 













buffer pr pared 
10mM sodium phosphate 
10mM Tris -HC1 
25mM Histidine HC1 
Polybuffer 74 -HC1 






E 8.9 20 °C 375mM Tris -HC1 
F 6.8 20 °C 125mM Tris -HC1 




H 6.7 4 °C 10mM potassium 
phosphate 
I 6.7 4 °C 500 mM potassium 
phosphate 
Table 2.1 Buffer compositions. 
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GENERAL ANALYTICAL METHODS 
Chromatography of bile acids 
Thin layer chromatography (TLC) was carried out on 
silica gel 60 glass plates (5 cm x 20 cm x 0.25 mm) 
(Merck -Darmstadt, FRG) or on Kodak chromagram silica gel 
plastic sheets (20 cm x 20 cm x 0.1 mm) (Eastman Kodak 
Co., Rochester, NY., U.S.A.). Column chromatography was 
performed in glass columns (2.5 cm x 70 cm) using silica 
gel N60 (43 -60 um) (Merck- Darmstadt, FRG). The following 
solvent systems were used for both thin layer and column 
chromatography: - 
1) Ethyl acetate: cyclohexane: acetic acid 
(23:7:3 v /v /v) 
2) Ethyl acetate: cyclohexane: acetic acid 
(100:40:1 v /v /v) 
3) Chloroform: methanol: acetic acid: water 
(30:10:3:2 v /v /v /v) 
4) Trimethyl pentane: isopropylalcohol:acetic acid 
(120:40:1 v /v /v) 
5) Ethyl acetate: toluene: methanol:triethylamine 
(5:2.5:2.5:1 v /v /v /v) 
Bile acids, including radiolabelled bile acids, were 
shown to be at least 99% pure by TLC before use, chroma- 
tography being carried out on glass plates using solvent 
system 4 for non -radiolabelled bile acids, and for 
radiolabelled bile acids, solvent system 3 (Kelly & Doisy, 
1964). 
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The purity of non -radiolabelled bile acids was 
assessed by staining the developed plates with acetic 
acid /sulphuric acid /anisaldehyde (100 :2 :1 v /v /v) and 
scanning the resulting chromatogram with a Vitatron TLD100 
Flying Spot densitometer (from Scientific Apparatus, 
Loughborough, Leics., U.K.) as described by O'Moore & 
Percy -Robb (1973). The purity of the radiolabelled bile 
acid samples was assessed by scraping portions (1 cm x 1 
cm) from the developed chromatograms and measuring the 
radioactivity contained in each silica gel slice by liquid 
scintillation spectrophotometry. In those cases 
involving histamine derivatives, the TLC plates were also 
stained with Pauly's Reagent, an equal mixture of 10% 
sulphuric acid in 1N hydrochloric acid (HC1) and 5% sodium 
nitrite (by vol., aq) mixed cold and sprayed on to the 
plates (Albright et al., 1953). This was followed by 
spraying with 15% sodium carbonate (by vol., aq) which 
formed the characteristic rose -brown colour with hista- 
mine. 
Radioactivity counting 
For 3H and 140, this was performed in a Packard 
Tri -Carb liquid scintillation spectrometer (Model 
3255- Technologies Packard, Caversham, Berks., U.K.) using a 
toluene -triton X 100 (2 :1 v /v) based scintillant con- 
taining 2,5- diphenyloxazole (PPO), 4 g/1 and p- bis(2 -(5- 
phenyloxazolyl)- benzene (POPOP), 0.2 g /l. Samples, 
either aqueous (100 ul) or solid (silica gel), were added 
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to the scintillant (5 ml) in polyethylene vials and 
counted for either 10 min or until a minimum of 10 000 
counts were detected. The counting efficiency was deter- 
mined by counting known amounts of [3H]cholic acid and 
[14C]lithocholic acid, and was found to be 60% and 85% 
respectively. 
For 125I, a Nuclear Enterprises NE1600 gamma counter 
(Nuclear Enterprises Limited, Sighthill Industrial Estate, 
Edinburgh, U.K.) was used. Samples were counted for a 
minimum of 10 000 counts. 
Equilibrium dialysis 
The Dianorm equilibrium dialysis equipment used was 
obtained from Fisons Ltd., Crawley, Sussex, U.K. The 
binding of 3 /3- azidocholic acid to bovine serum albumin was 
investigated at 200C in cells each of which consisted of 
two teflon half -cells separated by a semi -permeable 
membrane of 32/32 visking tubing. The BSA was charcoal - 
stripped to remove endogenous bile acids (Simmonds et al., 
1973). 
The dialysis experiment was run in duplicate. In the 
left -hand side of one pair of cells was placed 1 ml of 
10mM sodium phosphate pH 7.4 (buffer A) containing 0.5 mg 
3p azidocholic acid (4.5 nCi), which had been synthesized 
from a starting material which included tracer amounts of 
2,4 [3H]cholic acid. On the right -hand side was placed 
buffer A (1 ml) only. This pair of cells served as a 
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control. The second pair of cells was identical to the 
first except that the right -hand side also contained 
stripped BSA (20 mg /cell). 
The dialysis cells were rotated at 12 rpm for a total 
of 24 h. At timed intervals a sample (50,u1) was 
withdrawn from each side of both pairs of cells, and once 
scintillant (5 ml) had been added, was counted for 3H. 
Protein determinations 
Protein concentrations in samples eluted from columns 
were calculated from the extinction values at 280 nm. 
All other protein determinations were by the method of 
Bradford (1976) with bovine serum albumin as calibration 
standard. 
Glutathione S- transferase activity 
This was measured at 37 °C in a Aminco Rotochem IIa 
parallel fast analyser (American Instrument Co., Maryland, 
U.S.A.). The conjugation of glutath'ione with 1- chloro -2, 
4- dinitrobenzene was followed at 340 nm in 100mM sodium 
phosphate, pH 7.4. Reaction rates were corrected for 
non -enzymic conjugation. 
Discontinuous SDS /polyacrylamide -gel electrophoresis 
This was performed at room temperature (20 °C) in the 
presence of 0.1% (w /v) sodium dodecyl sulphate (SDS) using 
vertical slab gels (1.5 mm x 140 mm x 195 mm) in an IN /96 
electrophoresis apparatus (Raven Scientific Ltd., 
Haverhill, Suffolk, U.K.). The electrophoretic system 
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used was that of Laemmli (1970). The resolving gel was 
14 cm long, of either 12% or 16.5% (w /v) polyacrylamide 
containing 375mM tris -HC1, pH 8.9 (buffer E), and a 1.2 cm 
high stacking gel of 3.6% w/v polyacrylamide containing 
125mM tris HC1, pH 6.8 (buffer F) which was formed on top 
of the resolving gel. 
Molecular mass calibration of the gels was achieved 
using either a seven protein marker as standards (Figure 
2.1) or alternatively a four protein marker containing 
bovine serum albumin (66 000 Da), ovalbumin (45 000 Da), 
chymotrypsinogen A (24 000 Da) and myoglobin (17 000 Da). 
In those experiments where the gels were sliced, they 











FIGURE 2.1 Calibration of SDS /polyacrylamide gel. 
Plot of molecular mass of marker proteins 
against their electrophoretic mobility relative 
to bromophenol blue on an SDS /polyacrylamide gel 
(12% resolving gel). 
5 ug each of Bovine serum albumin (B; 66 000 Da); 
Ovalbumin (0; 45 000 Da); Glyceraldehyde-3- 
phosphate dehydrogenase (G; 36 000 Da); Carbonic 
anhydrase (C; 29 000 Da); Trypsinogen (T; 24 000 
Da); Trypsin inhibitor (TI; 20 000 Da); oC -lact- 
albumin (L; 14 200 Da). 
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SYNTHESIS AND CHARACTERISATION OF PHOTOAFFINITY LABEL 
Synthesis of [12óI]- 3pazidocholylhistamine 
This was performed in two steps - 
1) introduction of an azido(-N3) group at the 3f3- 
-position of cholic acid, essentially according to 
Kramer & Kurz (1983); 
2) conjugation of this bile acid -derivative with 
histamine and subsequent iodination. Following 
the method of Beckett et al., (1979); Figure 2.2 
shows the overall reaction pathway for the synthe- 
sis. 
1) Introduction of azido group 
A solution off-toluene sulphonyl chloride (5 mmol) in 
absolute pyridine (2 ml) was added (over 30 min, 00C with 
stirring), to a solution of cholic acid (5 mmol) in abso- 
lute pyridine (10 ml), also containing 2,4- [3H]- cholic acid 
(0.1 ,uCi, 6.5 ,umol) as tracer. The solution was warmed 
and stirred at room temperature for 3 h, the progress of 
the reaction being monitored by TLC in solvent system 1. 
When complete, the reaction mixture was added slowly, with 
stirring, to 1.5M hydrochloric acid (400 ml), the precipi- 
tate collected by filtration, and dried in vacuo over 
silica crystals. This material was dissolved in solvent 
system 1 and further purified by column chromatography in 
the same solvent system; 1.038 g of 3a- toluenesulphonyl 
cholic acid was recovered (1.85 mmol, 40% yield). The 
70. 
derivative was analysed by TLC (solvent systems 1 and 2) 
and infra -red spectrophotometry. 
The 306- toluenesulphonyl cholic acid (1.85 mmol) was 
dissolved with stirring in a warm solution of sodium azide 
(15.5 mmol) in dry dimethyl sulphoxide (23 ml) and the 
resulting solution kept in the dark at 1000C for approxi- 
mately 5 h. All further work was carried out in dim or 
red light. Reaction progress was monitored by TLC in 
solvent system 1 and, when complete, the solution was 
poured with stirring into 1M hydrochloric acid (500 ml). 
The resulting precipitate was collected by filtration and 
dried in vacuo over silica crystals. The products were 
further purified by column chromatography in solvent 
system 2. The final product was 3p- azidocholic acid (0.7 
mmol, 40% yield) and its identity was verified by analysis 
on TLC (solvent systems 1 and 2), melting point deter- 
mination, ultraviolet and infra -red spectrophotometry, and 
1H and 13C nuclear magnetic resonance spectrometry. 
2) Conjugation of 3p- azidocholic acid with histamine 
3p- azidocholic acid (0.25 mmol) and N- hydroxysucci- 
nimide (0.275 mmol) were dissolved in sodium -dried tetra - 
hydrofuran (3 ml) and cooled in ice. Dicyclohexyl car - 
bodiimide (0.275 mmol) in sodium dried -tetrahydrofuran 
(0.5 ml) was added and the mixture stirred at 00C for 1 h, 
and then at room temperature for 3 h. Following the 
addition of a single drop (100)ul) of glacial acetic 
NOTE: Exercise extreme caution when handling sodium azide 
or azide derivatives as these compounds are 


































FIGURE 2.2 Reaction pathway for synthesis of 
[125I]- 3ßazidocholylhistamine. 
1,2 - introduction of azido group. 
3,4 - conjugation with histamine and subsequent 
iodination. 
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acid, the mixture was stirred for a further 1 h. After 
filtration, the precipitate was washed with ethyl acetate, 
the washings and filtrate combined and taken to dryness on 
a rotary evaporator at approximately 60 0C. The residue 
was dissolved in dimethylformamide (3 ml) and histamine 
(0.275 mmol) added. The mixture was stirred overnight at 
room temperature. Using a rotary evaporator at approxi- 
mately 95 °C, dimethylformamide was removed and the residue 
dissolved in ethyl acetate (1 ml) at approximately 500C 
with stirring and dropwise addition of methanol. After 
cooling the solution, any crystals of bile acid and urea 
which immediately formed were removed by centrifugation. 
The remaining solution was evaporated at room temperature 
under nitrogen to approximately 0.5 ml and applied to two 
silica gel plates, which were developed in solvent system 
3. The histamine conjugate was visualised by spraying the 
two margins of the plate with anisaldehyde solution, and 
the area of the gel containing the product was scraped 
from the plate, eluted with methanol, evaporated at room 
temperature under nitrogen, weighed and re- dissolved in 
methanol to produce a 5 mmol /1 solution. The yield of 
3ß- azidocholylhistamine was 50 %, and it was analysed on 
TLC in solvent systems 1 and 2. 
The conjugate (50 mmol, 10,u1) was mixed with 
[1251]- sodium iodide (1 mCi, 10,u1) and a solution of 
chloramine T (0.18,umol, 10,u1) in buffer A, for 20 sec. 
73. 
The reaction was terminated by the addition of sodium 
metabisulphite (1.6 umol, 10 ul) in water. The solution 
was extracted with ethyl acetate (0.2 ml), the organic 
layer removed and dried with anhydrous sodium sulphate. 
The radiolabelled conjugate was then separated from 
unreacted [125I]sodium iodide and non -iodinated conjugate 
by TLC in solvent system 3 on plastic plates [1251] -3p 
-azidocholylhistamine was located on the plate using a 
scanning radiation counter and eluted from the silica gel 
by ethanol. Radioactive incorporation was 30 -50 %. The 
conjugate was stored in the dark at 40C, having a specific 
radioactivity of approximately 1900 Ci /mmol. [125I]_316 
-azidocholylhistamine was run on TLC in solvent systems 1 
and 2, and a "cold" iodination performed on a 103 times 
larger scale in order to generate an iodinated conjugate 
for infra -red spectrophotometry. 
Hepatic transport of [1251]_3_ azidocholylhistamine 
Female Wistar rats were anaesthetised with diethyl 
ether and the common bile duct cannulated with nylon 
tubing (0.1 mm i.d.). The test solutions were injected 
into the superior mesenteric vein in 150mM saline (75,111) 
containing approximately 20% ethanol by volume. Bile was 
collected at 1 min intervals in pre- weighed tubes and the 
radioactivity counted. In experiments using the 
[1251] -labelled derivative, the bile samples were counted 
directly whereas 14C- labelled bile acids were counted 
74. 
following the addition of scintillant. After extraction 
with ethanol, bile samples were run on TLC, solvent system 
3, and the plates scraped to locate the radioactivity. 
Gel filtration of rat hepatic cytosol incubated with 
radiolabelled bile acids 
A portion of dialysed rat hepatic cytosol (5 ml, 100 
mg) in buffer A was incubated with either (carboxy -14C) 
lithocholic acid (1.5 uCi) or [1251]-33azidocholylhista- 
mine (5 uCi) at 40C for 30 min. and, in the latter case, 
in the dark. The samples were then applied separately to 
a column of Sephadex G -75 superfine (2.6cm x 96cm) and 
eluted with buffer A. Fractions were analysed for pro- 
tein concentration, glutathione S- transferase activity, 
[14C] and [1251]. 
75. 
PHOTOLYSIS REACTOR AND PHOTOAFFINITY LABELLING 
Photoaffinity labelling 
Photolysis experiments were carried out in an annular 
photoreactor, (Applied Photophysics Ltd., London, U.K.), 
Figure 2.3, with a 400 watt medium pressure mercury arc 
lamp. This has an output of >5 x 1019 photons /sec, as 
measured by ferrioxalate actinometry, and radiates predo- 
minantly at 313 nm and 365 nm. The lamp was water - 
cooled, and a borosilicate glass filter with wavelength 
cut -off of approximately 300 nm was employed. Test solu- 
tions (8 -10 ml) were held in quartz tubes (11 mm i.d.) 
with a glass rod (7 mm o.d.) located centrally to give a 
thin film of approximately 2 mm . The tubes were rotated 
at 25 revolutions per minute around the light source. 
The iodinated photoaffinity label, proteins, or a mix- 
ture of protein with the label, were photolysed in either 
buffer A or B (8 -10 ml) following incubation in the dark 
at 20 °C for 15 min. The protein concentration ranged 
from 50,ug /ml to 0.5 mg /ml, and the concentration of 
[12511- 3pazidocholylhistamine from 1.25 pmol (2.5,uCi.) to 
5 
p 
mol (10 uCi). The duration of photolysis varied from 
15 min to 60 min. At timed intervals the solutions were 
mixed and, if relevant, portions were removed for analy- 
sis. All subsequent handling was done in the dark or 



















Motor drive (in base) 
FIGURE 2.3 Annular photoreactor (Applied Photophysics, 
Ltd). 
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Analysis of labelling 
After photolysis, the protein solutions (or portions 
of them) were precipitated by adding ice -cold tricho- 
loroacetic acid (TCA) to a final concentration of 10% by 
volume. After 30 min on ice, the samples were centri- 
fuged (MSE mistral 6L, MSE Scientific Instruments, 
Crawley, Sussex, U.K.), at 1500 g, 40C for 45 minutes. 
The supernatant was decanted, and the precipitates washed 
three times, each with 5 ml of 10% TCA, by the same proce- 
dure. The precipitates were then either taken up in the 
appropriate mixture and prepared for SDS/polyacrylamide - 
gel electrophoresis (see p.65) or taken up in buffer A 
containing 1% SDS. The protein solutions in the latter 
case were then applied to a 1 cm x 20 cm column of 
Sephadex G -25 fine, equilibrated with buffer A containing 
1% SDS, and eluted (25 ml /h) in the dark with the same 
buffer. Fractions of 4 ml were collected and analysed 
for [125I]. 
Alternatively, the photolysed protein solutions (or 
portions of them) were applied directly to a column (2.6 
cm x 42 cm) of Sephadex G -100 fine, equilibrated in buffer 
A. The labelled protein was eluted with buffer A. 
"Peptide mapping" was performed on photoaffinity 
labelled Y and Y proteins using reverse -phase high 
pressure liquid chromatography. Details are given later 
in this section (p. 84). 
78. 
PURIFICATION OF Y PROTEINS 
Purification of Y' proteins 
This was done esssentially as in Sugiyama et al. 
(1982, 1983) with important modifications which resulted in 
the discovery of previously unknown bile acid -binding pro- 
teins. These will be discussed in a later section. 
Table 2.2 gives the details of the columns used at 
each stage of the purification, and Table 2.3 shows a flow 
diagram of the purification scheme. 
Appendix III gives details of the preparation of rat 
hepatic cytosol. 
Cytosol, from eight rat livers, was dialysed (16 h, 
4 °C) against two changes, each of two litres, of buffer A. 
The dialysed solution was eluted (25 ml /h) from two 
columns of Sephadex G -100 fine, connected in series, and 
equilibrated with buffer A. Those fractions containing 
glutathione S- transferase activity were pooled and con- 
centrated to approximately 90 ml by ultrafiltration in a 
Millipore Ultrafiltration cell (Millipore (UK) Ltd., 
Harrow, Middlesex, U.K.) using oxygen -free nitrogen at a 
pressure of 40 pounds per square inch, and PT series 
membrane (Molecular mass cut -off approximately 10 000 Da). 
The concentrated protein solution was eluted (15 ml /h) 
from two columns of Sephadex G -75 superfine, connected in 
series and equilibrated with buffer A. Once again, frac- 
























































































































































































































































































































































































































































































































































































































Rat livers (8) removed in buffer G (ice cold), chopped 
finely and homogenised. 
Homogenate centrifuged 18,000 g, 40C for 30 min, and 
supernatant recentrifuged 100,000 g, 4°C for 60 min. 
Supernatant filtered through glass wool plug, then 
dialysed against 2 changes, each of 2 litres, of buffer A 
for 18 h. 
Dialysed material eluted from Sephadex G -100 fine 
equilibrated with buffer A. Fractions with glutathione 
S- transferase activity pooled and concentrated by 
ultrafiltration. 
Concentrated material eluted from Sephadex G -75 superfine 
equilibrated with buffer A. Fractions with Y' proteins 
on SDS /PAGE pooled and concentrated by ultrafiltration. 
Concentrated material eluted from Sephadex G -75 superfine 
equilibrated with buffer A. Fraction with Y' proteins 
pooled, dialysed against 2 changes, each of 2 litres, of 
buffer B for 18 h. 
Dialysed material applied to DEAE -Sephadex A -50 
equilibrated with buffer B. After washing with buffer B 
(100 ml), eluted with 0 -200mM linear NaC] gradient in 
buffer B, than two steps of 500mM and 1M NaCl. 
Peaks 5,6,7 and 8 pooled, dialysed against 2 changes, each 
of 1 litre, of buffer C for 12 h. Applied to PBE 94, 
equilibrated with buffer C, and eluted with buffer D. 
Further purification of bile acid -binding proteins on 
chromatofocusing or hydroxyapatite as required. 
FIGURE 2.3 Purification scheme for Y1 proteins 
81. 
tathione S- transferase activity. Portions of the frac- 
tions across the enzyme peak were run on SDS /PAGE. From 
these results, fractions from the latter half of the glu- 
tathione S- transferase peak were pooled and concentrated 
by ultrafiltration to approximately 40 ml. 
This solution was re- applied to the columns of 
Sephadex G -75 superfine and eluted with buffer A. 
Analysis of the fractions collected revealed a distinct 
protein peak which eluted just after the eluate with glu- 
tathione S- transferase activity (i.e. Y peak). Portions 
of the fractions from both peaks (Y and Yi ) were analysed 
by SDS /polyacrylamide electrophoresis, and the Yt - 
containing fractions were combined on the basis of these 
results so as to minimise cross -contamination of Y and 
Y . 
The YF peak was dialysed (16 h, 40C) against two 
changes, each of two litres of 10mM tris -HC1, pH 8 (buffer 
B), before being eluted from a column of diethylaminoethyl 
(DEAF) Sephadex A -50 equilibrated with buffer B. After 
300 ml had been collected, protein which had been retained 
on the column was eluted with a linear 0 -200mM sodium 
chloride gradient in buffer B, followed by two steps of 
500mM and 1M sodium chloride, both in buffer B. 
Each of the protein peaks resolved from the ion - 
exchange column were pooled and subjected to photoaffinity 
labelling to determine which possessed bile acid -binding 
82. 
activity. Peaks 5, 6, 7 and 8 were then dialysed (12 h, 
ROC) against two changes, each of 1 litre, of 25mM 
histidine-HC1 (buffer C), and concentrated to approxima- 
tely 10 ml by ultrafiltration. Each was then subjected 
to chromatofocusing on columns of PBE 94 equilibrated with 
buffer C. Each column was "primed" with approximately 
5 ml of polybuffer 74 -HC1 (buffer D) before application of 
the protein sample. The proteins were then eluted with 
buffer D (200 ml) over a pH gradient of approximately 6.4 
to 4. The fractions were analysed for protein con- 
centration and, also pH, using a Radiometer PHM 64 
Research pH meter (Radiometer, Copenhagen, Denmark). 
Portions of the resultant peaks from chromatofocusing were 
run on SDS /PAGE, and subjected to photoaffinity labelling 
to test for bile acid -binding. 
Those protein peaks from chromatofocusing which gave a 
high concentration of radioactive bile acid after photoaf- 
finity labelling were further purified, by either chroma- 
tofocusing (pH 6.0 - 5.0) or applications to a column of 
hydroxyapatite, equilibrated with 10mM potassium 
phosphate, pH 6.7 (buffer H), and elution with a linear 
gradient (200 ml) of 500mM potassium phosphate, pH 6.7 
(buffer I). 
83. 
PEPTIDE "MAPPING" OF BILE ACID -BINDING PROTEINS 
Y proteins by limited proteolytic digestion 
in the presence of SDS 
The method used was that of Cleveland et al. (1977). 
The purified bile acid -binding proteins from the 
Y' fraction after chromatofocusing were precipitated by 
addition of ice -cold TCA to a final concentration of 10% 
(w /v) and kept at 4 0C for 30 min. The proteins were 
centrifuged for 45 min at (1500 g), 4 °C, and the super- 
natant decanted. The precipitates were washed twice in a 
similar manner with ice -cold TCA (10% w /v, 2m1) before 
being re- dissolved at a concentration of approximately 0.5 
mg /ml in a sample buffer containing buffer F, 0.5% SDS, 
10% sucrose, and 0.2% bromophenol blue. After heating to 
100 °C for 2 min, the samples were cooled and oC- chymo- 
trypsin added to a final concentration of 100 ug /ml, 12.5 
ug /ml or 2.5 ug/ml. Digestion was then carried out at 
37 °C for 60 min. Proteolysis was stopped following the 
addition of 2- mercaptoethanol and SDS to final con- 
centration of 10% and 2% (v /v and w /v) respectively, by 
boiling the samples for 2 min. A portion of each sample 
(approximately 20 ug) was loaded into a sample well of a 
16.5% SDS /polyacrylamide gel, and the gel was run in the 
normal manner. Undigested samples of each protein, and 
also a sample of oC- chymotrypsin, were included on the 
gels for reference, along with a marker consisting of 
seven proteins as standards (Figure 2.1). 
84. 
Y' proteins and glutathione S- transferases by tryptic 
digestion and analysis on reverse -phase high performance 
liquid chromatography 
Portions (0.5 - 1.0 mg) of each bile acid -binding pro- 
tein identified and purified from the Y fraction were 
desiccated to dryness under vacuum and then oxidised on 
ice with performic acid for 2 h. The oxidised proteins 
were desiccated to dryness under vacuum once more and 
taken up in 0.2M ammonium acetate, a pH of 8.5 being 
achieved with 0.2M ammonia. Digestion was carried out at 
37 °C for 16 h using diphenyl carbamyl chloride- treated 
trypsin; a protein:protease ratio of 50 :1 was employed. 
The digested proteins were desiccated to dryness under 
vacuum and then dissolved in 0.1% (v /v) trifluoroacetic 
acid. 
The soluble tryptic peptides were resolved by reverse - 
phase high performance liquid chromatography (HPLC) on a 
Waters C -18 u Bondapak column (0.39 cm x 30 cm) in 0.1% 
trifluoroacetic acid with a gradient (0 - 60 %) of aceto- 
nitrile. The eluted peptides were detected by their 
absorbance at 254 nm. The HPLC system employed two 
Waters Model 510 HPLC pumps, a Model 680 Automated 
Gradient Controller, a Model 481 Lambda -Max absorbance 
detector and a Model U6K Universal injector (Waters 
Associates (Instruments) Ltd., Northwich, Cheshire). 
In those experiments where the Y` proteins and glu- 
tathione S- transferases were photoaffinity labelled prior 
to peptide "mapping ", these proteins were TCA precipitated 
85. 
and extensively washed as previously described (see p. 77) 
before being oxidised and digested. All handling of 
labelled proteins was performed under red light or in the 
dark. The HPLC system was connected to a Waters Model 
2211 superrac fraction collector to measure the radioac- 




SUMMARY OF EXPERIMENTS 
The object of this thesis was to investigate bile 
acid -binding proteins in rat liver cytosol employing the 
technique of photoaffinity labelling. A radioiodinated 
bile acid derivative, incorporating a photoreactive group, 
was synthesized and used as a photoaffinity probe in the 
study of such proteins. The molecule [125I]- 3ßazido- 
cholylhistamine, was shown to be transported by rat liver 
in a similar manner to a natural bile acid, and was 
comprehensively characterized. The recently- discovered 
Y group of bile acid- binding proteins was purified and 
previously undescribed proteins found. The site(s) of 
binding of bile acids to these proteins was investigated 
by "peptide mapping" with HPLC. In addition, certain 
glutathione S- transferases were studied to provide a com- 
parison of bile acid -binding sites. 
SYNTHESIS AND CHARACTERIZATION OF PHOTOAFFINITY LABEL 
Synthesis of [125I]- 3Qazidocholylhistamine 
A scheme for the synthesis of [1251]-3pazidocholyl- 
histamine is shown in Figure 3.1. The initial step 
involves the selective tosylation in pyridine of the 3a- - 
position of cholic acid (Barrett & Reichstein, 1938). If 
the reaction is allowed to continue for a longer period 
and /or in the presence of excess p- toluenesulphonyl 
chloride, di- and tri- tosylate derivatives of cholic acid 
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[1251]-33- azidocholylhistamine 
FIGURE 3.1 Synthesis of [1251]_3pazidocholylhistamine. 
89. 
-position would be expected to react before the 7«C- and 
that in turn before the 120C-position. The reagents used 
must be absolutely dry, in order to avoid hydrolysis of 
the tosyl moiety after formation. Similarly, at the next 
stage of synthesis, the reaction was performed in absolute 
dimethysulphoxide in order to protect the tosylate. 
Addition of histamine and subsequent iodination was 
carried out using a well -proven method which is simple and 
quick to perform (Beckett et al., 1979). The yield of 
radioiodinated ligand was good, at approximately 25 %, with 
a high specific radioactivity of approximately 1900 
Ci /mmol. Good separation of iodinated from non -iodinated 
derivative is essential if a high specific radioactivity 
is to be attained. Figure 3.2 demonstrates this point, 
and illustrates why solvent system 3 was chosen for use in 
the iodination procedure. 
Characterisation 
Characterisation of the intermediates and the final 
product of the synthesis procedure was carried out at each 
stage. Table 3.1 summarises the relevant information. 
Figures 3.3 to 3.6 show the infra -red spectra obtained 
from the intermediates. The presence of the azido group 
is demonstrated by the characteristic peak at 2120 
cm-1 (Figures 3.4, 3.5). The other peaks common to all 
the intermediates, at approximately 3500 cm-1, 2950 cm -1 
and 1705 cm-1, are due to 0 -H, C -H and C -0 bond -stretching 
respectively (Barrow, 1973). 
90. 
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FIGURE 3.2 Separation of [1251]_3ßazidocholylhistamine 
(a - - - -G) from 3ßazidocholylhistamine 
( ) on TLC (0.15 )umol and 0.1 iuCi , 






































































































































































































































































































































































































































































































































































































































































































Characterization of the intermediates in the 
synthesis of [125I]- 3pazidocholylhistamine. 
TLC figures (A -C) are Rf values in solvent 
system 1 /solvent system 2; D and E are Rfs in 
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FIGURE 3.3 Infra -red spectrum of cholic acid. Sample 
was mixed with dry, pure potassium bromide 
and ground finely before being pressed into 
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FIGURE 3.4 Infra -red spectrum of 30C toluenesulphonyl 
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FIGURE 3.5 Infra -red spectrum of 31B- azidocholic acid 
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FIGURE 3.6 Infra -red spectrum of 3ß- azidocholylh.istamine 
(sample preparation as Figure 3.3). 
97. 
An infra -red spectrum of [12511- 3fiazidochohylhistamine was 
also carried out, and is essentially the same, in all 
important features, as that of its immediate precursor 
(Figure 3.6). 
Proton and 13C nuclear magnetic resonance spectroscopy 
was employed to help confirm the molecular structure of 
3p- azidocholic acid. The results of the proton NMR scan 
(Figure 3.7) were in agreement with that of Kurz & Gerok 
(1983). 13C NMR confirmed that the molecule did have 24 
carbon atoms, with the distinctive carboxyl peak at a high 
a distortionless enhanced polarisation transfer (DEPT) 
field position (Figure 3.8). In addition, 130 
NMR scan was carried out (Figure 3.9). This technique 
enables a count of the total number of -CH and -CH 3 groups 
in the molecule to be made, and also the total number of 
-CH2 groups. The results correspond to the predicted 
figures for 3,- azidocholic acid. 
It was demonstrated that bovine serum albumin rever- 
sibly bound 3R- azidocholic acid by equilibrium dialysis, 
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FIGURE 3.7 Proton NMR scan of 3ß- azidocholic acid 
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FIGURE 3.8 13C NMR scan of 3p- azidocholic acid (inset 
shows structure of molecule). Total number 
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FIGURE 3.9 13C NMR scan of 33 -azidocholic acid (inset 
shows structure of molecule). Total -CH/ 























































































FIGURE 3.10 Investigation by equilibrium dialysis of the 
binding of 3,- azidocholic acid to bovine 
serum albumin. A,B = controls; C,D = BSA 
on right side of cells. 
3ß- azidocholic acid (0.5 mg) with trace 
amounts of 2,4[3H]- label, was placed on the 
left side of each cell. Dialysis was 
carried out at 20 °C for 24 h, with portions 
of 50 ul being removed from both sides of 
each cell, at timed intervals, for counting. 
103. 
Heaatic transport of [125I] -3p azidocholylhistamine 
In order to assess the capacity of rat liver to handle 
the photoaffinity label, the molecule was injected into 
the hepatic portal system via the superior mesenteric 
vein, and bile collected from a cannula. Figure 3.11 
shows the results of an experiment in which [125I]- 3ßazi- 
docholylhistamine only was injected, the test being per- 
formed in duplicate. Radioactivity first appeared in 
bile after 3 min, and reached a peak at 8 min, thereafter 
falling away to zero after approximately 60 min. The 
results from both rats were virtually identical, as can be 
seen from the figure. Bile flow was also measured, and 
showed no appreciable change during the course of the 
experiment. 
To obtain a comparison with a natural bile acid 
5I 
[ 
12] -3p azidocholylhistamine was injected together with 
[14C]_taurocholate, and bile collected. Figure 3.12 
rapidly 
shows that both bile acids/appeared in bile, 
although taurocholate peaked 2 min earlier than the 
photoaffinity label. Apart from this difference, the 
excretion profiles of the two molecules were essentially 
the same, suggesting that [1251]_3p azidocho- 
lylhistamine was handled efficiently by rat liver. 
NOTE: Investigation of bile acid transport using 
[125I]- cholylglycltyrosine, which has a net 
negative charge, has demonstrated the relatively 
inefficient uptake of neutral molecules such as 
[1251]_3,3 -azidocholylhistamine. (Spenney et 
al., 1979; van Dyke et al., 1982; Suchy et al., 























































































FIGURE 3.11 Hepatic handling of [1251]-3flazidocho- 
lylhistamine. Biliary excretion of 
[125I]- 3pazidocholylhistamine in each of 
two rats after injection (250 fmol, 0.5 /uCi) 
in 154mM saline (75/u1) with 15% ethanol 
(v /v), into the superior mesenteric vein. 
Rat 1 at e; Rat 2 o - - -o; inset 
shows bile flow over first 30 min following 
injection. 
106. 
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FIGURE 3.12 Hepatic handling of [125I]- 3,0azidocho- 
lylhistamine and [14C]- taurocholate. 
Biliary excretion of [1251]-3ßazidocho- 
lylhistamine and [14C]- taurocholate after 
injection (125 fmol, 0.25,,uCi and 0.8 mmol, 
0.5 )uCi respectively) in 154mM saline (75 
Ail) with 15% ethanol (v /v) into the superior 
mesenteric vein. 
107. 
Binding of radiolabelled bile acids to rat hepatic cytosol 
The binding of both [140]- lithocholic acid and 
[1251]- 3pazidocholylhistamine to components of rat hepatic 
cytosol was investigated by gel filtration on Sephadex 
G -75 superfine. The results are shown in Figures 3.13 
and 3.14 respectively. 
[14c] -lithocholic acid showed three major peaks of 
binding to rat hepatic cytosol. One was a high molecular 
mass peak of approximately 70 000 Da, one the glutathione 
S- transferase (Y) peak, and the third a peak of approxima- 
tely 35 000 Da molecular mass, termed by Sugiyama et al. 
(1983) as Y). The greatest amount of binding was to the 
Y peak. 
In contrast, [ 1251]- 3pazidocholylhistamine showed one 
major peak of (non -covalent) binding, the glutathione S- 
transferase fraction, and several smaller peaks - one was 
void volume material, molecular mass approximately 
100 000 Da or greater, one of the peaks at approximately 
70 000 Da, and lastly the Y' peak. The latter two 
binding peaks can be seen in Figure 3.14. 
108. 
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FIGURE 3.13 Binding of [14C]- lithocholic acid to rat 
hepatic cytosol. A portion (100 mg, 5m1) 
of freshly prepared rat hepatic cytosol was 
incubated with (carboxy -14C)- lithocholic 
acid (1.5 ,uCi) at 40C for 30 min. The 
sample was then applied to a column of 
Sephadex G -75 superfine (2.6 cm x 96 cm) 
and eluted with buffer A. Flow rate was 
9 ml /h , and the fraction volume 1.5 ml. 
110. 
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FIGURE 3.14 Binding of [125I] -3 3azidoeholylhistamine to 
rat hepatic cytosol. A portion (100 mg, 
5 ml) of freshly prepared rat hepatic 
cytosol was incubated with [1251]-3fazi.do- 
-cholylhistamine (5,uCi, 2.5 pmol) at 40C 
for 30 min in the dark. The sample was 
then applied to a column of Sephadex G -75 
superfine (2.6 cm x 96 cm) and eluted with 
buffer A. Flow rate was 9 ml /h and the 
fraction volume 1.5 ml. 
112. 
PHOTOAFFINITY LABELLING 
Photolysis of [125I]- 3ßazidocholylhistamine 
Before being able to use the molecule as a photoaf- 
finity label, it was necessary to investigate the interac- 
tion with ultraviolet light of different wavelengths. 
Thus, [125I]- 3ßazidocholylhistamine alone was photolysed 
in buffer A, and the results are shown in Figure 3.15. 
In both cases, with and without the filter, a loss of 
radioactivity from the parent peak on TLC (Rf 0.79) 
resulted from the photolysis. At the same time, radioac- 
tivity on the TLC plate increased at the origin or at a 
point close to but clearly distinct from the origin (Rf 
approximately 0.2). With no filter in position, the 
solution was exposed to ultra- violet light of wavelength 
less than 300 nm, and loss of radioactivity was rapid from 
the parent peak, reappearing mostly at the origin, con- 
sistent with the mobility of free iodide. However, some 
20% of the radioactivity appeared at a position 
corresponding to that of iodinated histamine (Rf 0.2). 
Photolysis with the filter, cutting out ultraviolet 
light below 300 nm, resulted in a slower loss of radioac- 
tivity from the parent peak, all of which reappeared at a 
position consistent with iodinated histamine (Rf 0.2). 
After 30 min, approximately ü0% of the radioactivity was 
still at the position of the original bile acid deriva- 































































FIGURE 3.15 Photolysis of [125I]- 3pazidocholylhistamine. 
The molecule (5 pmol, 10;uCi) was photo - 
lysed, with and without filter, in buffer A 
(10 ml). Photolysed samples (0,5,10,20 and 
30 min) were run on TLC in solvent system 
scraped and counted for [1251]. 
115. 
Stability of protein durina. photolysis 
A known bile acid -binding protein, bovine serum albu- 
min, was used in an experiment to determine the effect of 
ultra -violet light on proteins during photolysis. BSA 
was photolysed alone, with and without the filter, for 
different lengths of time, and the results of the 
SDS /polyacrylamide -gel electrophoresis analysis are shown 
in Figure 3.16. These results demonstrate that light 
below 300 nm is the more destructive, with less than 10% 
of the BSA containing the correct electrophoretic mobility 
after 60 min photolysis. With the filter in place, 
however, more than 90% of the BSA is unaltered after the 
same length of photolysis. 
Photoaffinit labelling of bovine serum albumin with 
[125I]- 3ßazidocholylhistamine 
Bile acid -free BSA was photolysed for different times 
with the putative photoaffinity label, both with and 
without the borosilicate glass filter; portions were 
removed at timed intervals and analysed on SDS /PAGE. The 
results are shown in Figure 3.17. The extent of covalent 
labelling of BSA is clearly greater with light above 300 nm 
than below. Indeed, whereas the amount of radioactivity 
associated with the BSA band on SDS /PAGE with no filter 
decreases after 60 min, when the filter is used the extent 
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FIGURE 3.16 Stability of bovine serum albumin during 
photolysis. Stripped BSA (100 mg) in 
buffer A (10 ml) was photolysed for 60 min 
without (A) and with (B) borosilicate glass 
filter. 
Tracks 1 and 7 - control (unphotolysed BSA), 
Track 2 - 6 - BSA photolysed for 
5,10,20,30 and 60 min 
respectively. 
Portions (50,u1) were removed at each 
interval, prepared for SDS/polyacrylamide - 
gel electrophoresis and analysed on a 12% 
resolving gel. 
118. 
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FIGURE 3.17 Photoaffinity labelling of bile acid -free 
BSA with [1251]- 3pazidocholylhistamine. 
Stripped BSA (100 mg) in buffer A (10 ml) 
was photolysed in the presence of [125I] -3p 
azidocholylhistamine (5 pmol, 10 uCi) both 
with and without the borosilicate glass 
filter, for 60 min. At 0,5,10,20,30 and 
60 min, portions (50»1) were removed, pre- 
pared for SDS /polyacrylamide -gel 
electrophoresis, and analysed on a 12% 
resolving gel. 
Inset at bottom shows position of BSA 
band on gel. 
120. 
As an alternative means of demonstrating covalent 
attachment of the label to protein, the photolysed solu- 
tions (after 60 min) were applied to columns of Sephadex 
G -100 fine and eluted with buffer A (Figure 3.18). A 
control solution, (Figure 3.18c) where no photolysis had 
taken place, shows the BSA elutes at a volume of approxi- 
mately 100 ml, with no associated radioactivity. The 
label appears in the salt volume (250 ml) of the column. 
Analysis of the Sephadex G -100 eluate obtained from 
the photolysed mixture, shown in Figure 3.18 A and B, 
revealed the free unreacted label again eluted at 200 - 
250 ml in the salt volume of the column, but there was 
also radioactivity associated with the BSA. When the 
filter used during photolysis (B), BSA /radio- 
activity eluted at approximately the same volume as the 
BSA in the control (C) i.e., 100 ml. In contrast, with 
no filter used (A), the majority of the BSA /radio- activity 
appeared in the void volume of the column (approximately 
50 ml), with only a small amount of BSA alone at a volume 
of 100 ml. The void volume material represents BSA 
aggregates formed during photolysis, and is consistent 
with the high molecular mass band seen at the top of the 























































































































































FIGURE 3.18 Gel filtration of photolysis products. 
After 60 min photolysis without (A) and with 
(B) the borosilicate glass filter, the solutions 
(10 ml) of BSA and [125I]- 3pazidocholylhistamine 
(10 mg /ml and 0.5 pmol /ml respectively) were 
applied to columns of Sephadex G -100 fine (2.6 cm 
x 12 cm) and eluted with buffer A. Flow rate was 
21 ml /h and the fraction volume 5 ml. 
A control (C), where no photolysis had taken 
place, is also shown. 
123. 
Photoaffinity labelling of rat material 
(i) Whole rat hepatic cytosol 
A portion of rat hepatic cytosol was photolysed in the 
presence of [125I]- 3pazidocholylhistamine for a total 
period of 3 h and samples were taken at intervals for ana- 
lysis by SDS /polyacrylamide -gel electrophoresis (Figure 
3.19). A portion of the final reaction mixture was ana- 
lysed by gel filtration chromatography on Sephadex G -75 
superfine (Figure 3.20). 
The SDS /polyacrylamide -gel electrophoresis showed the 
appearance of labelling after 1 h, increasing to 2 h, 
labelling is 
and then 3 h. The - , - associated with protein 
bands of approximate molecular masses 60 000 Da (albumin), 
45 000 Da (hydroxycholanoyl transferase), 35 000 Da and 25 
labelling 
000 Da (glutathione S- transferase). The ,, at 35 000 Da 
is suggested to be the Y' fraction, containing new binding 
protein. This overall picture is supported by gel filtra- 
tion of the 3 h photolysed sample, which shows labelling 
of the Y1 region. Radioactivity can also be seen at the 
top of the resolving gel, still increasing after 3 h. 
This is thought to be due to photolytically- mediated 
aggregations of labelled proteins, forming so large a mass 
as to be unable to enter the resolving gel. 
NOTE: As the cytosol used in these experiments was 
derived from unperfused liver, consideration must 
he given to the possibility of the contribution 
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FIGURE 3.19 Photoaffinity labelling of whole rat hepatic 
cytosol with [1251]- 3pazidocholylhistamine. 
A portion of rat hepatic cytosol (100 mg, 10 
ml) was photolysed for a total of 3 h with 
[1251]- 3ßazidocholylhistamine (10;uCi., 5 pmol). 
Samples were taken at 0, 1 h, 2 h and 3 h, pre- 
pared for SDS /polyacrylamide -gel electrophoresis 
and analysed on a 12% gel. Three proteins were 
used as standards - BSA (66 000 Da), ovalbumin 
(45 000 Da) and myoglobin (17 000 Da). The gel 
tracks were cut into 0.5 cm slices and counted 
for 1251. 
126. 
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FIGURE 3.20 Gel filtration of photoaffinity labelled rat 
hepatic cytosol on Sephadex G -75 superfine. 
A portion of rat hepatic cytosol (50 mg, 5 
ml) which had been photolysed with [1251]- 3$azi- 
docholylhistamine (10,uCi, 5 pmol) for 3 h, was 
applied to a column (2.6 cm x 100 cm) of Sephadex 
G -75 superfine and eluted with buffer A. Flow 
rate was 9 ml /h and the fraction volume 1.5 ml. 
128. 
(ii) Glutathione S- transferase fraction (Y peak) 
A portion of rat liver cytosol from the second 
Sephadex G -75 superfine step of the Y' protein purifica- 
tion scheme (see next section), containing mainly the glu- 
tathione S- transferases, was photolysed for a total period 
of 2 h. Samples were taken at intervals and analysed by 
SDS /polyacrylamide -gel 
shown in Figure 3.21. 
The majority of labelling on the gel is 
with the glutathione S- transferase subunits 
electrophoresis - the results are 
associated 
Ya, Yb and Yc. 
However, a smaller degree of labelling is seen with pro- 
teins in the 30 000 -40 000 Da range 
and with two proteins of approximate molecular mass 15 000 
(i.e all components of the Y` fraction on sephadex). 
Da./ The extent of labelling still apparently increases 
after 2 h, although the amount of radioactivity found at 
the top of the resolving gel (Figure 3.21, left) also 
increases. This may again be due to photolytically- 
mediated aggregation of labelled proteins, as explained in 
the previous section. 
Purified glutathione S- transferases were also photoaf- 
finity labelled and assessed for the covalent incor- 
poration of [1251]- 3pazidocholylhistamine. The results 
of this experiment, using glutathione S- transferases AA, 
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FIGURE 3.21 Photoaffinity labelling of glutathione 
S- transferase fraction with [1251]-3f3azidocho- 
lylhistamine. 
A portion of the glutathione S- transferase 
fraction (30 mg, 10 ml) from rat hepatic cytosol 
was photolysed for a total of 2 h with [125I] -3p 
azidocholylhistamine (10uCi, 5 pmol). Samples 
were taken at 0, 1 h and 2 h, prepared for 
SDS /polyacrylamide -gel electrophoresis and ana- 
lysed on a 12% resolving gel. The gel tracks 
were cut into 0.5 cm slices and counted for 
[1251]. 
These protein bands as marked * on the gel track 
reproduced opposite are components of the Y1fraction. 
The three subunits of the glutathione S- transferases are 
indicated as shown (Ya, Yb, Ye). 
131. 
Table 3.2. Photoaffinity labelling of purified glu - 







Subunit Incorporation of [1251] 





Portions (50 ug) of glutathione S- transferases AA, A, D 
and F were photolysed with [1251] -3fl azidocholylhistamine 
(2.5uCi, 1.25 pmol) for 15 min. After TCA precipitation 
and extensive washing, the proteins were taken up in 
buffer A, containing 1% SDS (w /v) (500,u1). Samples were 
applied to a column (1.5 cm x 20 cm) of Sephadex G -25 fine 
and eluted with the same buffer. Flow rate was 25 m1 /h 
and fraction volume 4 ml. 
132. 
PURIFICATION OF Y' PROTEINS FROM RAT HEPATIC CYTOSOL 
Y' Protein Purification 
The purification scheme for Yt proteins is shown in 
Table 2.4, and essentially consists of three gel filtra- 
tion steps, followed by ion exchange, chromatofocusing and 
finally hydroxyapatite chromatography. 
Cytosol (approximately 7 g of protein) from 90 -100 g 
of rat liver was applied to a column of Sephadex G -100 and 
eluted with buffer A (Figure 3.22). The glutathione S- 
transferase fractions were pooled and concentrated by 
ultrafiltration. 
The concentrated Y peak (approximately 2 g of protein, 
80 ml) was centrifuged (20 min. 40C, 20 000 g) and applied 
to a column of Sephadex G -75 superfine which was eluted 
with buffer A. The resulting elution profile is shown in 
Figure 3.23. From the results of SDS /polyacrylamide -gel 
electrophoresis, those fractions which contained polypep- 
tides in the range 30 000 Da to 15 000 Da were pooled 
(Figure 3.24). As Figure 3.24 shows, the Y' proteins 
were not completely resolved from the glutathione S- 
transferases. A second gel filtration step on Sephadex 
G -75 superfine was generally required to achieve this 
separation. 
The partially purified Y1 peak (approximately 40 ml, 
500 mg of protein) was re- applied to the column of 

























































FIGURE 3.22 Gel filtration of rat hepatic cytosol on 
Sephadex G -100. Freshly prepared rat hepatic 
cytosol (approximately 7 g of protein) was 
applied to two columns in series of Sephadex 
G -100 fine (total volume 2675 ml) and eluted 
with buffer A. Flow rate was 22.5 ml /h and the 
fraction volume 3.7 ml. The bar in the figure 
represents the material which was pooled for the 






























































































FIGURE 3.23. Gel filtration of the Y'peak on Sephadex 
G -75 superfine. 
The glutathione S- transferase peak from the 
G -100 step was applied to two columns in series 
(total volume 2050 ml) of Sephadex G -75 superfine 
and eluted with buffer A. Flow rate was 15 ml /h 
and the fraction volume 2.5 ml. 
The bar in the figure represents the 
material which was pooled for the next stage of 
the purification. The letters beside certain 
fractions indicate those which were analysed by 

















































































































FIGURE 3.24 SDS /polyacrylamide -gel electrophoresis of 
fractions from first Sephadex G -75 superfine 
step. 
Portions of the fractions from the first 
G -75 gel filtration step, represented by letters 
in Figure 3.23 and also shown above, were pre- 
pared for SDS /polyacrylamide -gel electrophoresis 
and analysed on a 12% resolving gel. 
139. 
described above. Figure 3.25 shows that the Y' peak was 
almost completely resolved from the Y peak and, on the 
basis of SDS /polyacrylamide -gel electrophoresis of the 
peak fractions, (Figure 3.26), the material represented by 
the bar was pooled for the next purification step. 
The pooled Y. peak was applied to a column of DEAE 
Sephadex and eluted as described in the Materials and 
Methods. The resulting elution profile is shown in 
Figure 3.27 and the electrophoretic analysis of the peak 
fractions in Figure 3.28. A total of 12 peaks were 
eluted from the ion - exchange column. Each was tested for 
glutathione S- transferase activity; only the void volume 
fraction, peak 1, showed any significant enzyme activity 
(Table 3.3). Bands which co- migrated during 
electrophoresis with glutathione S- transferase subunits 
could be seen in peak 1. The molecular masses of the 
proteins from each peak are summarised in Table 3.4. 
Portions of each peak obtained from DEAE -Sephadex were 
subjected to photoaffinity labelling with [125I]_3pazi- 
docholylhistamine, in order to determine the bile acid - 
binding potential of the proteins. This is described in 
more detail later (p.167). 
On the basis of the results from photoaffinity 
labelling, peaks 5, 6, 7 and 8 were pooled, as repre- 
sented by the bars in Figure 3.27, and dialysed against 
buffer C. Each peak was then individually applied to 
chromatofocusing columns of PBE 94 and eluted with buffer D. 
140. 
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FIGURE 3.25 Gel filtration of partially purified Y' peak 
on Sephadex G -75 superfine. 
The partially purified Y' peak from the 
first G -75 step was re- applied to the two 
columns of Sephadex G -75 superfine (total volume 
2050 ml) and eluted with buffer A. The flow 
rate was 15 ml /h and the fraction volume 2.5 ml. 
The bar in the figure represents the material 
which was pooled for the next stage of the puri- 
fication. The letters beside certain peak 
fractions indicate those which were analysed by 































FIGURE 3.26 SDS /polyacrylamide -gel electrophoresis of 
peak fractions from second Sephadex G -75 step. 
Portions of the fractions from the second 
G -75 step, represented by letters in Figure 
3.25 and also shown opposite, were prepared for 
SDS /polyacrylamide -gel electrophoresis and ana- 





































































































































































FIGURE 3.27 Y' peak on DEAE Sephadex. 
The pooled Y' peak from the second gel 
filtration step (approximately 100 ml, 175 mg 
protein) was applied to a column (2.2 cm x 25 
cm) of DEAF Sephadex A -50 (total volume 95 ml) 
equilibrated with buffer B. Elution was as 
described in the Material and Methods. 
Portions of each of the peak fractions were pre- 
pared for SDS /polyacrylamide -gel electrophoresis 







































FIGURE 3.28 SDS /polyacrylamide -gel electrophoresis of 
Y' proteins from DEAE Sephadex. 
Portions of each peak fraction from the DEAE 
Sephadex step (Figure 3.27) were prepared for 
SDS /polyacrylamide -gel electrophoresis and ana- 
lysed on a 12% resolving gel. The marker pro- 
tein had seven standards and a typical 
calibration is shown in Figure 2.1. 
148. 
Table 3.3: Glutathione S- transferase activity of Yi 
Peak 
peaks from DEAE Sephadex 














Table 3.4: Molecular masses of YI_proeins from 
DEAE Sephadex 
Peak Molecular mass of rotein bands (Da) 
1 17 700; 14 900; 
2 28 600; 
3 28 600; 
4 50 600; 37 900; 28 600; 
5 37 900; 34 400; 33 500; 32 700; 
17 400; 16 000; 13 000; 
6 35 300; 34 400; 32 400; 17 500; 
7 37 200; 35 000; 13 100; 12 700; 
8 31 800; 30 400; 
9 31 800; 24 000; 
10 31 800; 24 000; 15 100; 
11 24 000; 15 100; 
12 NO VISIBLE BANDS. 
Calibration of a 12% resolving gel using a seven protein 
standard - see Figure 2.1. The approximate molecular 
masses given here are derived from the SDS/polyacrylamide - 
gel in Figure 3.25; no attempt has been made here to indi- 
cate whether a band is a major or minor component of a 
peak. 
150. 
The elution profiles of peaks 5 to 8 are given in Figures 
3.29 to 3.32 respectively. Figures 3.33 and 3.34 show 
the electrophoretic analysis of the peak fractions from 
each chromatofocusing run. The molecular masses of the 
protein bands are summarised in Table 3.4. 
Each of the peaks from the four chromatofocusing runs 
were photoaffinity labelled with [125I]-3fiazidocho- 
lylhistamine to test for bile acid -binding. This is 
described in more detail later (p.167), and the results 
given in Table 3.5. 
Those proteins which were photoaffinity labelled could 
be divided into two groups - those with a high specific 
labelling following photolysis (> 1 x 105 counts per 
minute per 50 ug protein - 5B, 6E, 7F) and those with a 
high total labelling (> 1 x 106 counts per minute per peak 
5C, 5D, 8c). In order to perform peptide "mapping" on 
these proteins and also to raise antisera against them, it 
was necessary to remove all traces of impurities. Peaks 
6E and 7F were not further purified as they were present 
in small quantities and were estimated to be >95% pure. 
However, peaks 5B, 5C, 5D and 8C were applied separately 
to a column of hydroxyapatite (2.2 cm x 13 cm) equilibrated 
with buffer H and eluted with a 0 -500 mM potassium 
phosphate linear gradient (150 ml) buffer I. The peaks 
were then pooled as shown in Figure 3.35. Further puri- 
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FIGURE 3.29 Chromatofocusing of Y' peak 5 from DEAE 
Sephadex. Peak 5 from DEAE (9 ml, 9 mg of 
protein) was applied to a column, 1 cm x 28 cm 
(22m1), of PBE 94 equilbrated with buffer C, and 
eluted with buffer D. Flow rate was 15.2 ml /h 
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FIGURE 3.30 Chromatofocusing of Y` peak 6 from DEAE 
Sephadex. Peak 6 from DEAE (11 ml, 9 mg) was 
applied to a column, 1 cm x 28 cm (22 ml), of 
PBE 94, equilibrated with buffer C, and eluted 
with buffer D. Flow rate was 15.2 m1 /h and 
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FIGURE 3.31 Chromatofocusing of Y' peak 7 from DEAE 
Sephadex. Peak 7 from DEAE (9 ml, 12 mg) was 
applied to a column, 1 cm x 28 cm (22m1), of PBE 
94 equilibrated with buffer C, and eluted with 
buffer D. Flow rate was 15.2 ml /h and the 
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FIGURE 3.32 Chromatofocusing of Yi peak 8 from DEAE 
Sephadex. Peak 8 from DEAE (10 ml, 15.5 mg) 
was applied to a column, 1cm x 28 cm (22 ml), of 
PBE 94 equilibrated with buffer C, and eluted 
with buffer D. Flow rate was 15.2 ml /h and the 





























FIGURE 3.33 SDS /polyacrylamide -gel electrophoresis of 
chromatofocusing fractions from peaks 6 and 8. 
The fractions shown below were prepared for 
SDS /polyacrylamide -gel electrophoresis and ana- 
lysed on a 12% resolving gel. The sample let- 
tering refers to Figures 3.30 and 3.32 
(NOTE: B/C refers to the peak between B and C 
in peak 8). 
Marker contained four proteins as standards 
































FIGURE 3.31 SDS /polyacrylamide -gel electrophoresis of 
chromatofocusing fractions from peaks 5 and 7. 
The fractions shown below were prepared for 
SDS /polyacrylamide -gel electrophoresis and ana- 
lysed on a 12% resolving gel. The sample let- 
tering refers to Figures 3.29 and 3.31. 
Table 3.5: 
159. 
Molecular masses of, proteins from 
chromatofocusi.ng of Y' peaks 5, 6, 7 and 8 
Peak Molecular mass (Da) 
5 A 14 300 
B 19 600 
C 36 200 
D 36 200 




B 35 800 
C 35 800 
D 35 800 
E 15 600 
F ND 
7 A ND 
B 39 000 
C 39 000 
D 39 000 
E 35 800 
F 14 900 
G ND 
8 A 33 000 
B 33 000 




The approximate molecular masses given 
here are 
derived from the gels in Figures 3.30 
and 3.31. A 12% 
resolving gel was used, with a four protein 
marker as 
standard. 
ND - Not detected; 
* - insufficient material. 
160. 
achieved by re- chromatofocusing with a shallower pH gra- 
dient (Figure 3.36) and the peaks pooled as shown. 
Analysis of the purified peaks by SDS /polyacrylamide -gel 
electrophoresis (Figure 3.37)illustratedthe purity of the 
proteins. 
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FIGURE 3.35 Purification of peaks 5B, 5C, 5D and 8C on 
hydroxyapatite. Peaks 5B (2.75 mg), 5C (10.5 
mg), 5D (5.6 mg) and 8C (6.9 mg) were applied to 
a column of hydroxyapatite (22 cm x 13 cm) 
equilibrated with buffer H and eluted with a 
0 -500 mM potassium phosphate linear gradient 
(150 ml buffer I). Flow rate was 13 ml /h and 





















FIGURE 3.36 Purification of peaks 5B and 5C by re- 
chromatofocusing. Peaks 5B (1.4 mg) and 5D 
(8.2 mg) were applied to a column of PBE 74 (1 
cm x 28 cm) and equilibrated with buffer C (pH 
6.2). The protein was then eluted with buffer 
D (pH 4.8). Flow rate was 14.5 ml /h and frac- 







































FIGURE 3.37 SDS /polyacrylamide -gel electrophoresis of 
pure Y1 proteins. Samples were prepared for 
SDS /polyacrylamide -gel electrophoresis and ana- 
lysed on a 12% resolving gel. The marker con- 
tained seven proteins as standards and a typical 
calibration is shown in Figure 2.1. 
The streaks at the bottom of some tracks are 
due to polybuffer present in the sample. 
167. 
Photoaffinity labelling of Y' proteins 
At each stage during the purification of Y' proteins a 
portion (50 Aig) was subjected to photoaffinity labelling. 
Table 3.6, which summarises the purification procedure, 
includes the results of these experiments. 
As a first experiment, portions of each peak from 
DEAF Sephadex were photoaffinity labelled with [125I] -3fl 
azidocholylhistamine for up to 60 min, and after TCA pre- 
cipitation and extensive washing, the products were ana- 
lysed by SDS /polyacrylamide -gel electrophoresis. The 
results are shown in Figure 3.38. It can clearly be seen 
that only peaks 5, 6, 7 and 8 have any substantial amounts 
of labelling; it was this result which prompted the 
further investigation of these peaks. 
Subsequent photoaffinity labelling experiments, 
however, utilised less protein, a shorter photolysis time 
and a different, faster, separation method for analysis of 
the covalent incorporation of [1251]. A small pilot 
experiment with peak 5B, thought to be a bile acid -binding 
protein, confirmed the validity of this approach and is 
shown in Figure 3.39. With lower concentrations of pro- 
tein e.g. 5,ug /ml instead of 1 -10 mg /ml, a shorter photo- 
lysis time can be employed. The optimal time, for maxi- 
mal covalent incorporation of [125I], as indicated in 
Figure 3.39 was 15 min. TCA precipitation alone was 
found to be insufficient for the removal of all non - 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































FIGURE 3.38 Photoaffinity labelling of peaks from DEAE 
Sephadex. Portions of each peak from DEAE 
Sephadex were photolysed with [125I]-33azidocho- 
lylhistamine (10uCi, 5 pmol) for 60 min. The 
protein was precipitated with 10% TCA, prepared 
for SDS /polyacrylamide -gel electrophoresis and 
analysed on a 12% resolving gel. After 
staining, the gel tracks were cut into 0.5 cm 
slices and counted for [1251]. 
Broken lines indicate top and bottom of 
resolving gel; an attempt has been made to 
represent the various protein bands in accor- 
dance with their original appearance. 
B- bovine serum albumin; 0- ovalbumin; M- 
myoglobin. 
`w


































FIGURE 3.39 Photoaffinity labelling of peak 5B at low 
protein concentration (50 /ug) with [125I] -30 
azidocholylhistamine (2.5 uCi, 1.25 pmol) in 
buffer A (10 ml) for the times shown below. 
The samples were precipitated with TCA, exten- 
sively washed, then taken up in buffer A con- 
taining 1% SDS (w /v) (500)u1). Samples were 
run on a column (1.5 cm x 20 cm) of Sephadex 
G -25 fine and eluted with the same buffer. 
Flow rate was 25 ml /h and fraction volume 4 ml. 
174. 
(Table 3.7). A quicker method, capable of handling more 
samples, was employed. This involved gel filtration of 
the labelled proteins under denaturing conditions, i.e. in 
buffer A containing 1% SDS (w /v). With the protein 
structure in random coil formation, all non -covalently 
bound label was separated from labelled protein, the 
former eluting from the column in the salt volume, the 
latter in the void volume. The figures given in Table 
3.6 are derived from analysis of the labelled proteins 
using this method. The Y' peaks from DEAE Sephadex were 
also analysed in this way following photoaffinity 
labelling, and the results are shown in Table 3.8 for com- 
parison with the electrophoretic analysis (Figure 3.38). 
PEPTIDE "MAPPING" OF BILE ACID -BINDING PROTEINS 
Peaks 5B, 5C, 5D, 6E, 7F and 8C from chromatofocusing 
were analysed by peptide "mapping ". These proteins had 
been identified as putative bile acid -binding proteins 
from the results of photoaffinity labelling experiments, 
and could be split into two categories: - 
1) Proteins with a high specific labelling ()1 x 
105 counts per minute per 50 ug protein) - 5B, 6E and 
7F; 
2) Proteins with a high total labelling (J1 x 106 
counts 
per minute) - 5C, 5D, 8C. 
Peptide "mapping" was carried out using two 
different 
methods - by limited proteolytic digestion in 
the presence 
of SDS and analysis on SDS /PAGE (Cleveland 
gels), and by 
175. 
Table 3.7 Comparison of TCA precipitation and TCA 
precipitation /denaturing del filtration 
for analysis of labelled proteins 
Fraction 
[1251] CPM x 10- 3 /50,ug protein 
TCA TCA_precipitati.on /denaturing 
Precipitation gel filtration 
Peak 5B 213 
Peak 5D 118 
34 
8 
Peaks 5B and 5D (50ug each) were photoaffinity 
labelled with [125I]- 3azidocholylhistamine (2.5,uCi, 
1.25 pmol). Following TCA precipitation, the protein 
samples were counted for [1251], before application to a 
column of G -25 Sephadex fine, 1.5 cm x 20 cm, and eluted 
with buffer A containing 1% SDS (w /v). Fraction volume 
was 4 ml and the flow rate 25 ml /h. The labelled pro- 
tein eluted from the column in the void volume 
(approximately 10 ml) and the non -covalently -bound label 
in the salt volume (approximately 25 ml). 
Table 3.8 
176. 
Photoaffinity labelling of Y' peaks from 
DEAE Sephadex and analysis by TCA 
precipitation /denaturing gel filtration. 
Peak 
[1251] counts 













Portions (50,,ug) of each Y' peak from DEAE Sephadex 
were photoaffinity labelled with [1251]-3/3azidocho- 
lylhistamine (2.5,uCi, 1.25 pmol) in buffer A (10 ml) for 
15 min. The samples were precipitated with 10% TCA, 
extensively washed, then taken up in buffer A (500,,u1) 
containing 1% SDS (w /v). Samples were then eluted from a 
column (1.5 cm x 20 cm) of Sephadex G -25 fine with the 
same buffer. Flow rate was 25 ml /h and fraction volume 
4 ml. * = analysis not performed. 
177. 
tryptic digestion and analysis on reverse -phase high per- 
formance liquid chromatography. 
Limited proteolytic digestion in the presence of SDS 
The peptide "maps" derived from limited digestion by 
-chymotrypsin are shown in Figures 3.40 and 3.41. The 
"maps" of 5B, 6E and 7F show that these proteins are 
somewhat resistant to digestion, with only a small number 
of peptides being generated even at a protease con- 
centration of 100,ug /ml. Two, or possibly three, pep- 
tides, of approximate molecular masses 10 000 Da, 11 000 
Da and 15 000 Da, may be common to these three proteins, 
and the latter perhaps also to 5C, 5D and 8C. However, as 
these bands run close to the lower molecular mass com- 
ponent of CC- chymotrypsin, a difficulty arises in 
distinguishing between them. These are indicated in 
Figure 3.40. 
Proteins 5C, 5D and 8C digested somewhat better 
(Figure 3.41) and show two peptides apparently common to 
all three, with approximate molecular masses of 18 000 Da 






























FIGURE 3.40 Peptide "maps" of peaks 5B, 6E and 7F by 
limited proteolyti.c digestion in presence of 
SDS. 
A portion (100)ug) of each protein was par- 
tially digested in 0.5% SDS (w /v) for 60 min at 
37 °C in the presence of either 100jug /ml, 12.5 
,pug /ml or 2.5iug /ml of oC- chymotrypsin. The reac- 
tion was stopped by boiling after the addition of 
SDS and mercaptoethanol to final concentrations 
of 2% and 10% respectively. The samples were 
then analysed by SDS /polyacrylami.de -gel 
electrophoresis on 16.5% resolving gel. 
The samples applied were 1: o(- chymotrypsin 
(10,ug), 2 -4: binder 5B and 2.5, 12.5, 100)ug /ml 
o(- chymotrypsin respectively, 5 -8: binder 6E 
(2/ug) and 2.5, 12.5, l00 íug /ml cC- chymotrypsin 
respectively, 9 -12: binder 7F (2,ug) and 2.5, 
12.5, 100ìug /ml 0(- chymotrypsin respectively. 
off- chymotrypsin, treated in the same way as 
the Y1 binders, was dissociated into its 
subunits (approximate molecular masses 17 000 Da 
and 11 000 Da respectively) and used as a molecu- 
lar mass marker (Track 1). 
Common peptides are indicated, with approxi- 















































FIGURE 3.41 Peptide "maps" of peaks 5D and 8C by limited 
proteolytic digestion in the presence of SDS. 
A portion (100,ug) of each protein was par- 
tially digested in 0.5% SDS (w /v) for 60 min at 
37 °C in the presence of either 100/ug /ml, 12.5 
,ug /ml or 2.5 ,ug /ml of % chymotrypsin. The 
reaction was stopped by boiling after the addi- 
tion of SDS and mercaptoethanol to final con- 
centrations of 2% and 10% respectively. The 
samples were then analysed by SDS /polyacrylamide - 
gel electrophoresis on 16.5% resolving gel. 
The samples applied were 1: o(- chymotrypsin 
(10,0g), 2 -5: binder 5C (1qug) and 2.5, 12.5, 
100 ,ug /ml o chymotrypsin respectively, 11 -14: 
binder 8C (5,ug) and 2.5, 12.5, 100/ug /m10C- 
chymotrypsin respectively. 
06chymotrypsin, treated in the same way as 
the Y' binders, was dissociated into its subu- 
nits (approximate molecular masses 17 000 Da and 
11 000 Da respectively) and was used as a mole- 
cular mass marker. 
Common peptides are indicated, with approxi- 
mate molecular masses in Da (x 10-3). 
182. 
Tryptic digestion and analysis on reverse -phase 
high performance liquid chromatography 
The peptide "maps" of the six Y' proteins and four 
glutathione S- transferases are shown to Figures 3.42 to 
3.51 and Tables 3.9 to 3.11 summarises the results. 
The dried, digested proteins were taken up in a volume 
of starting solvent (water and trifluoroacetic acid (TFA), 
0.05% (v /v)) such that the resulting solution was approxi- 
mately 1 mg /mi with respect to protein concentration. 
The solution was centrifuged (1500 g, 15 min) immediately 
prior to application to the HPLC system in order to remove 
insoluble material which was present in all the digests. 
In addition, each of the ten bile acid -binding pro- 
teins were photoaffinity labelled and then peptide 
"mapped" as previously described. Fractions were 
collected from the column and counted for radioactivity. 
Figures 3.52 to 3.54 show these results, with a summary in 
Tables 3.12 to 3.14. A portion of unreacted [1252] -33 
azidocholylhistamine was eluted from the reverse -phase 
column under the same conditions as for the peptide "maps" 




FIGURE 3.42 Peptide "map" of binder 5B. 
A portion of binder 5B (500)ug) was oxidised 
with performic acid and then digested with tryp- 
sin. The resulting peptides (25,ug) were 
eluted from a reverse -phase HPLC column (0.39 cm 
x 30 cm) with a linear gradient (0 - 60 %) of 
acetonitrile. 
The flow rate was 1 ml /min and the peptides were 
detected by their absorbance at 254 nm. 
Key to common peaks - A: 5B - 6E 
B: 5B - 7F 
C: 6E - 7F 
*: common to group 1 binders 
o: common to group 1 and group 2 binders 
p: common to Y1 binders and glutathione S- 
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FIGURE 3.43 Peptide "map" of binder 6E. 
A portion of binder 6E (200,ug) was oxidised 
with performic acid and then digested with tryp- 
sin. The resulting peptides (70,ug) were 
eluted from a reverse -phase HPLC column (0.39 
cm x 30 cm) with a linear gradient (0 - 60 %) of 
acetonitrile. The flow rate was 1 Ml/min and 
the peptides were detected by their absorbance 
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FIGURE 3.44 Peptide 'map" of binder 7F. 
A portion of binder 7F (600 ug) was oxidised 
with performic acid and then digested with tryp- 
sin. The resulting peptides (50 ug) were 
eluted from a reverse -phase HPLC column (0.39 
cm x 30 cm) with a linear gradient (0 - 60 %) 
of acetonitrile. The flow rate was 1 ml /min 
and the peptides were detected by their absor- 
bance at 254 nm. Key to common peaks - See 
legend to Figure 3.42. 
INJ: injection. 
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FIGURE 3.45 Peptide "map" of binder 5C. 
A portion of binder 5C (5001ug) was oxidised 
with performic acid and then digested with tryp- 
sin. The resulting peptides (100áug) were 
eluted from a reverse -phase HPLC column (0.39 
cm x 30 cm) with a linear gradient (0 - 60 %) of 
acetonitrile. The flow rate was 1 ml/min and 
the peptides were detected by their absorbance 
at 254 nm. 
Key to common peaks - D: 5C - 5D 
E: 5C - 8C 
F: 5D - 8C 
0 : common to group 2 binders 
o : common to group 1 and group 2 binders 
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FIGURE 3.46 Peptide "map" of binder 5D. 
A portion of binder 5D (500,ug) was oxidised 
with performi.c acid and then digested with tryp- 
sin. The resulting peptides (75iug) were 
eluted from a reverse -phase HPLC column (0.39 cm 
x 30 cm) with a linear gradient (0 - 60 %) of 
acetonitrile. The flow rate was 1 ml /min and 
the peptides were detected by their absorbance 
at 254 nm. 




FIGURE 3.47 Peptide "map" of binder 8C. 
A portion of binder 8C (500iug) was oxidised 
with performic acid and then digested with tryp- 
sin. The resulting peptides (100iug) were 
eluted from a reverse -phase HPLC column (0.39 
cm x 30 cm) with a linear gradient (0 - 60 %) of 
acetonitrile. The flow rate was 1 ml/min and 
the peptides were detected by their absorbance 
at 254 nm. 
































































































FIGURE 3.48 Peptide "map" of glutathione S- transferase AA 
A portion of glutathione S- transferase (500/ug) 
was oxidised with performic acid and then 
digested with trypsin. The resulting peptides 
(125,ug) were eluted from a reverse -phase HPLC 
column with a linear gradient (0 - 60 %) of ace - 
tonitrile. The flow rate was 1 ml/min and the 
peptides were detected by their absorbance at 
254 nm. 
Key to common peaks - G: AA -A K: A -D 
H: AA -D L: A -F 
J: AA -F M: D -F 
o: common to glutathione S- transferases AA, A, 
D and F. 
common to Y binders and glutathione S- 
transferases AA, A, D and F. 
INJ: injection. 
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FIGURE 3.49 Peptide "map" of glutathione S- transferase A. 
A portion of glutathione S- transferase A (500 
lug) was oxidised with performi.e acid and then 
digested with trypsin. The resulting peptides 
(85,ug) were eluted from a reverse -phase HPLC 
column (0.39 cm x 30 cm) with a linear gradient 
(0 - 60%) of acetonitrile. The flow rate was 
2 ml /min and the peptides were detected by their 
absorbance at 254 nm. 




FIGURE 3.50 Peptide "map" of glutathione S- transferase 
A portion of glutathione S-transferase (500 
jug) was oxidised with performic acid and then 
digested with trypsin. The resulting peptides 
(100,ug) were eluted from a reverse -phase HPLC 
column (0.39 cm x 30 cm) with a linear gradient 
(0 - 60 %) of acetonitrile. The flow rate was 
1 ml /min and the peptides were detected by their 
absorbance at 254 nm. 
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FIGURE 3.51 Peptide "map" of glutathione S- transferase F. 
A portion of glutathione S- transferase F (500 
iug) was oxidised with performic acid and then 
digested with trypsin. The resulting peptides 
(100,ug) were eluted from a reverse -phase HPLC 
column (0.39 cm x 30 cm) with a linear gradient 
(0 -60 %) of acetonitrile. The flow rate was 
1 ml /min and the peptides were detected by their 
absorbance at 254 nm. 
Key to common peaks - See legend to Figure 3.48. 
INJ: injection. 
203. 
Table 3.9 Comparison of peptide "maps" of Y1 bile acid- 
binding proteins 
Comparison of Number of Key symbol on 
binders common_epti_ des peptide "maps" 
Group t 5B - 7F 4 A 
- 7F 4 B 
6E - 7F 20 C 
5B -6E -7F 4 
Group 2 5C - 5D 13 D 
5C - 8C 12 E 
5D - 8C 11 F 
5C -5D -8C 7 
Group 1 - Group 2 2 0 
Refer to Figures 3.42 to 3.47 for peptide "maps" of 
Y' bile acid -binding proteins. 
Table 3.1-0 
204. 
Comparison of peptide "maps" of glutathione 
S- transferases AA, AL D and F 
Comparison of Number of Key symbol on 
binders common peptides peptide "maps" 
Glutathione S- transferase 
AA -A 8 G 
AA -D 12 H 
AA -F 17 J 
A - D 13 K 
A - F 9 L 
D - F 18 M 
AA -A -D -F 5 
Refer to Figures 3.48 to 3.51 for peptide "maps" 
of glutathione S- transferases AA, A, D and F. 
205. 
Table 3.11 Comparison of peptide "maps" of Y' bile acid - 
binding proteins and lutathi.one S- trans- 
ferases AA, A, D and F 
Comparison of Number of Key symbol on 
binders common peptides peptide "maps" 
Y' binders 
Group 1 - Group 2 
Glutathione S- transferases 
2 0 
AA -A -D -F 5 4 
Y' and GST 1 A 
Refer to Figures 3.42 to 3.51 for peptide "maps" 
of Y' bile acid- binding proteins and glutathione S- 
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FIGURE 3.52 Peptide "maps" of photoaffinity labelled 
group 1 Y1 binders. 
Portions of binders 5B (500/ug), 6E (200/ug) and 
7F (600,ug) were photoaffinity labelled with 
[1251]- 3ßazidocholylhistamine (10)uCi, 5 pmol) 
for 15 min. The proteins were then oxidised 
with performic acid and digested with trypsin. 
The resulting peptides were eluted from a 
reverse -phase HPLC column (0.39 cm x 30 cm) with 
a linear gradient (0 - 60 %) of acetonitrile. 
The flow rate was 1 ml /min and fractions of 0.5 
ml were collected and counted for radioactivity. 
The position of the free, unreacted photoaffinity 
label is also shown (lab). 
Key to common peaks - A: 5B - 6E 
B: 5B - 7F 
C: 6E - 7F 
*: common to group 1 binders 
o: common to group 1 and group 2 binders 
L\: common to Y binders and glutathione S- 
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FIGURE 3.53 Peptide "maps" of photoaffinity labelled 
group 2 Yi binders. 
Portions of binders 5C, 5D and 8C (500 jag) were 
photoaffinity labelled with [125I]-3pazidocho- 
lylhistamine (10,uCi, 5 pmol) for 15 min. The 
proteins were then oxidised with performic acid 
and digested with trypsin. The resulting pep- 
tides were eluted from a reverse -phase HPLC 
column (0.39 cm x 30 cm) with a linear gradient 
(0 - 60 %) of acetonitrile. The flow rate was 1 
ml /min and fractions of 0.5 ml were collected 
and counted for radioactivity. The position of 
the free, unreacted label is also shown (lab). 
Key to common peaks - D: 5C - 5D 
E: 5C - 8C 
F: 5D - BC 
1: common to group 2 binders 
o: common to group 1 and group 2 binders 
/ common to Yi binders and glutathione S- 
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FIGURE 3.54 Peptide "maps" of photoaffinity labelled 
glutathione S- transferases AA, A, D and F. 
Portions of GST AA, A, D and F (500,ug each) 
were photoaffinity labelled with [12511- 3j3azi- 
docholylhistamine (10 uCi, 5pmol) for 15 min. 
The proteins were then oxidised with performi.c 
acid and digested with trypsin. The resulting 
peptides were eluted from a reverse -phase HPLC 
column (0.39 cm x 30 cm) with a linear gradient 
(0 - 60 %) of acetonitrile. The flow rate was 1 
ml /min and fractions of 0.5 ml were collected 
and counted for radioactivity. The position of 
the free, unreacted label is also shown (lab). 
Key to common peaks - G: AA -A K: A -D 
H: AA -D L: A -F 
J: AA -F M: D -F 
o: common to glutathione S- transferases 
AA, A, 
D and F 
L: common to Y' binders and glutathione 
S- 
transferases AA, A, D and F. 
212. 
Table 3.12 Comparison of peptide "maps" of photoaffinity 
Y' bile acid- binding proteins 
Comparison of Number of 
binders common peptides 
Group 1 5B - 6E 5 
5B - 7F 5 
6E - 7F 5 
5B -6E -7F 5 
Group 2 5C - 5D 4 
5C - 8C 4 
5D - 8C 4 
5C -5D -8C 4 
Group 1 - Group 2 4 









Refer to Figures 3.52 and 3.53 for peptide "maps" 
of photoaffinity labelled Yi bile acid- binding proteins. 
213. 
TABLE 3.13 Comparison of peptide "maps" of photoaff.inity 
labelled glutathione S- transferases AA GAZ D 
and F 
Comparison of Number of Key symbol on 
binders common peptides peptide "maps" 
Glutathione S-transferase 
AA-A 4 G 
AA-D 4 H 
AA-F 4 J 
A - D 4 K 
A - F 4 L 
D - F 4 M 
AA-A-D-F 4 0 
Refer to Figure 3.54 for peptide "maps" of pho- 
toaffinity labelled glutathione S- transferases AA, A, D 
and F. 
214. 
Table 3.14 Comparison of peptide "maps" of photoaffinity 
labelled Y1 bile acid -binding proteins and 




Number of Key symbol on 
peptide "maps" common peptides 
Group 1 - Group 2 4 
Glutathione S-transferases 
AA-A-D-F 




Refer to Figures 3.52 to 3.54 for peptide "maps" of 
photoaffinity labelled Yi bile acid -binding proteins and 
glutathione S- transferases AA, A, D and F. 
215. 
Tryptic digestion and analysis on thin -layer 
chromatography 
The Y' bile acid -binding proteins and glutathione S- 
transferases which had been photoaffinity labelled and 
then digested with trypsin were also analysed by thin - 
layer chromatography. The results are shown in Figures 
3.55 to 3.60, and Tables 3.15 and 3.16. 
Two solvent systems were employed - 
A) Chloroform:methano1:30% ammonia 
(2:2:1 v /v /v) 
B) n- butanol:2- propanol:acetic acid:water:pyridine 
(15:10:3:12:10 v /v /v /v /v) 
- as recommended for separation of peptides on 
silica gel (Brown et al., 1975). A portion of unreacted 
[125I]- 3pazidocholylhistamine was also run on TLC in order 
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FIGURE 3.55 Separation of peptides from the tryptic 
digestion of photoaffinity labelled group 1 
Y binders by TLC, solvent system A 
The mixtures of peptides from the tryptic digests 
of binders 5B, 6E and 7F (100)ug each) were 
separated by TLC in solvent system A. The deve- 
loped plate was divided into 0.5 cm squares, the 
silica scraped into tubes, and counted for 
radioactivity. The position of the free, 
unreacted photoaffinity label is also shown (lab). 
Key to common peaks - A: 5B -6E 
B: 5B -7F 
C: 6E -7F 
*: common to group 1 binders 
o: common to group 1 and group 2 binders 
A: common to Yi binders and glutathione S- 
transferases AA, A, D and F. 
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FIGURE 3.56 Separation of peptides from the tryptic 
digestion of photoaffinity labelled group 2 
Y1 binders by TLC, solvent system A. 
The mixtures of peptides from the tryptic digests 
of binders 5C, 5D and 8C (100 ug each) were 
separated by TLC in solvent system A. The deve- 
loped plate was divided into 0.5 cm squares, the 
silica scraped into tubes, and counted for 
radioactivity. The position of the free, 
unreacted photoaffinity label is also shown 
(lab). 
Key to common peaks - D: 5C -5D 
E: 5C -8C 
F: 5D -8C 
common to group 2 binders 
o: common to group 1 and group 2 binders 
common to Y' binders and glutathione S- 
transferases AA, A, D and F. 
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FIGURE 3.57 Separation of peptides from the tryptic 
digestion of photoaffinity labelled glu - 
tathione S- transferases AA, A, D and F by 
TLC, solvent system A. 
The mixtures of peptides from the tryptic digests 
of glutathione S- transferases AA, A, D and F (100 
,,ug each) were separated by TLC in solvent system 
A. The developed plate was divided into 0.5 cm 
squares, the silica scraped into tubes and 
counted for radioactivity. The position of the 
free, unreacted photoaffinity label is also shown 
(lab). 
Key to common peaks - G: AA -A K: A -D 
H: AA -D L: A -F 
J: AA -F M: D -F 
e: common to glutathione S- transferases AA, A, 
D and F 
Z\: common to Y' binders and glutathione S- 
transferases AA, A, D and F. 











FIGURE 3.58 Separation of peptides from the tryptic 
digestion of photoaffinity labelled group 1 
Y' binders by TLC, solvent system B. 
The mixtures of peptides from the tryptic digests 
of binders 5B, 6E and 7F (100;ug each) were 
separated by TLC in solvent system B. The deve- 
loped plate was divided into 0.5 cm squares, the 
silica scraped into tubes, and counted for 
radioactivity. The position of the free, 
unreacted photoaffinity label is also shown 
(lab). A: 5B -6E 
B: 5B -7F 
C: 6E -7F 
*: common to group 1 binders 
o: common to group 1 and group 2 binders 
A: common to Yf binders and glutathione S- 
transferases AA, A, D and F. 
Dotted line indicates position of solvent front. 
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FIGURE 3.59 Separation of peptides from the tryptic 
digestion of photoaffinity labelled group 2 
Y1 binders by TLC, solvent system B. 
The mixtures of peptides from the tryptic digests 
of binders 5C, 5D and 8C (100,ug each) were 
separated by TLC in solvent system B. The deve- 
loped plate was divided into 0.5 cm squares, the 
silica scraped into tubes, and counted for 
radioactivity. The position of the free, 
unreacted photoaffinity label is also shown 
(lab). 
Key to common peaks - D: 5C -5D 
E: 5C -8C 
F: 5D -8C 
0: common to group 2 binders 
o: common to group 1 and group 2 binders 
_.: common to Y' binders and glutathione S- 
transferases AA, A, D and F. 
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FIGURE 3.60 Separation of peptides from the tryptic 
digestion of photoaffinity labelled 
glutathione S- transferases AA, A, D and F 
by TLC, solvent system B. 
The mixtures of peptides from the tryptic digests 
of glutathione S- transferases AA, A, D and F (100 
Jug each) were separated by TLC in solvent system 
B. The developed plate was divided into 0.5 cm 
squares, the silica scraped into tubes, and 
counted for radioactivity. The position of the 
free, unreacted photoaffinity label is also shown 
(lab). 
Key to common peaks - G: AA -A K: A -D 
H: AA -D L: A -F 
J: AA -F M: D -F 
o: common to glutathione S- transferases AA, A, 
D and F 
\: common to V biudcrs and glutathione S- 
transferases AA, A, D and F. 
Dotted line indicates position of solvent front. 
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Table 3.15 Comparison of peptide separation) TLC solvent 
systems A and B, for photoaffinity labelled 
Y' bile acid- binding proteins 
Group 1 









5C -5D -8C 
Group 2 
























Refer to Figures 
separation of peptides, in solvent systems A and B, from 
tryptic digest, Y1 bile acid -binding proteins. 
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Table 3.16 Comparison of peptide separation,TLC solvent 
systems A and BL for photoaffinity labelled 
glutathione S- transferases AA, At D and F 
Comparison of 
binders 
Number of Key symbols on 




AA-A 4 1 G 
AA-D 3 1 H 
AA-F 2 1 J 
A-D 3 2 K 
A-F 2 2 L 
D-F 4 2 M 
AA-A-D-F 2 1 e 
Refer to Figures 3.57 and 3.60 for TLC separation of 
peptides, in solvent systems A and B, from tryptic digests 
of glutathione S- transferases AA, A, D and F. 
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Table 3.17 Comparison of peptide se.aration,TLC solvent 
systems A and B for photoaffinitlabelled 
Y' bile acid -binding proteins and glutathione 







Key symbols on 
Eeptide "maps" 
Y' binders 
Group 1- Group 2 1 0 0 
Glutathione S- transferases 
AA -A -D -F 2 1 O 
Y. and GST 1 0 L 
Refer to Figures 3.55 to 3.60 for TLC separation of 
peptides, in solvent systems A and B, from tryptic digests 
of Y' bile acid -binding proteins and glutathione S- 





Hepatic transport of bile acids and bile salts 
Bile acids are the major group of anions transported 
by the liver - in man and the rat 30 g and 200 mg of(bile 
acids plus bile salts) are transported each day respec- 
tively. The enterohepatic circulation is dependent on 
this mechanism operating efficiently in order to re -cycle 
bile acids and bile salts from the intestine back into 
bile. Transport across the hepatocyte can be broken down 
into several stages - uptake at the sinusoidal membrane, 
intracellular transport, and secretion into the canalicu- 
lus. Of these, only the uptake process has been well 
characterised; details of intracellular events are less 
clear. 
Several theories for the transcellular movement of 
bile acids have been put forward. The diffusion of bile 
acids across the hepatocyte in free solution, with passive 
partitioning of the molecules between organelle membranes 
and the cytosol, has received considerable attention. 
The rate of transport across the cell would depend on the 
proportion of bile acid in free solution, and the results 
of measurement of the diffusion coefficient for various 
bile acids are apparently compatible with their crossing 
the liver in free solution. 
Another potential route for bile acids is 
by translo- 
cation in membrane -bound vesicles. Several 
studies have 
provided evidence in support of this process, 
with experi- 
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ments utilising electron microscopic autoradiography to 
visualise the process at different stages. More 
recently, however, workers using the microtubule- 
disrupting agent, colchicine, which interferes with the 
movement of secretory vesicles within hepatocytes, have 
shown it to have no effect on the secretion of taurode- 
hydrocholate into bile (Barnwell et al., 1984). These 
workers suggest that vesicular packaging of bile salts is 
unlikely to occur during the cellular transit from sinu- 
soidal to canalicular membranes, and that movement of bile 
salts is probably in free solution in the cytosol. 
Several groups of bile acid -binding proteins have been 
found in the liver; for example the Y fraction 
(consisting of the glutathione S- transferases), the Z 
fraction, and more recently the Y 
r 
fraction. It is 
uncertain whether such proteins play an "active" role in 
bile acid transport, or whether they serve to prevent 
efflux of bile acids from the hepatocyte as they are con- 
centrated within the cell. Indeed, it is not clear 
whether the glutathione S- transferases bind 
bile acids in 
vivo (Abberger et al., 1983) (see p.258). 
Aims of the study 
The aims of this thesis were as follows 
- 
1) To synthesize the novel bile acid 
derivative [1251] -3p 
-azidocholylhistamine, radioiodinated 




2) To use this molecule as a photoaffinity probe in the 
investigation of bile acid -binding proteins in rat hepatic 
cytosol. 
3) To identify and characterize such proteins from the Y` 
fraction in particular, and to assess the bile acid - 
binding capabilities of these proteins. 
The results of the studies presented in this thesis 
will be discussed as follows: - 
Photoaffinity labelling; 
Purification and characterization of Y' proteins; 
Peptide "mapping" of bile acid -binding proteins; 




Synthesis of [1252]_3 azidocholylhistamine 
Perhaps the most crucial aspect in the synthesis of a 
photoaffinity label is the design of the molecule. 
Consideration must be given to the location of the photo - 
labile group within the molecule - ideally it should be 
positioned such that it does not interfere to any great 
extent with the binding of the ligand to the binding pro- 
tein. In addition, photoaffinity probes which are 
radiolabelled should be constructed such that the radioac- 
tive atom is as close as possible to the photolabile 
group, and not separated from it by any links which may be 
liable to cleavage during subsequent manipulations. In 
practice, this latter criterion may be difficult to 
achieve. 
The importance of using reagents, both chemical and 
radiochemical, of the highest purity, and which are also 
absolutely dry, cannot be overstressed. Small impurities 
with a structure similar to the reagent being synthesized 
could lead to inefficient phut naffinity labelling of the 
target molecule(s). 
The synthesis of [1252]_3pazidocholylhistamine was 
achieved using cholic acid as starting material 
(Figure 
3.1). The first step involved the selective 
3 oC- 
-tosylation of this molecule. It was observed 
on TLC 
that 3 , 7 di- and 3 , 7 12 -tri- 
tosylates of cholic acid 
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also occurred; particularly if the reaction time was 
extended or an increased concentration of p- toluene 
sulphonylchloride was used. It was, therefore, necessary 
to separate the 3o(- tosylate from other reaction products 
by silica gel column chromatography, before the next step 
in the synthesis. 
Addition of the azido group to the 3p position of cho- 
lic acid was carried out in the dark and all subsequent 
manipulations with this molecule were also carried out in 
dim or red light to avoid destruction of the photolabile 
group. Addition of histamine to yield 3pazidocholyl- 
histamine gave a stock solution which was stored in etha- 
nol at -20 0C. The molecule remained stable in this form 
for 18 months as demonstrated on TLC. 
Iodination of 3pazidocholylhistamine, using the 
chloramine T reaction, gave a good yield with a high spe- 
cific radioactivity (approximately 1900 Ci /mmol) after 
separation on TLC of iodinated from non -iodinated ligand. 
The iodinated molecule was kept in ethanolic solution at 
4 °C and used within one month of synthesis. The sen- 
sitivity of photoaffinity labelling with this molecule 
was greater due to the high specific radioactivity, 
enabling investigation of bile acid- binding proteins 
which 
may be present in small quantities in the 
hepatocyte. 
Characterisation of [1251]_3Rrazidocholylhistamine 
The photoaffinity label was characterised 
extensively 
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at each stage of the synthesis, using a variety of tech- 
niques (Table 3.1). Infra -red spectroscopy served prin- 
cipally to confirm the incorporation of the photolabile 
azido group into the molecule, (Figures 3.3 to 3.6), with 
the characteristic peak at approximately 2100 cm -1. 
Perhaps the most valuable test performed on the molecule, 
however, was 1H and 13C nuclear magnetic resonance 
spectroscopy. The results of these scans confirmed the 
overall molecular structure of the label, and provided a 
means of checking the total number of -CH, -CH2 and 
-CH3 groups present (Figures 3.7 to 3.9). 
The hepatic transport of [ 12511-3p azidocholylhistamine 
was assessed by injection of the molecule into the hepatic 
portal system, both on its own, and with [14C]- tauro- 
cholate as a comparison. Subsequent analysis of 
collected bile (Figures 3.11 and 3.12) showed that not 
only was the label handled efficiently by rat liver, but 
that it was transported into bile in essentially the same 
manner as taurocholate, a naturally- occurring bile salt. 
Experiments with similar molecules, 
131I_ß 1251- or 1 231- 
cholylglycylhistamine (Grandjean et al., 
1978; Spenny et 
al., 1978; Jones et al., 1980) have shown 
that hepatic 
uptake and excretion of these derivatives is 
similar to 
physiological bile salts. Since both these 
molecules and 
[1251]_3pazidocholylhistamine are neutral bile acid deri- 
vatives, Grandjean et al. (1978) have 
suggested that the 
sidechain of a bile acid molecule need 
not possess an 
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anionic charge in order to be taken up and excreted by the 
liver, as had previously been proposed for intestinal 
transport (Wilson & Treanor, 1975). In addition, the 
fact that [1251]- 3ßazidocholylhistamine is transported 
efficiently by the liver would tend to suggest that 
alteration of the molecular structure by insertion of an 
azido group and addition of a histamyl moiety with an 
[125T] atom has not greatly affected the properties of the 
derivative as a bile acid. The label was also shown to 
bind (non -covalently) to components of rat hepatic cytosol 
by gel filtration (Figures 3.13 and 3.14), and to bovine 
serum albumin by equilibrium dialysis (Figure 3.10). 
Use of [1251]- 3jazidocholylhistamine as a photoaffinity 
label 
Photolysis of [125I]- 3j3azidocholylhistamine was shown 
to be more successful with ultraviolet light above 300 
nm, as judged by the slower breakdown of the derivative 
(with release of iodinated histamine) on TLC (Figure 3.15) 
and the greater incorporation of radioactivity into the 
bovine serum albumin band on SDS /polyacrylamide -gel 
electrophoresis (Figure 3.17). With ultraviolet light 
below 300 nm, photolytic destruction of the derivative 
was 
rapid, resulting mainly in the release of free iodide, 
but 
also, to a lesser extent, in the release of iodinated 
histamine, due to cleavage of the internal peptide 
bond 
between the steroid ring structure and the histamyl 
moiety. In addition, the breakdown of bovine 
serum albu- 
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min on exposure to ultraviolet light as observed on SDS/ 
polyacrylamide -gel electrophoresis (Figure 3.16) was more 
marked with ultraviolet light below 300 nm, as might have 
been expected, since such light contains the biologically - 
damaging wavelengths at 254 nm and 280 nm. 
This last result illustrates an important point in the 
choice of photolysis conditions for photoaffinity 
labelling experiments. It has been shown that in some 
cases the rate of photolysis of the label at 254 nm com- 
pares favourably with the rate of destruction of the 
biological system being labelled (Cooperman & Brunswick, 
1973). However, the much more rapid degradation of 
bovine serum albumin shown here (Figure 3.16) with ultra- 
violet light below 300 nm demonstrates that this is not 
always the case. One of the main advantages of arylazi- 
des over diazo compounds as photoaffinity labels is the 
capacity of the former for photolysis at longer wave- 
lengths, for example, above 300 nm, where damage to biolo- 
gical systems is negligible. Indeed, some arylazide com- 
pounds have shown higher labelling efficiencies on irra- 
diation with longer wavelengths (Katzenellenbogen, 1974). 
With [1251]- 3ßazidocholylhistamine, ultraviolet light 
above than 300 nm was chosen, as it has been by other 
workers, in order to optimise photolysis of the derivative 
against the potential destruction of the biological 
system, i.e. the protein(s), being labelled (Kramer 
et 
al., 1982, 1983; von Dippe et al., 1983). 
The fact that 
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photolysis of the derivative occurred, when the maxima of 
ultraviolet absorption for [125I]- 3pazidocholylhistamine 
are at 220 nm and 285 nm, is probably due to absorption of 
light by the molecule at the long wavelength tail of its 
285 nm maximum, which is sufficient to stimulate the pho- 
tolabile azido group. This possibility has been 
discussed in more detail recently (Nielsen et al., 1983). 
Other variables in a photoaffinity labelling experi- 
ment, which are in fact inter -related, are the con- 
centration, both of label and target protein(s), and the 
duration of photolysis. Ideally, photolysis time should 
be kept as short as possible in order to minimise non- 
specific labelling; however, this will depend on the half - 
life of the photoaffinity label when photolysed i.e. the 
time taken for half the amount of label to react. The 
half -life of a photoaffinity label varies according to its 
molecular structure and the substituent groups present 
within the molecule. Although the half -life of [1251] -3ß 
azidocholylhistamine was not determined owing to the small 
amounts of material synthesized, it should be approxima- 
tely the same as a similar derivative, 3pazidocholic acid, 
used by Kurz and Gerok (1983) and having a half -life of 
18.5 min. 
The concentration of label used in an experiment 
is 
important. To maximise labelling specificity 
(at the 
expense, however, of a high extent of site labelling), 
a 
241. 
low label concentration is used with respect to the pro- 
tein concentration. However, in order to achieve a useful 
level of site labelling, it is then necessary that the 
label has a very high specific radioactivity; [1252]_33 
azidocholylhistamine, for example, has a specific radioac- 
tivity of approximately 1900 Ci /mmol. 
With many photoaffinity labels, as is the case with 
[125I]- 3 /3azidocholylhistamine, they must of necessity be 
added to the reaction system in organic solvent owing to 
their relative insolubility in water. The amount of 
organic solvent used should be very small, owing to the 
possibility of deleterious effects on the biological com- 
ponents of the reaction system. In this study, the label 
was dissolved in ethanol; the volume of ethanol added with 
the label to the reaction system was less than 1% of the 
total volume of the system. In these studies, a ratio of 
protein :label of approximately 8000 :1 (w /w) was employed. 
It is also imperative that the photoaffinity label 
be 
fully equilibrated with the biological preparation, i.e. 
protein(s), prior to photolysis. This was achieved 
in 
the experiments reported here by mixing the label 
and 
protein(s) together in the absence of light 
at 25 °C for 30 
min. Longer pre- equilibration times did 
not increase the 
extent of covalent labelling of the protein(s). 
Initial experiments using 
[1252]_3f3azidocholylhista- 
mine to photoaffinity label bovine 
serum albumin (Figure 
3.17) showed that, with a protein 
concentration of 10 mg /ml 
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(label 0.5 pmol, 1)uCi /ml), covalent incorporation of 
label into the protein was still increasing after a photo- 
lysis time of 60 min. However, a later study with one of 
the putative bile acid -binding proteins from the Y' frac- 
tion (Peak 5B), at a lower concentration of 5 /ug /ml (label 
0.15 pmol, 0.3,uCi /ml), demonstrated that the covalent 
incorporation of [12511- Vazidocholylhistamine reached a 
maximum between photolysis times of 10 and 20 min (Figure 
3.39). Thus, the latter of these two methods was adopted 
for photoaffinity labelling experiments, having not only 
the advantage of using less protein, but also being 
quicker to perform. These results illustrate the 
screening effects present in a biological preparation, 
owing to the absorption of ultraviolet light by the 
protein(s). The half -life of a photoaffinity label can 
thus be increased not only on binding to the protein, but 
also in preparations where the protein concentration is 
high, such as discussed earlier. 
Analysis of photoaffinity labelling 
Various methods were employed to analyse the photoaf- 
finity labelled rat cytosolic proteins, both as a complex 
mixture and as pure, individual proteins. In initial 
experiments with bovine serum albumin, whole rat hepatic 
cytosol and the glutathione S- transferase fraction, samples 
were taken at various times during the photolysis and 
ana- 
lysed by SDS /polyacrylamide -gel electrophoresis (Figures 
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3.17, 3.19 and 3.21). This method involved diagram- 
matically reproducing the polypeptide band patterns from 
the gels, cutting the gel tracks into slices and counting 
each slice for 1251. This approach had significant disad- 
vantages. Apart from being time- consuming, potential 
errors could arise as a result of mis- matching of polypep- 
tides on the gel and the radioactive counts obtained from 
the gel slices. Further, the method of counting the gel 
slices themselves will possess an intrinsic error. 
In addition, the final, photolysed reaction mix- 
ture was analysed as a whole by gel filtration (Figures 
3.18 and 3.20) for the bovine serum albumin and whole rat 
hepatic cytosol experiments. This system was adequate to 
remove non -covalently bound label from the proteins as 
evidenced by the appearance of free label in the salt 
volume of the gel filtration columns. However, large 
amounts of photolysed proteins were required to use this 
method. 
Alternatively, when the bile acid- binding activity of 
the partially purified cytosolic proteins was examined 
(e.g. the Y' peaks from DEAE Sephadex), the reaction mix- 
ture obtained after photolysis was precipitated with 10% 
TCA and the resulting precipitate analysed by SDS/poly- 
acrylamide-gel electrophoresis. However, since in the 
pellet even after extensive washing non -covalently bound 
label still remained, it was found necessary to analyse 
the TCA precipitated -proteins by gel filtration 
under 
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denaturing conditions (Table 3.7). The use of small G -25 
Sephadex columns (1 cm x 20 cm), equilibrated and eluted 
with buffer containing 1% SDS, proved sufficient to remove 
all non -covalently bound label from the photolysed pro- 
teins. This was, therefore, found to be the most satis- 
factory method for quantifying the amount of bile acid 
incorporated following photolysis. Small amounts of pro- 
tein (50 ug) could be used with this method, thus enabling 
each peak from the chromatofocusing of the Y fraction to 
be analysed using the photoaffinity label (Table 3.6). 
Pure glutathione S- transferases AA (YcYc protein), A 
(Yb1Yb1 protein), D (Yb2Yb2 protein) and F (YaYa protein) 
were also analysed in this way, in order to give a com- 
parison between photoaffinity labelled Y and Y proteins 
in terms of covalent incorporation of radioactivity. 
PURIFICATION AND CHARACTERIZATION OF Y PROTEINS 
Purification of YI proteins 
The major bile acid- and organic anion -binding com- 
ponents of rat hepatic cytosol have been considered to be 
the glutathione S- transferases (Strange et al., 1977a, b; 
Hayes et al., 1981). This family of enzymes elutes as 
a 
single peak (the Y fraction) on Sephadex G -100 chroma- 
tography, with a molecular mass range of approximately 
50 
000 - 60 000 Da. Recently. however, the 
bile acid- 
1 
binding and the organic anion- binding within 
the Yfrac- 
tion have both been split into two distinct 
peaks of acti- 
vity (Sugiyama et al., 1982, 1983). The 
glutathione S- 
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transferases were reported to be responsible for one peak 
of bile acid -binding and organic anion -binding activity 
whilst the other peak of binding was attributed to a newly 
discovered fraction, previously hidden within the Y peak, 
and termed the Y fraction. 
Sugiyama et al. (1982) reported that the YI fraction 
contains proteins with an affinity for organic anions com- 
parable to the glutathione S- transferases. In addition, 
proteins from this fraction, along with glutathione S- 
transferase B, were suggested to be the major hepatic 
cytosol bile acid -binding proteins in the rat. Two bile 
acid -binding proteins, designated binders I and II, have 
been purified from the YI fraction and partially charac- 
terised (Sugiyama et al., 1983). The purification proce- 
dure for these proteins is shown in Table 4.1, and Table 
4.2 shows the purification scheme for Y' proteins pre- 
sented in this thesis. (This is an abridged version of 
Table 2.3). 
The major difference between the two purification pro- 
cedures lies in the number of proteins resolved. The 
introduction of an ion - exchange step between 
the gel 
filtration and chromatofocusing stages resulted 
in greater 
resolution of the Y1 fraction. The DEAE Sephadex 
step 
was particularly useful since it enabled 
a significant 
proportion of the non -binding proteins to 
be discarded 
prior to chromatofocusing. This, therefore, 
reduced the 
*NOTE: The possibility exists, however, 
that some of 
these proteins may be derived 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































risk of the chromatofocusing column being overloaded. 
[1251]_3p azidocholylhistamine was used as a means of 
assessing the bile acid- binding potential of the Y' pro- 
teins both at the ion -exchange and chromatofocusing sta- 
ges, and thus assisted in the elucidation of the proteins 
of interest from what was a highly complex mixture of pro- 
teins. 
The twelve peaks resolved after ion -exchange were pho- 
toaffinity labelled and analysed by two different methods 
(Figure 3.38 and Table 3.8). Both sets of results showed 
that peaks 5, 6, 7 and 8 gave a higher incorporation of 
radioactivity and thus contained proteins with significant 
bile acid -binding activity. Peak 1, although not as 
great as the other four, showed an increased incorporation 
of radioactivity above background. The organic anion - 
binding protein, Dv (Sugiyama et al., 1982), was shown to 
be present in this peak on the basis of elution position 
from DEAE Sephadex and mobility on SDS /polyacrylamide -gel 
electrophoresis. With electrophoresis analysis (Figure 
3.38) peak 8 showed the highest degree of labelling, 
followed by peaks, 6, 7 and 5. However, using the TCA 
precipitation /denaturing gel filtration method (Table 
3.8), peak 5 had the greatest incorporation of label, 
followed by 6, 7 and 8. This latter situation probably 
more accurately reflects the ultimate distribution of 
putative bile acid -binding proteins in the Y fraction 
(Table 3.6), and thus the denaturing gel 
filtration method 
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was chosen in preference to electrophoretic separation as 
the method of analysis of photoaffinity labelling. 
The subsequent application of chromatofocusing to the 
peaks of interest (i.e. 5, 6, 7 and 8) from ion -exchange 
was successful in obtaining purified, homogeneous pro- 
teins. Using the denaturing gel filtration method as the 
means of analysis, all the peaks from the chromatofocusing 
stage were photoaffinity labelled (Table 3.6). Those 
proteins designated bile acid -binders have either a high 
specific ( >, 1 x 105 counts per minute per 50íug) and /or 
high total (>, 1 x 106 counts per minute) incorporation of 
radioactivity. Other proteins also show covalent incor- 
poration of the label, although in most cases this amounts 
to less than 10% of the lowest total incorporation of 
radioactivity in the bile acid -binding proteins. This is 
probably due to non- specific or "background" labelling. 
Identity of Y' proteins 
As already mentioned, the purification scheme 
described here (Table 4.2) results in the resolution of a 
greater number of proteins from the Y' fraction than found 
by Sugiyama et al. (1983) (Table 4.1). 
The proteins described for the first time in this the- 
sis are listed in Table 4.3, along with the glutathione S- 
transferases studied as part of this work. 
The group 1 Yf proteins - binders 5B, 6E and 7F - are 
entirely new, hitherto undescribed, proteins from rat 










































































































































































































































































































































































































































































































































































































































































































































In contrast to previously reported bile acid -binders from 
the Y fraction (Sugiyama et al., 1983), which are mono- 
meric (binders "I" and "II "), the group 1 proteins are 
dimeric, with subunit molecular masses ranging from 
approximately 15 000 Da - 19 000 Da. Although present in 
the liver in low concentration, these binders exhibit a 
high specific binding of bile acids, as demonstrated by 
the level of incorporation of [12511 -3ß azidocholyl- 
histamine (Table 4.3). Indeed, the specific incor- 
poration of the photoaffinity label into the group 1 Y' 
proteins is of the same order of magnitude as that of the 
glutathione S- transferases studied in this project (Table 
4.3). 
It is difficult to interrelate the two binders of 
Sugiyama et al., with any of the bile acid -binding pro- 
teins described in this thesis (Table 4.4). It is 
possible that binders 5C and 5D may be binders I and II; 
the isoelectric points of the two sets of proteins are 
very similar, and, although their molecular masses are 
different, both proteins within a pair have the same mass, 
i.e. binders I and II, 33 000 Da, and binders 5C and 5D, 
36 200 Da. However, Sugiyama et al. (1983) reported that 
binders I and II had "very similar amino acid 
compositions ", whereas the evidence presented here from 
peptide "maps" using both limited proteolysis in the pre- 
sence of SDS and tryptic digestion with HPLC analysis 
(Figures 3.41, 3.45 and 3.36) shows that, although binders 
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5C and 5D may have some sequence homology and possess 
several common peptides, they are distinct proteins (see 
p.256). In addition, Sugiyama and his colleagues stated 
that binders I and II had different binding charac- 
teristics for bile acids, binder II having a greater affi- 
nity than binder I for most bile acids. Binders 5C and 
5D, however, exhibit the same degree of labelling, both 
specific and total, (Table 4.3), approximately 20,000 
counts per minute per 50 /ug and 1 x 106 counts per minute, 
respectively. This would tend to suggest that both pro- 
teins have a similar affinity for [1251]-3r azidocholyl- 
histamine, and probably also for bile acids. 
On balance, although it seems that binders 5C and 5D 
are not equivalent to binders I and II, it is difficult to 
understand how the latter proteins were not purified from 
the Y fraction in this project, or why they were not 
identified by photoaffinity labelling. Alternatively, if 
the two pairs of binders are equivalent, as is almost cer- 
tainly the case, then the data of Sugiyama et al. must be 
called into question. 
PEPTIDE MAPPING OF BILE ACID -BINDING PROTEINS 
Partial proteolytic digestion in the presence 
of SDS - Y` proteins 
The limited digestion of all six Y` binders with - 
chymotrypsin yielded the peptide "maps" shown in Figures 
3.40 and 3.41. The group 1 binders generally, and binder 




























































































































































































































































































































































































































































However, the sequence of proteolysis in all three binders 
was similar, suggesting that there may be a relationship 
between these proteins in terms of amino acid composition 
and protein structure. The peptide "maps" of binders 6E 
and 7F were particularly alike; these two proteins are 
probably more closely related to each other than to binder 
5B. 
Partial proteolysis of binders 5B, 6E and 7F each 
yielded three polypeptides, of approximate molecular 
masses 10 000 Da, 11 000 Da and 15 000 Da, which appear to 
be common to all three digests. 
Digestion of the group 2 binders (5C, 5D and 8C) was 
far more extensive when compared to the group 1 binders. 
Despite the fact that the proteolytic sequence was dif- 
ferent in each case, two polypeptides were found to be 
common to all three proteins. The approximate molecular 
masses of these were 15 000 Da and 18 000 Da. However, 
it appears improbable that a structural relationship 
exists between the proteins of this group, because their 
degradation pathways are quite distinct. 
Tryptic digestion and analysis on reverse -phase high 
performance liquid chromatography - Y1 proteins 
and glutathione S- transferases 
Greater resolution of peptides, and thus more infor- 
mation regarding the relationship(s) between the different 
bile acid- binding proteins, was obtained using reverse - 
phase HPLC, which achieves a separation of peptides based 
on their differential hydrophobic nature. More hydro- 
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phobic (and generally larger) peptides are retained for a 
longer time on the column and thus elute further down the 
solvent gradient. All six Y' binders and four glu- 
tathione S- transferases (AA, A, D and F) were peptide 
"mapped ", both before and after photoaffinity labelling 
with [1251] -3j3 azidocholylhistamine. 
Non -photoaffinity labelled bile -acid binding proteins 
Reference to the peptide "maps" of the group 1 and 
group 2 Y' binders (Figures 3.42 to 3.47) shows that bin- 
ders 5B, 6E and 7F produce a smaller number of peptides 
following tryptic digestion. These data allow specula- 
tion on the amino acid composition of these proteins; 
there are probably few lysine or arginine residues (target 
amino acids for trypsin) and few non -polar residues such 
as tryptophan, phenylalanine, leucine and methionine 
(target amino acids for oc- chymotrypsin). A comparison 
of the peptide "maps" of the group 1 Y' binders (Figures 
3.142 to 3.411 and Table 3.9) dramatically confirms the 
results of the partial proteolytic digestion with Jt chymo- 
trypsin; namely, that binders 6E and 7F are more closely 
related to each other, having 20 peptides which co- eluted 
from thew Bondapak column. In contrast, binder 5B, only 
appeared to share four peptides in common with binders 6E 
and 7F. Therefore, as a group, binders 5B, 6E and 7F 
have four common peptides. 
However, this is on the basis of only a single 
separation procedure. 
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The relationships between the group 2 binders are not 
so unequivocal (Figures 3.45 to 3.47). Binder 5C shares 
only one or two more peptides with the other binders in 
the group than binder 5D does with binder 8C. Within the 
group, the three binders have seven common peptides, and 
between group 1 and group 2 there are two common peptides. 
Thus, in summary, it can be said that the six Y bin- 
ders described here are genetically distinct proteins. 
However, it is possible that some sequence homology, and 
thus a limited structural relationship, may exist between 
these proteins. 
Figures 3.48 to 3.51 show the peptide "maps" of glu- 
tathione S- transferases AA, A, D and F. The rela- 
tionships between these four bile acid -binding proteins 
are more complex and fall outwith the scope of this the- 
sis. However, what is of interest is the fact that in 
the glutathione S- transferases digests (Table 3.10), there 
is one peptide which appears to be common to group 1 and 
group 2 Y' bile acid -binders (Table 3.11), having a Rt 
value of approximately 24.5 min. It could thus be postu- 
lated that this common peptide might represent the site, 
or part of the site, at which bile acids bind to these 
proteins. The technique of photoaffinity labelling was 
used to explore this possibility further. 
Photoaffinity labelled bile acid -binding proteins 
The peptide "maps" of photoaffinity labelled Y' bin- 
ders and glutathione S- transferases are shown in Figures 
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3.52 to 3.54. Peaks of radioactive labelling can clearly 
be seen, and the "background" radioactivity (due to non- 
specific photoaffinity labelling of the proteins) is low, 
being less than 5% of the peak totals. The fact that the 
peaks are sharp, with no shoulders, and occur within a 
single (or at most two) fractions, would tend to suggest 
that they are associated with single peptides, although 
this is obviously speculation. 
There are five common peaks of labelling within the 
group 1 Y' binders, four of which are also common to the 
group 2 binders, and furthermore are common to both group 
1 and group 2 binders (Table 3.12). The four peaks of 
labelling which are common to glutathione S- transferases 
AA, A, D and F (Table 3.13) are the same four which are 
shared by both groups of Y' binders (Table 3.14), with Rt 
values of approximately 27.5, 31, 33 and 34 min. 
Thus, despite only a single common peptide being found 
between all the non -labelled bile acid -binding proteins, 
four common peptides were shown to exist after photoaf- 
finity labelling of these proteins. Although the reason 
for this is unclear, the result itself is not surprising. 
It may be that there is more than one bile acid -binding 
site on the proteins. Perhaps more likely is that the 
labelled peptides represent different parts of a single 
site, having been labelled as the result of movement both 
of the label itself, and of the azido group in the label, 
within the binding site prior to photoactivation. 
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Indeed, such is the arrangement of the tertiary structures 
of proteins that it is unlikely that a ligand- binding site 
will be formed from a single peptide. If the bile acid - 
binding site is positioned within the proteins such that 
various different sections of the primary structure 
contribute to the site as a whole, then subsequent 
digestion may yield several peptides which have been pho- 
toaffinity labelled. Of the four common peptides, in all 
cases one, (Rt 27.5 min), is labelled to a much greater 
extent than the other three. This peptide may represent 
a major part of the bile acid -binding site. 
Of the bile acid -binding proteins studied in this the- 
sis, only binder 5B possesses an additional peak of 
labelling, not found in the other binders. As binder 5B 
exhibits the highest specific incorporation of [125I] -3p 
azidocholylhistamine, it may be that this additional peak 
represents part of a high affinity bile acid -binding site, 
or a second bile acid -binding site, found only in binder 
5B. 
It is not clear why the bile acid -binding proteins 
yielded more peptides which appeared to be common after 
photoaffinity labelling. This may be due to alteration 
of the retention times of peptides on the reverse -phase 
column following the covalent attachment of the label, 
[125I]_3,3 azidocholylhistamine. Alternatively, it may be 
that photoaffinity labelling of the proteins provides an 
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extra degree of sensitivity in the detection of the 
peptides. 
Tryptic digestion and analysis on thin -layer chromato- 
graphy - Y' proteins and glutathione S- transferases 
Whereas the separation of the peptides by HPLC was 
based on their hydrophobic properties, separation by TLC 
was on the basis of the relative charges of the peptides. 
Two different solvent systems were employed, A and B (see 
p.215), the former giving better separation. In both 
these modes of separation, smaller numbers of common pep- 
tides were found. Between the group 1 and group 2 Y4 
binders, no common peptides were found when solvent system 
B was used, although this was probably due to lack of 
resolution using this solvent system. A single common 
peptide having a mobility just behind the solvent front 
was found between the Y' binders and the glutathione S- 
transferases using solvent system A. However, in solvent 
system A the mobility of the free, unreacted label coin- 
cided with this peak, making interpretation difficult. 
The data from the HPLC separation of the photoaffinity 
labelled peptides indicated that very little free label 
existed in the digests and thus any radioactive contribu- 
tion from this source to the common labelled peptide 
described above would be minimal. 
In summary, those Y' proteins shown to bind bile acids 
through investigation by photoaffinity labelling have been 
divided into two groups, based on the covalent incor- 
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poration of [1251] -3f3 azidocholylhistamine into the pro- 
teins. These groups have been shown to be structurally 
related to each other and to a group of four glutathione 
S- transferases by peptide "mapping" of both labelled and 
non -labelled proteins. 
On the basis of these results, it would appear that, 
although the Y' binders and glutathione S- transferases 
share common labelled peptides in terms of molecular size 
(HPLC separation), these peptides are sufficiently dissi- 
milar in terms of amino acid composition for them to be 
able to be distinguished by virtue of their different 
molecular charges (TLC separation). The amino acid com- 
position and sequence of such peptides should provide 
valuable information regarding the bile acid -binding 
site(s) of these proteins. 
Y' PROTEINS AS CYTOSOLIC BILE ACID -BINDING 
PROTEINS IN RAT LIVER 
The central question raised by this study is - 
"What role do the bile acid- binding proteins of the Y' 
fraction play in the cytosol of the hepatocyte "? 
In comparison with the glutathione S- transferases, 
only the group 1 category of Y' bile acid -binding proteins 
approaches the same degree of specific incorporation of 
[125I]_3,13 azidocholylhistamine following photoaffinity 
labelling (Table 4.3). Despite an apparently similar 
affinity for bile acids, the group 1 binders, being pre- 
sent in much lower concentrations in the hepatic cytosol 
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than the glutathione S- transferases, will contribute less 
to the total bile acid- binding capacity of the hepatocyte. 
The group 2 binders show a level of specific labelling at 
least an order of magnitude less than that of the glu- 
tathione S- transferased and group 1 binders, implying a 
lower affinity for bile acids. 
These arguments are, of course, based on the assump- 
tion that the glutathione S- transferases bind bile acids 
in vivo. Doubt has recently been cast on this concept by 
work on the photoaffinity labelling of intact isolated 
hepatocytes (Abberger et al., 1983). Cytosol from iso- 
lated hepatocytes photoaffinity labelled and this exhi- 
bited peaks of labelling associated with proteins iden- 
tified as albumin, hydroxycholanoyl transferase and glu- 
tathione S- transferase subunits (Table 4.5). In addi- 
tion, unidentified peaks were found with approximate mole- 
cular masses of 95 000 Da, 55 000 Da and 35 000 Da 
(Abberger et al., 1983). When the intact hepatocytes 
were photoaffinity labelled first and the cytosol then 
extracted, virtually no labelling of glutathione S- 
transferases, hydroxycholanoyl transferase or albumin was 
found. However, peaks of labelling were associated with 
a number of proteins, including four of molecular masses 
similar to the Y' binders described herein - 35 000 Da, 
33 000 Da, 18 000 Da and 14 000 Da. 
If these proteins detected by Abberger et al. (1983) 
are Y° proteins, then it may be the case that glutathione S- 
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Table 4.5 Photoaffinity labelling of intact rat 
Cytosol 
hepatocytes 
masses of polypeptides revealed 
(Da7-- 
Molecular 
by photoaffinity labelling 
Isolated then 95 000; 67 000; 55 000; 43 000; 35 000; 
labelled 27 000; 
Labelled then 94 000; 55 000; 35 000; 33 000; 18 000; 
isolated 14 000; 
Intact hepatocytes, and cytosol from intact hepatocy- 
tes, photoaffinity labelled with (7,7-azo-3a,12xdihydroxy- 
5ß- C3- 3H]cholan- 24- oyl) -2- aminoethanesulphonate (Abberger 
et al., 1983); cytosol isolated and analysed on SDS/poly- 
acrylamide-gel electrophoresis. 
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transferases do not bind bile acids to any great extent in 
vivo, and that binding proteins from the Yf fraction are 
responsible for the majority of bile acid- binding within 
the heptatocyte. Further studies by the same workers 
utilising photolabile derivatives of precursors of bile 
acids yielded the data shown in Table 4.6. These results 
again exhibit labelling of peaks with molecular masses 
similar to those bile acid -binding proteins of the Y1 
fraction that have been described in this thesis. Along 
with the results shown in Table 4.7 (Abberger et al., 
1983), which demonstrate a polypeptide of molecular mass 
33 000 Da isolated from the mitochondria of photoaffinity 
labelled intact hepatocytes, these data allow speculation 
as to the function of Y proteins in hepatic cytosol. It 
is known that the synthesis of bile acids occurs at 
various sites within the hepatocyte (see p.8), although it 
is uncertain how the reactants and products at each stage 
are moved within the cell between reactions. The Y' 
bile acid -binders, in addition to transporting conjugated 
and unconjugated bile acids across the hepatocyte as part 
of the enterohepatic circulation, may also be involved in 
the synthesis of bile acids, shuttling various components 
of the reaction chain from one part of the cell to 
another, for example, between Golgi- endoplasmic reticulum, 
cytosol and mitochondrion. 
What of the glutathione S- transferases, known to bind 
bile acids with high affinity in vitro? Within the hepa- 
Table 4.6 
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Photoaffinity labelling of intact hepato- 
cytes with photolabile precursors of bile 
acids 
Photoaffinity Molecular masses of poly- 
label peptides revealed by 
photoaffinity labelling(Da) 
7,7-azo-5ß-[12-3H]cholestane 57 000; 43 000; 14 000; 
-3c(, 12oC-diol 
7,7-azo-3D(,12X- dihydroxy-5ß 67 000; 60 000; 55 000; 
[3 -3H]cholestan-26-oate 43 000; 35 000; 14 000; 
7,7-azo-30C, 12oc-dihydroxy-513 67 000; 55 000; 43 000; 
[3 ,12 -3H]cholan-24-oate 35 000; 33 000; 28 000; 
18 000; 14 000; 
(7,7-azo-30c.,12:-dihydroxy- 67 000; 55 000; 35 000; 
5A-[3 -311-cholan-24-0y1)- 33 000; 28 000; 18 000; 
2-aminoethane sulphonate 14 000; 
Intact hepatocytes photoaffinity labelled with deriva- 
tives described above (Abberger et al., 1982). Cytosol 
extracted and analysed by SDS /polyacrylamide -gel 
electrophoresis. 
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Table 4.7 Photoaffinity labelling of intact hepatocytes 
and isolation of mitochondria 
Photoaffinity 
label 
Molecular masses of poly- 
peptides revealed by 
photoaffinity labelling(Da) 
7,7-azo-5ß-[12-3H]cholestane 33 000; 28 000 (slight); 
-3tX,12oC diol 25 000 (slight); 
7, 7-azo-3oC, 1 C dihydroxy-5 33 000; 
[3 -3H]cholestan-26-oate 
7,7-azo-),1206- dihydroxy-5ß 33 000; 
[3 ,12 - H]cholan-24-oate 
(7,7-azo-30(412S-dihydroxy- 33 000; 
5g-[3 -317-cholan-24-oyl)- 
2-aminoethane sulphonate 
Intact hepatocytes photoaffinity labelled with deriva- 
tives described above (Abberger et al., 1982). 
Mitochondrial fraction isolated and analysed on SDS/ 
polyacrylamide -gel electrophoresis. 
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tocyte, the bile acid -binding site(s) of these enzymes may 
be occupied by other molecules, concerned with the detoxi- 
fication role of the glutathione S- transferases, thus pre- 
venting them from participating in bile acid transport in 
vivo. In addition, neither the studies described here 
nor those of others (Abberger et al., 1983) utilizing pho- 
tolabile bile acid derivatives as photoaffinity probes of 
cytosolic bile acid -binding proteins, have shown Z 
protein(s) to be involved. Thus, although it may seem 
that there are a large number of bile acid -binding pro- 
teins present in the hepatocyte, in reality only a few of 
these may actually be involved in the transport of bile 
acids across the liver in vivo. 
On the basis of peptide "mapping ", it seems improbable 
that an evolutionary relationship exists between Y pro- 
teins and the glutathione S- transferases. However, the 
subunit molecular masses of the group 1 Y1 proteins are 
very similar to those of Z protein(s); a mass of 14 000 Da 
has been reported (Takahashi et al., 1983). Further 
investigations, i.e. comparative peptide "mapping" of 
these proteins, may yield information regarding their evo- 
lutionary origins. 
Alternative functions of Y proteins 
It may be that Yf proteins bind substances other than 
bile acids; the bile acid -binding site could consist of 
nothing more than a hydrophobic "pocket ", to which many 
different compounds bind. Indeed, Y' proteins may play a 
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detoxification role in the hepatocyte, similar to that 
proposed for the glutathione S- transferases, binding such 
molecules as benz -pyrene and methylcholanthrene. The 
answer to this speculation lies in the further charac- 
terization of the bile acid -binding site(s) of these pro- 
teins, perhaps by an extension of the photoaffinity tech- 
nique already applied, and also employing equilibrium 
dialysis and fluorescence inhibition methods. 
A further clue to the role of Y proteins may be 
obtained from knowledge of their location within the hepa- 
tocyte, and their distribution in other tissues. 
PHOTOAFFINITY LABELLING AND THE INVESTIGATION 
OF BILE ACID -BINDING PROTEINS 
The use of [125I] -3p azidocholylhistamine as a pho- 
toaffinity label in this study has proved successful in 
the search for previously undescribed bile acid -binding 
proteins in rat hepatic cytosol. The very high specific 
radioactivity of the molecule, 1900 Ci /mmol, has resulted 
in a more sensitive probe, as demonstrated when comparing 
the specific incorporations of label into proteins in this 
work and that of Abberger et al., (1981, 1983). The 
latter group demonstrated, on average, specific radioac- 
tive incorporations of approximately 500 counts per minute 
per 50 ug protein. This study has produced specific 
radioactive incorporations of between two and three orders 
of magnitude higher than this, 20,000 to 100,000 counts 
per minute per 50 ug protein. 
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FUTURE EXPERIMENTS 
Further work on the Y' bile acid -binding proteins is 
necessary in order to complete their characterisation. 
Antisera have been raised against binders 5C and 8c. 
These may be of use both in the elucidation of the 
relation -ship(s) between the Yi binders and in "screening" 
for further bile acid -binders in liver and other tissues, 
for example, by using the "Western blot" technique. The 
production of antibodies against other Y' proteins, par- 
ticularly the group 1 binders, awaits the purification of 
these proteins in sufficient quantities. 
Determination of the amino acid composition of Y' pro- 
teins would be another useful step in the characterisation 
procedure. Similarly, the amino acid composition and 
sequence of the common, photoaffinity labelled, peptides 
of the Y' binders and glutathione S- transferases may 
reveal further information regarding not only the struc- 
ture of the proteins but also their bile acid- binding 
sites. 
Further study of the Y' binders by photoaffinity 
labelling, employing a range of photolabile bile acid 
derivatives, may yield more data concerning the bile acid - 
binding capabilities of these proteins, and of their rela- 
tionship to one another. 
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APPENDIX I 
A) CHEMICALS AND SUPPLIERS 
This Appendix contains a full list of chemicals, 
radiochemicals and solvents used in this study, and 
arranged according to supplier. 
Amersham International, Amersham, Bucks, U.K. 
(Carboxy- 14C)- lithocholic acid (approximately 59 Ci/ 
mmol); [1251].. sodium iodide (approximately, 1900 Ci /mmol); 
tauro(carboxyl -14C)- cholic acid, sodium salt (approxim- 
ately 61 Ci /mmol). 
Bio -Rad Laboratories Ltd., Watford, Herts, U.K. 
Biogel HT 
Macfarlane Robson Ltd., Glasgow, U.K. (BDH Agents) 
Acetone; acetic acid; acrylamide; 2- amino -2- (hydroxy- 
methyl) propane -1,3 -diol (Tris); ammonium persulphate; 
anisaldehyde; butan -2 -ol; chloramine T; 1- chloro -2,4- 
dinitrobenzene; chloroform; dicyclohexylcarbodimide; 
diethyl ether; dimethyl formamide; dimethylsuphoxide; 
dipotassium hydrogen orthophosphate, disodium hydrogen 
orthophosphate; ethanol; ethyl acetate; histamine; 
hydrochloric acid; N- hydroxy succinimide; isopropyl - 
alcohol; 2- mercaptoethanol; methanol; NN -methylene 
bisacrylamide; potassium dihydrogen orthophosphate; 
pyridine; sodium azide; sodium chloride; sodium dihydrogen 
orthophosphate; sodium dodecyl sulphate; sodium 
metabisulphite; sodium sulphate; sucrose; sulphuric acid; 
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tetrahydrofuran; NNNcNi -tetramethyl ethylenediamine; 
toluene; trichioroacetic acid; triton X -100; 
2,2,11- trimethylpentane. 
Maybridge Chemical Co., Tintagel, Cornwall, U.K. 
Cholic acid. 
Nuclear Enterprises Ltd., Sighthill, Edinburgh, U.K. 
p- bis(2- (5- phenyloxazolyl))- benzene. 
Packard Instrument Co., Inc., Illinois, U.S.A. 
2,5- diphenyloxazole. 
Rathburn Chemicals Ltd., Walkerburn, Peeblesshire, 
Scotland 
Acetonitrile; methanol; water (HPLC grade); 
trifluoroacetic acid (sequencer grade). 
Sigma Chemical Co.(London) Ltd., Poole, Dorset, U.K 
Blue dextran; bovine serum albumin; p(- chymotrypsin; 
Qk- chymotrypsinogen A; Coomassie brilliant blue R; DEAE- 
Sephadex A -50; glutathione (reduced); lithocholic acid; 
myoglobin; ovalbumin; polybuffer 74; polybuffer exchanger 
921; Sephadex G -25 fine, Sephadex G -75 superfine; Sephadex 
G -100 fine; SDS /molecular mass calibration kit; trypsin. 
Scientific Instrument Centre Ltd., London, U.K. 
Visking dialysis tubing (molecular cut off approxima- 
tely 10 000 Da). 
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B) FURTHER PURIFICATION OF CHEMICALS 
Listed here are those chemicals which it was necessary 
to further purify. Also given are the procedures used 
for purification. 
Cholic acid - recrystallised four times from methanol. 
Dimethylsulphoxide - dried by refluxing with sodium 
hydroxide pellets for 30 min and collected by distillation 
at 189°C. 
Pyridine - dried by refluxing with potassium hydroxide 
pellets for 2 h and collected by distillation at 1140C. 
Sodium tetrahydrofuran - dried over sodium wire. 
p- toluene sulphonyl chloride - recrystallised hot from 
petroleum ether (40 -600C) as white monoclinic crystals. 
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APPENDIX II 
This appendix contains a list of the techniques used 
in the characterisation of the intermediates in the 
synthesis of [1251]- 3fiazidocholylhistamine. 
Ultraviolet 
Ultraviolet spectra of bile acid -derivatives were 
measured on a Pye -Unicam SP 1800 double -beam spectrophoto- 
meter (Pye -Unicam Ltd., Cambridge, U.K.). 
Infra -red 
Infra -red spectra of bile acid derivatives were 
measured on a Pye -Unicam SP 200 double -beam spectrophoto- 
meter (Address as above). 
Melting points 
Melting points were determined with a Reichert 
Thermopan Microscope (C. Reichert, Optische Werke AGm, 
Wien, Austria). 
Nuclear magnetic resonance 
Proton and 13C nuclear magnetic resonance spectra were 
measured on a Bruker 200 MH3 instrument (Bruker, Zurich, 
Switzerland). The solvent for the proton scans was 




This appendix lists the procedure used in the prepara- 
tion of rat hepatic cytosol for the purification of Y 
proteins. 
Preparation of cytosol 
Male Wistar rats were killed under ether anaesthetic 
and the livers removed immediately into ice -cold buffer H. 
After weighing, the livers were chopped finely and homoge- 
nized in buffer H (volume = twice total liver weight in 
ml). The homogenate was centrifuged for 30 min at 18,000 g, 
4 °C. After decantation, the supernatant was recentri- 
fuged for 60 min at 100,000 g, 4 °C. The supernatant was 
then filtered through a glass wool plug and stored on ice 
until the purification procedure was begun. 
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APPENDIX IV 
This appendix lists all the abbreviations used in the 
thesis. The abbreviations are defined both here and the 
first time they appear in the text. 
ANS 1- anilino -8- naphthalene sulphonate 
ATPase adenosine triphosphatase 
BSA bovine serum albumin 
CPM counts per minute 
DEAE diethylaminoethyl 
HC1 hydrochloric acid 
HPLC high performance liquid chromatography 
HMG CoA 3- hydroxy -3- methyl -glutaryl coenzyme A 
pI isoelectric point 
POPOP 1,4- di(2- (5- phenyloxazolyl)- benzene 
PPO 2,5- diphenyloxazole 
Rt retention time 
SDS sodium dodecyl sulphate 
TCA trichloroacetic acid 
TFA trifluoroacetie acid 
TLC thin layer chromatography 
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The synthesis and characterisation of a novel iodinated bile salt derivative, 125I- labelled 3i6-azidocholylhista- 
mine, is described. The derivative is handled by rat liver in a similar manner to taurocholate and binding to 
bovine serum albumin, a well- characterised bile acid -binding protein, is demonstrated. The suitability of the 
derivative for photoaffinity labelling is assessed. 
Introduction 
The enterohepatic circulation describes the re- 
cycling of bile salts between the intestine and the 
liver. The transport systems involved in carrying 
the bile salts across the intestinal epithelium [1,2] 
and from the sinusoidal border of the hepatocytes 
to the canaliculi [3 -5] have been partially char- 
acterised. Bile salt- binding proteins have been 
demonstrated in both the intestinal mucosa [6] and 
hepatocyte sinusoidal and canalicular membranes 
[7 -11]. 
One potential transcellular route for bile salts is 
in association with cytosolic proteins [12]. Three 
main groups of bile salt- binding proteins have so 
far been described. The glutathione S- transferases 
(EC 2.5.1.18) have received particular attention 
[13,14]; these enzymes have a molecular mass of 
approx. 45 kDa and are abundant in the hepato- 
cytes, making up 3 -5% of the total cytosolic pro- 
tein. Bile salt binding to proteins with a molecular 
mass of approx. 12 kDa, which has been called Z 
protein [15], fatty acid -binding protein [16], 
aminoazodye- binding protein A [17], squalene and 
Abbreviations: PPO, 2,5- diphenyloxazole; POPOP, p- bis(2 -(5- 
phenyloxazolyl))benzene; ACH, 3ß- azidocholylhistamine. 
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sterol carrier protein [18], has been recognised for 
a number of years. A newly discovered group, 
termed Y' (molecular mass approx. 35 -40 kDa), 
has also been proposed as a component of the bile 
salt transport system [19]. 
The bile acid- binding properties of these pro- 
teins have been demonstrated using reversible 
techniques. However, experiments to identify the 
polypeptides responsible for binding and the 
structures of the binding sites themselves require 
the formation of stable bile acid -protein complexes 
which are amenable to further study using proce- 
dures such as proteolytic digestion and peptide 
analysis. Such ligand- protein complexes could be 
achieved by using the technique of photoaffinity 
labelling. Although the first experiments in this 
area were performed over 20 years ago [20], recent 
reviews testify to the expanding nature of this field 
[21,22]. The method employs a photolytically gen- 
erated intermediate of the ligand, which has very 
high reactivity and which will covalently attach to 
the ligand- binding site of the protein. 
The synthesis of bile acid -derived photoaffinity 
probes has been described [23,24]. In each case, 
these have been radiolabelled using beta- emitting 
isotopes, in most the specific activity being low 
(1 -3 Ci /mmol). To be able to work at the con- 
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centration of free bile acid in the hepatocyte, 
estimated to be in the nmol or pmol range, and 
subsequently to analyse the binding, it is necessary 
to use a photolabile bile acid with a high specific 
radioactivity. We now describe the synthesis of a 
novel bile salt derivative, 1251- labelled 3ß- 
azidocholylhistamine, which is radioiodinated for 
high specific activity (approx. 1900 Ci /mmol); 
gamma labelling of the derivative improves the 
sensitivity and convenience of detecting and 
counting the radioactive polypeptides. The synthe- 
sis, characterisation, hepatic transport and cova- 
lent linking to albumin of the derivative are de- 
scribed. 
Materials 
All chemicals were purchased from either Mac- 
farlane Robson Ltd., Glasgow, U.K. (BDH agents) 
or Sigma Chemical Co. (London) Ltd., Poole, 
Dorset, U.K., and were of analytical grade. Toluene 
used for scintillation counting was scintillation 
grade. Cholic acid was recrystallised four times 
from methanol. Sodium [125I]iodide (approx. 1900 
Ci /mmol) and tauro[carbonyl- 14C]cholic acid, 
sodium salt (60.9 mCi /mmol), were from 
Amersham International, Amersham, Bucks, U.K., 
and 2,4- [3H]cholic acid (3 Ci /mmol) was from 
New England Nuclear, Boston, MA, U.S.A. All 
bile salts were shown to be at least 99% pure on 
TLC. Pyridine was dried by refluxing with potas- 
sium hydroxide pellets for 2 h and collected by 
distillation at 114°C. The p- toluenesulphonyl 
chloride was recrystallised hot from petroleum 
ether (40 -60 °C) as white monoclinic crystals. Di- 
methyl sulphoxide was dried by refluxing with 
sodium hydroxide pellets for 30 min and collected 
by distillation at 189 °C. 
Methods 
Characterisation of bile acid derivatives. Ultra- 
violet scans were performed on a Pye -Unicam 
SP -1800 double -beam spectrophotometer and in- 
frared scans on a Pye -Unicam SP -200 double -beam 
spectrophotometer (Pye -Unicam Ltd., Cambridge, 
U.K.). Melting points were determined with a 
Reichert Thermopan Microscope (C Reichert, Op- 
tische Werke AGm, Wien, Austria). 1H- and 13C- 
NMR spectra were measured on a Bruker 200 
MH3 instrument (Bruker, Zurich, Switzerland). 
The solvent for 11-I scans was deuterated chlo- 
roform, (C2HC13) and for '3C, dimethyl sulpho- 
xide -d5. 125í was measured in a Nuclear Enter- 
prises NE16 gamma counter (Nuclear Enterprises, 
Sighthill Industrial Estate, Edinburgh, U.K.) and 
14C was counted in a Packard A3255 scintillation 
counter (Technologies Packard, Caversham, Bucks, 
U.K.) using a toluene -based scintillant (6 g PPO, 
0.3 g POPOP, 1 1 toluene, 0.5 1 Triton X -100). 
Photolysis. Photolysis experiments were carried 
out at 37 °C in an annular photoreactor (Applied 
Photophysics Ltd., London, U.K.) with a 400 W 
medium -pressure mercury arc lamp having an out- 
put of more than 5 1019 photons /s and radiating 
predominantly at 313 nm and 365 nm, using a 
borosilicate glass filter with wavelength cut -off of 
approx. 300 nm. Test solutions (10 ml) were held 
in quartz tubes (11 mm i.d.) with a glass rod (7 
mm o.d.) located centrally to give a thin liquid 
film of approx. 2 mm. The tubes were rotated at 
25 rpm around the light source. 
Electrophoresis. SDS- polyacrylamide gel electro- 
phoresis was carried out by the method of Laem- 
mli [25] using Raven apparatus (Raven Scientific, 
Haverhill, Suffolk, U.K.) with a 3.6% stacking and 
7.5% resolving gel (195 x 40 x 1.5 mm). 
Chromatography. Gel filtration was performed 
at 4°C on columns (2.6 X 42 cm) of Sephadex 
G -100 fine which were eluted with 0.1 M sodium 
phosphate (pH 7.4) (buffer A). Fractions of 7 ml 
were collected. 
Thin -layer chromatography was performed on 
silica gel 60 plates (5 x 20 cm) and silica gel col- 
umn chromatography in glass columns (2.5 x 90 
cm) using silica gel N- 60-(43 -60 SM), both from 
Merck (Merck, Darmstadt, F.R.G.). The following 
solvent systems were used: 1, ethyl acetate/ 
cyclohexane /acetic acid (23:7:3 v /v); 2, ethyl 
acetate /cyclohexane /acetic acid (100 : 40:1 v /v); 
3, trimethylpentane /isopropyl alcohol /acetic acid 
(120:40:1 v /v); 4, chloroform /methanol /acetic 
acid /water (30 : 10 : 3 : 2 v /v). 
Bile acids were visualised on the TLC plates 
with a freshly prepared solution of glacial acetic 
acid /sulphuric acid /anisaldehyde (100 : 2 :1 v /v). 
Synthesis of 1251- labelled 3ß- azidocholylhistamine 
[23]. A solution of p- toluenesulphonyl chloride (5 
mmol) in absolute pyridine (2 ml) was added (over 
30 min, 0 °C with stirring) to a solution of cholic 
acid (5 mmol) in absolute pyridine (10 ml), also 
containing 2,4- [3H]cholic acid (0.1 tCi, 65 IL mol) 
as tracer. The solution was warmed and stored at 
room temperature for 3 h, the progress of the 
reaction being monitored by TLC in solvent sys- 
tem 1. When complete, the reaction mixture was 
added slowly, with stirring, to 1.5 M hydrochloric 
acid (400 ml) and the precipitate collected by 
filtration and dried in vacuo over silica crystals. 
This material was dissolved in solvent system 1 
and applied to a 2.5 X 70 cm column of silica gel, 
developed with solvent system 1; 1.038 g of 3a- 
toluenesulphonyl cholic acid was recovered (1.85 
mmol, 40% yield). 
The 3a- toluenesulphonyl cholic acid (1.85 
mmol) was dissolved with stirring in a warm solu- 
tion of sodium azide (15.5 mol) in dry dimethyl 
sulphoxide (23 ml) and the resulting solution was 
kept in the dark at 100 °C for approx. 5 h. All 
further work was carried out in dim or red light. 
The progress of the reaction was monitored by 
TLC in solvent system 1 and, when complete, the 
solution was poured with stirring into 1 M hydro- 
chloric acid (500 ml). The resulting precipitate was 
collected by filtration and dried in vacuo over 
silica crystals. The products obtained were purified 
by chromatography on a 2.5 X 70 cm column of 
silica gel, eluted using solvent system 2, yielding 
300 mg of 3ß- azidocholic acid (0.7 mmol, 40% 
yield). 
Addition of histamine and subsequent iodina- 
tion of 3ß- azidocholic acid was carried out accord- 
ing to Beckett et al. [26], TLC in solvent system 4 
being used to separate iodinated from non - 
iodinated conjugate in order to maximise the 
specific radioactivity of the final product. 
'25I- labelled ACH was eluted from the silica gel by 
ethanol and stored in the dark at 4°C. The yield 
was 25 nmol of 125I -ACH with a specific radioac- 
tivity of approx. 1900 Ci /mmol. The iodination 
procedure was used on a 103 -times larger scale 
with unlabelled sodium iodide to synthesise iodo- 
ACH for infrared spectroscopy. The structures of 
the cómpounds involved in the synthesis are shown 
in Fig. 1. 
Stability of '251 -A CH in ultraviolet light. 1251- 
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ACH (10 SCi) in methanol (10 ml) was photolysed 
for varying times (0 -60 min) both with and without 
the borosilicate glass filter. At 0, 5, 10, 20 and 30 
min, portions (50 µl) were removed and spotted on 
to silica gel TLC plates (5 X 20 cm) and developed 
in solvent system 4. After drying, the silica gel was 
divided into 1 cm squares which were scraped into 
vials before counting in a gamma counter. 
Stability of bovine serum albumin in ultra -violet 
light. Bovine serum albumin (98 -99 %, essentially 
fatty acid -free) had endogenous bile acids removed 
by the method of charcoal- stripping and was shown 
to be bile acid -free by radioimmunoassay [27]. 
Portions of bovine serum albumin (100 mg) in 
buffer A (10 ml) were photolysed both with and 
without the glass filter. Portions (50 µl) were re- 
moved from these solutions at timed intervals and 
analysed by SDS- electrophoresis. 
Photolysis of 1251 -A CH with bovine serum al- 
bumin. Bovine serum albumin (98 -99 %, essentially 
fatty acid free) had endogenous bile acids removed 
by the method of charcoal -stripping and was shown 
to be bile acid -free by radioimmunoassay [27]. 
Portions of bovine serum albumin (100 mg) in 
buffer A (10 ml) were photolysed in the presence 
of 125I -ACH (10 p.Ci, 5 pmol), both with and 
without the glass filter. Portions (50 µl) were re- 
moved from these solutions at timed intervals and 
analysed by SDS -electrophoresis. After staining, 
the gel tracks were cut out, sliced into 0.5 cm 
pieces and the amount of 1251 -ACH associated 
with each was determined. In addition, the 60 min 
sample in each case was applied to a column of 
Sephadex G -100 fine (2.6 x 42 cm). 
Hepatic transport of '251 -ACH. Wistar rats, 
150 -250 g, fed ad libitium, were anaesthetised 
with diethyl ether and the common bile duct was 
cannulated with nylon tubing (i.d. 0.1 mm). The 
test solutions were injected into the superior 
mesenteric vein in 150 mM saline (75 µl) contain- 
ing approx. 20% ethanol (v /v). Bile was collected 
at 1 min intervals in pre -weighed tubes and the 
radioactivity counted. For detection of the 125I- 
labelled derivative, the bile samples were counted 
directly, whereas 14C-labelled bile acids were 




The structures of the starting material (A) and 
intermediate products (B -D) and 1251 -ACH (E) 
are shown in Fig. 1. The formation of the 3a- 
toluenesulphonyl derivative of cholic acid was 
demonstrated on TLC and confirmed by infrared 
spectroscopy. A characteristic peak at 1705 cm- 
confirmed that the saturated ketone (C = O) from 
the carboxylic side -chain of the bile acid was still 
present. Formation of the 3ß -azido derivative of 
cholic acid was also demonstrated by a change in 
the mobility of the substrate on TLC. Infrared 
spectroscopy confirmed the incorporation of the 


















Fig. 1. A, 3a, 7a, 12a- trihydroxy- 5ß- cholan- 24 -oic acid (cholic 
acid); B, 3a- toluenesulphonyl cholic acid; C, 3ß- azidocholic 
acid; D, 3ß- azidocholylhistamine; E, 1251- labelled 3ß- 
azidocholylhistamine. 
cm -1 peak, and also showed the retention of the 
1705 cm- I peak for the bile acid side -chain. The 
data from TLC mobilities, melting points and 
ultraviolet scan were all consistent with those of 
Kurz and Gerok [23]. The NMR spectra con- 
firmed the final structure of the molecule. 
The third stage of the synthesis involves the 
histamination and subsequent iodination of the 
3ß- azidocholic acid, shown on TLC, and the azido 
(N3) group demonstrated on infrared. 
Stability of 1251 -ACH. The stability of the pho- 
tolabile derivative during photolysis was assessed. 
A solution of 125I -ACH was exposed to ultraviolet 
light both with and without the borosilicate glass 
filter which provided a wavelength cut -off at ap- 
prox. 300 nm. In both cases the photolysis led to a 
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Fig. 2. Photolysis, with and without filter, of 1251- labelled 
3ß- azidocholylhistamine (5 pmol, 10 µCi) in buffer A. Samples 
were run on TLC, solvent system 4. 
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the derivative (RE. 0.79) and an increase of radio- 
activity at the origin or at a point close to but 
clearly different from the origin (RF 0.21, see Fig. 
2). With no filter in position, the loss of radioactiv- 
ity was rapid, the majority of the radioactivity 
appearing at the origin. This is consistent with the 
mobility of free iodide. About 20% of the radioac- 
tivity appeared at a position corresponding to that 
of iodinated histamine (RF 0.2). With the filter in 
position, the loss of radioactivity was slower; ap- 
prox. 40% of the radioactivity was still at the 
position of the original bile acid derivative after 30 
min. In this case, no free iodide was detected, all 
of the released radioactivity being at a position 
consistent with that of iodinated histamine (RF 
0.2). 
Stability of protein during photolysis. When bile 
acid -free bovine serum albumin was photolysed 
under similar conditions, light below 300 nm 
proved to be more destructive. On SDS- electro- 
phoresis, less than 10% of the bovine serum al- 
bumin retained the correct electrophoretic mobil- 
ity after 60 min photolysis without the filter, 
whereas more than 90% remained with the filter in 
place (Fig. 3). 
Photolysis of '251 -ACH with bovine serum al- 
bumin. A solution of bile acid -free bovine serum 
albumin incubated with 125I -ACH which was pho- 
tolysed both with and without the filter for 60 min 
was analysed by gel filtration (Fig. 4A and B). In 
the presence of the filter, the 125I label was associ- 
ated with the bovine serum albumin peak (Mr 
approx. 70 kDa), and unreacted label was found in 
the salt volume of the column (Mr < 1000 Da). 
However, without the filter, the radioactivity was 
found with a higher molecular mass peak (Mr 150 
A 




Fig. 3. Photolysis, with (A) and without (B) filter, of bile 
acid -free bovine serum albumin in buffer A. Tracks 1 and 7, 
control (unphotolysed) bovine serum albumin. Tracks 2 -6, 
bovine serum albumin photolysed for 5, 10, 20, 30 and 60 min, 
respectively. 
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Fig. 4. Gel filtration on Sephadex G -100 fine of photolysed (60 
min, no filter and filter) bovine serum albumin samples (A and 
B) and control (C). Bile acid -free bovine serum albumin (5 ml, 
10 mg /ml) and 1251- labelled 3ß- azidocholylhistamine (2.5 pmol 
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Fig. 5. SDS -electrophoresis of photolysis (filter and no filter) 
samples and control. Bile acid -free bovine serum albumin (10 
ml, 10 mg /m1) and 125I- labelled 3ß- azidocholylhistamine (5 
pmol 10 p.Ci). Insets show bovine serum albumin band after 60 
min photolysis. 
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kDa), the result of photolytic- mediated aggre- 
gation of the protein. Again, unreacted label was 
found in the salt volume of the column. A mixture 
of bovine serum albumin and 1251 -ACH was passed 
down the column (Fig. 4C) without prior photol- 
ysis, and served as a control. 
The labelling of bovine serum albumin with 
125I -ACH was also investigated by SDS- electro- 
phoresis. Fig. 5 shows the incorporation of 1251 
into the bovine serum albumin band after photol- 
ysis both with and without the filter for times 
between 0 and 60 min. Labelling of bovine serum 
albumin was greater when the filter was used. 
With no filter, 1251 was found in high and low 
molecular weight bands at the top and bottom of 
the gel, respectively. 
Hepatic transport of '251 -ACH. 125I -ACH and 
14C- labelled taurocholate were injected simulta- 
neously into the superior mesenteric vein following 
bile duct cannulation. For both bile acids, radioac- 
tivity first appeared after approx. 3 min (Fig. 6). 
However, although the maximum of 14C- labelled 
taurocholate excretion was slightly earlier (6 min) 
than that of 125I -ACH (8 min), the overall excre- 
tion profiles of the two compounds were very 
similar. 
10 20 30 
Time (minutes) 
Fig. 6. Biliary excretion of 125I- labelled 3ß- azidocholyl hista- 
mine and 14C- labelled taurocholate after injection (125 fmol, 
0.25 µCi and 0.8 nmol, 0.5 p.Ci, respectively) in 154 mM saline 
(75 Al) with 15% ethanol (v /v) into the superior mesenteric 
vein. 14C, x - --x; 1251, . 
Discussion 
The introduction of a photolabile azido group 
into the cholic acid molecule has resulted in a 
compound with a wide range of applications as a 
photoaffinity probe. Conjugation of this molecule 
with histamine and subsequent iodination yields 
the high specific radioactivity (approx. 1900 
Ci /mmol) necessary to investigate bile acid -bind- 
ing to cytosolic proteins in the liver. 
It is essential that this compound is handled by 
the liver in a similar manner to physiological bile 
salts in order to be able to relate experimental 
results with the photoaffinity probe to events oc- 
curring within the hepatocyte. The studies with rat 
liver demonstrate that 125 í- labelled 3ß- azidocho- 
lylhistamine is cleared from the liver and excreted 
into bile in a manner which closely resembles that 
of the natural bile salt, taurocholate. A similar 
molecule, 131I 125I- or 1231- cholylglycylhistamine 
has been used by several groups [28 -30] in experi- 
ments to demonstrate hepatic uptake and excre- 
tion and to show the existence of a hepatic con- 
centration gradient for bile acid uptake in rats. In 
each case, hepatic handling of the bile salt deriva- 
tive was similar to physiological bile salts. Indeed, 
Grandjean et al. [30] have suggested that the side - 
chain of a bile acid molecule need not possess an 
anionic charge in order to be taken up and ex- 
creted by the liver, as had previously been pro- 
posed for intestinal transport [1]. 
The results of the study in which 1251 -ACH was 
photolysed alone showed that the wavelength of 
light used is important. With light below 300 nm, 
destruction of the derivative was rapid, resulting 
mainly in the release of free iodide, but also, to a 
smaller extent, in the release of iodinated hista- 
mine, due to breakage of the internal peptide bond 
of the derivative between the steroid ring structure 
and the histamyl moiety. However, with light above 
300 nm, destruction of the derivative was much 
slower, the breakdown occurring by release of 
iodinated histamine only. This information, to- 
gether with the results of the test photolysis of bile 
acid -free bovine serum albumin with 125I -ACH, 
would suggest that the derivative can be employed 
as a photoaffinity label, and that irradiation should 
be carried out, as it has been by other groups 
[6,11,24], with light above 300 nm. However, the 
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TABLE I 





a a max E 1H 13C 
Cholic acid 0.19/0.02 1705 cm-1 
(C = O) 
3a- Toluenesulphonyl 
cholic acid 
0.86/0.54 1705 cm-' 
(C=0) 
C2HC13 S = DMSO-d6 S 
3ß- Azidocholic acid 209-212 0.85/0.39 220 nm 262 2105 cm-' (N3) 0.7 (S, CH3-18) 174.9 (CO2H) 
285 nm 45 1700 cm-' 0.92 (S, CH3 -19) Total = 24 C atoms 
(C=0) 0.97 ( d,J = 6Hz, 
CH3-21) 
C = 3 
CH = 9 
C1-12 = 9 
CH3= 3 
24 
125I- labelled 3ß- azidocholyl 
histamine 
0.68/0.82 2100 cm-1 (N3) 
1570 cm-2 
a Data are RF values in solvent system 1 /solvent system 2. 
maxima of ultraviolet absorption of the derivative 
are at 220 and 285 nm (Table I) and the most 
efficient photolysis should be affected at these 
wavelengths. 
The photolysis was more successful with light 
above 300 nm, as judged by the greater incorpora- 
tion of radioactivity observed in the bovine serum 
albumin band on SDS- electrophoresis (Fig. 5). 
However, using light below 300 nm, the bovine 
serum albumin was broken down more rapidly, 
which may partly explain the lower incorporation 
of 125I. The fact that photolysis has occurred at all, 
when the ultraviolet absorption maxima of the 
derivative lie below 300 nm, is probably due to the 
absorption of light by the molecule at the long - 
wavelength tail of its 285 nm maximum, which is 
sufficient to stimulate the photolabile azido group. 
This has been discussed in more detail recently 
[31]. 
These studies have shown that the new deriva- 
tive of cholic acid, with very high specific radioac- 
tivity, is suitable for photoaffinity labelling stud- 
ies, being linked covalently to protein. The deriva- 
tive is also handled effectively as a bile salt by the 
liver. Experiments with 125I -ACH using rat liver 
cytosolic proteins are being performed. 
Acknowledgements 
Colin J. Henderson thanks the University of 
Edinburgh for a Faculty of Medicine Scholarship. 
We thank Dr. I. Gosney of the Chemistry Depart- 
ment, University of Edinburgh for 'H and '3C 
NMR spectra and Dr. J.E.T. Corrie, Teaching and 
Research Unit, Western General Hospital, Edin- 
burgh, for advice. We are greatly indebted to 
Professor G. Kurz, Chemisches Laboratorium der 
Universtat Freiburg, D -7800, Freiburg, F.R.G., for 
generously sending us a copy of his paper before 
its publication. We also thank Professor L.G. 
Whitby and Dr. J.D. Hayes for critically reading 
this manuscript and Mrs. E. Ward and Mrs. C. 
Veitch for their secretarial assistance. 
References 
1 Wilson, F.A. and Treanor, L.L. (1975) Biochim. Biophys. 
Acta 406, 280 -293 
2 Wilson, F.A. (1981) Am. J. Physiol. 241, 083 -92 
3 Van Dyke, R.W., Stephens, J.E. and Scharschmidt, B.F. 
(1982) Am. J. Physiol. 243, G484 -492 
4 Reichen, J. and Paumgartner, G. (1976) Am. J. Physiol. 231, 
734 -742 
5 Blitzer, B.L., Rataash, S.l.., Donovan, C.B. and Boyer, J.)`. 
(1982) Am. J. Physiol. 243, G48 -53 
6 Kramer, W., Burckhardt, G., Wilson, F.A. and Kurz, G. 
(1983) J. Biol. Chem. 258, 3623 -3627 
264 
7 Anwer, M.S., Kroker, R., Hegner. D. and Petter, A. (1978) 
Hoppe -Seyler's Z. Physiol. Chem. 358. 543 -553 
8 Anwer, M.S., Kroker, R., and Hegner, D. (1976) Hoppe - 
Seyler's Z. Physiol. Chem. 357, 1477 -1486 
9 Accatino, L. and Simon, F.R. (1976) J. Clin. Invest. 57, 
496 -508 
10 Ohkima, S. and Kuriyama, K. (1982) Steroids 39, 7 -21 
11 Kramer, W., Bickel, U., Buscher, H.P., Gerok, W. and 
Kurz, G. (1982) Eur. J. Biochem. 129, 13 -24 
12 Strange, R.C. (1981) Hepatic bile salt transport. Biochem. 
Soc. Trans. 9, 170 -174 
13 Hayes, J.D., Strange. R.C. and Percy -Robb, I.W. (1979) 
Biochem. J. 181, 699 -708 
14 Hayes, J.D., Strange, R.C. and Percy -Robb, I.W. (1980) 
Biochem. J. 185, 83 -87 
15 Levi, A.J., Gatmaitan, Z. and Arias, I.M. (1969) J. Clin. 
Invest. 48, 2156 -2167 
16 Ockner, R.K., Manning, J.A., Poppenhausen, R.B. and Ho, 
W.K.L. (1972) Science 177, 56 -88 
17 Ketterer, B., Tipping, E., Hackney, J.F. and Beale. D. 
(1976) Biochem. J. 155, 511 -521 
18 Dempsey, M.E., McCoy, K.E., Baker, H.N., Dmitriadou- 
Vafiadou, A., Lorsbach, T. and Howard, J.B. (1981) J. Biol. 
Chem. 256, 1867 -1873 
19 Sugiyama, Y., Yamada, T. and Kaplowitz, N. (1983) J. Biol. 
Chem. 258, 3602 -3607 
20 Singh. A.. Thornton, E.R. and Westheimer, F.H. (1962) J. 
Biol. Chem. 237, 3006 -8 
21 Chowdhry, V. (1979) Annu. Rev. Biochem. 48, 293 -325 
22 Bayley, H. and Knowles, J.R. (1977) Methods Enzymol. 46, 
69 -114 
23 Kurz, G. and Gerok, W. (1983) J. Lip. Res. 24, 910 -923 
24 Von Dippe, P., Drain, P. and Levy, D. (1983) J. Biol. Chem. 
258, 8890 -8895 
25 Laemmli, U.K. (1970) Nature (London) 227, 680 -685 
26 Beckett, G.J., Corrie, J.E.T. and Percy -Robb, I.W. (1979) 
Clin. Chim. Acta 93, 145 -150 
27 Beckett, G.J., Hunter, W.M. and Percy -Robb, I.W. (1978) 
Clin. Chim. Acta 88, 257 -266 
28 Spenny, G.J., Tobin, M.M., Mihas, A.A., Gibson, R.G., 
Hirschowitz, B.I., Johnson, B.J. and Tauxe, W.N. (1978) 
Gastroenterology 76, 272 -278 
29 Jones, A.L., Hradek, G.T., Renston, R.H., Wong, K.Y., 
Karlaganis, G. and Paumgartner, G. (1980) Am. J. Physiol. 
238, G233 -237 
30 Grandjean, E.M., Karlaganis, G., Noelpp, U., Hwegli, H., 
Roesler, H. and Paumgartner, G. (1978) in The Liver -3rd 
International Gstaad Symposium (Preisig, R. and Paum- 
gartner, G., eds.), Edition Cantor, pp. 255 -262, Aulendorf, 
F.R.G. 
31 Nielsen, P.E., Hansen, J.B., Thomsen, T. and Buchardt, O. 
(1983) Experientia 39, 1063 -1072 
